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6ABSTRACT
Stroke is one of the leading causes of mortality and the loss of quality life years
worldwide. Ischemic stroke is a vascular disease that is characterized by insufficient
flow of blood to brain tissue. In general, stroke results from the occlusion of an
intracranial artery by a thrombus. Therapeutic interventions are aimed at restoring
the normal circulation and limiting the extent of irreversible damage. Thus,
therapies that elicit reperfusion, such as intravenous thrombolysis (IVT) and intra-
arterial interventions, are of special interest. Imaging has a central role in the
evaluation of acute-stroke patients. It enables the detection of intracranial
hemorrhage, the approximation of the volume of reversible and irreversible
ischemic changes and provides information on cerebral vasculature. These data can
be used to predict the clinical outcome and the risk of hemorrhagic complications
and to triage the patients to different therapeutic approaches. Multimodal computed
tomography CT, especially parameters derived from CT angiography (CTA) and CT
perfusion (CTP) studies, holds promise for achieving these goals with increased
precision.
This thesis examined, in a retrospective, observational cohort, the utility and the
predictive performance of imaging parameters derived from CTA and CTP scans
obtained upon admission  in the evaluation of acute (less than 3 h from the onset of
the symptoms) ischemic stroke patients who received IVT during the years 2004 to
2007. The 3-month functional outcome was the main prognostic end point. The
parameters studied included the Alberta Stroke Program Early CT Score
(ASPECTS) that was assigned to different CTP maps and the CTP ASPECTS
mismatch, the Boston Acute Stroke Imaging Scale (BASIS), the Clot Burden Score
(CBS), and the location of the clot. In addition, two modified imaging parameters
(M1-BASIS and CBSV) were introduced. The quality of CTP scans using scanners
with detector widths of either 16 or 64 rows was also investigated.
7The CTP ASPECTS parameters were found to detect reversible ischemia and to
correlate with the clinical outcome. The CTP ASPECTS mismatch adequately
identified the amount of potentially salvageable tissue. CBS, BASIS and the
cerebral blood volume (CBV) ASPECTS scores were statistically robust and
sensitive but unspecific predictors of a favorable clinical outcome. The two
modified imaging parameters, CBSV and M1-BASIS, shared these same properties
and appeared to provide slightly improved prognostic accuracy. The functional
outcomes of an acute internal carotid artery (ICA) occlusion and/or a proximal M1
segment of the middle cerebral artery (MCA) occlusion were typically found to be
poor even if treated with IVT. A cut-point between the proximal and the distal M1
segments showed the highest accuracy in discerning favorable from poor clinical
outcome. CTP scans performed using a 16-row scanner were significantly less
sensitive in the detection of perfusion defects in the cranial parts of the MCA region
compared with a 64-row scanner. The 16-row scans showed more uncorrected
motion artifacts that resulted from periodic small-scale patient movements.
Overall, the parameters derived from the multimodal CT provided added value in
the evaluation of acute ischemic stroke.
Keywords: ASPECTS, Boston Acute Stroke Imaging Scale, Clot Burden Score,
computed tomography perfusion, computed tomography angiography, stroke,
thrombolytic therapy.
8TIIVISTELMÄ
Aivoverenkiertohäiriö (AVH) on eräs merkittävimpiä kuolemaan johtavia tai
elämän laatua heikentäviä kansansairauksia. Iskeeminen AVH eli aivoinfarkti
aiheutuu riittämättömästä veren virtauksesta aivokudoksessa. Yleisimmin tämä
johtuu kallon sisäisen valtimon tukkeutumisesta verihyytymän vuoksi. Aivoinfarktin
hoito tähtää normaalin verenkierron palauttamiseen ja palautumattoman
kudosvaurion rajoittamiseen. Näin ollen tukkeutuneen verisuonen avaamiseen
perustuvat hoidot, kuten laskimonsisäinen liuotushoito ja valtimonsisäiset
toimenpiteet, ovat avainasemassa. Lääketieteellisellä kuvantamisella on keskeinen
rooli akuutin aivoverenkiertohäiriön diagnostisessa selvittelyssä. Kuvantaminen
mahdollistaa aivoverenvuodon toteamisen, palautuvien ja palautumattomien
iskeemisten muutosten laajuuden arvioimisen sekä verisuonen tukoksen
paikantamisen. Näitä tietoja käytetään ennusteen määrittämiseen, komplikaatioiden
todennäköisyyden arviointiin ja hoidon valintaan. Multimodaalisen
tietokonetomografiatutkimuksen erityisesti angiografia- ja perfuusio-
osatutkimuksiin (CTA ja CTP) perustuvat tunnusluvut mahdollisesti helpottavat
näiden tavoitteiden saavuttamista.
Tässä väitöstutkimuksessa tarkasteltiin retrospektiivisessä asetelmassa akuutisti
(oireiden alkamisesta alle kolme tuntia) aivoinfarktioireistoon sairastuneiden,
laskimonsisäisen liuotushoidon saaneiden potilaiden kohorttia vuosilta 2004–2007.
Tutkimuksen tavoitteena oli selvittää akuutin vaiheen CTA- ja CTP-kuvauksista
saatujen muuttujien ominaisuuksia ja hyödyllisyyttä aivoinfarktin ennusteen
arvioinnissa. Näitä muuttujia olivat CTP-karttoihin sovellettu Alberta Stroke
Program Early CT Score (ASPECTS) -pisteytys, CTP ASPECTS -poikkeama,
Boston Acute Stroke Imaging Scale (BASIS) -pisteytys, Clot Burden Score (CBS) -
pisteytys ja verisuonen tukoksen sijainti. Pisteytyksistä muokattiin kaksi uutta
muuttujaa vastaavaa tarkastelua varten. Ennustemuuttujana käytettiin kolmen
9kuukauden kohdalla arvioitua potilaan funktionaalista tilaa. Lisäksi vertailtiin 16- ja
64-leikelaitteilla tehtyjen CTP-tutkimusten laatua.
CTP ASPECTS -muuttujat mahdollistivat palautuvien ja palautumattomien
iskeemisten muutosten määrällisen arvioinnin ja korreloivat funktionaalisen
lopputuloksen kanssa. CBS, BASIS ja aivojen veritilavuuskartan (CBV) ASPECTS-
pisteytys olivat tilastollisesti merkitseviä ja herkkiä, mutta epätarkkoja hyvän
funktionaalisen lopputuloksen ennustamisessa. Kahdella muokatulla pisteytyksellä,
joille annettiin nimet CBSV ja M1-BASIS, oli vastaavat ominaisuudet, mutta
hieman parempi ennustearvo. Sisemmän kaulavaltimon distaaliosien ja
keskimmäisen aivovaltimon M1-segmentin proksimaalipuoliskon tukosten todettiin
johtavan huonoon lopputulokseen laskimonsisäisestä liuotushoidosta huolimatta;
M1-segmentin puoliväli erotteli tarkimmin hyvän ja huonon funktionaalisen
lopputuloksen. 16-leikelaitteella tehtyjen CTP-tutkimusten herkkyys havaita
perfuusiohäiriö oli merkitsevästi huonompi 64-leikelaitteella tehtyihin tutkimuksiin
verrattuna erityisesti keskimmäisen aivovaltimon suonitusalueen yläosissa. Lisäksi
16-leikelaitteella tehdyissä tutkimuksissa oli enemmän potilaan vähäisistä liikkeistä
johtuvia, tulkintaa vaikeuttavia häiriöitä.
Yhteenvetona, multimodaalisen tietokonetomografiatutkimuksen avulla saatavilla
muuttujilla on lisäarvoa akuutin aivoverenkiertohäiriön diagnostisessa arvioinnissa.
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ABBREVIATIONS
2D two-dimensional
3D three-dimensional
A1 A1 segment of the anterior cerebral artery
ACA anterior cerebral artery
AComm anterior communicating artery
ADC apparent diffusion coefficient
AFL activities of daily living
AHA American Heart Association
AIF arterial input function
AIS acute ischemic stroke
ASPECTS Alberta Stroke Program Early CT Score
ATLANTIS Alteplase Thrombolysis for Acute Noninterventional Therapy in
Ischemic Stroke
AUC area under the curve
AVH aivoverenkiertohäiriö
BASIS Boston Acute Stroke Imaging Scale
CBF cerebral blood flow
CBS clot burden score
CBV cerebral blood volume
CCS causative classification system for ischemic stroke
CECT contrast-enhanced computed tomography
CI confidence interval
CT computed tomography
CTA computed tomography angiography
CTA-SI CTA source images
CTP computed tomography perfusion
DEFUSE Diffusion-weighted imaging Evaluation For Understanding Stroke
Evolution
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?mRS delta-mRS, change in mRS (postictal vs. preictal)
DIAS Desmoteplase in Acute Ischemic Stroke
DSA digital subtraction angiography
DWI diffusion-weighted imaging
ECASS European Cooperative Acute Stroke Study
EIC early ischemic change
EMS Emergency Management of Stroke
EPITHET Echoplanar Imaging Thrombolytic Evaluation
FDA Food and Drug Administration
FLAIR fluid-attenuated inversion recovery
GRE gradient echo
H-L Hosmer-Lemeshow
IAT intra-arterial thrombolysis
ICA internal carotid artery
IMS Interventional Management of Stroke
IS ischemic stroke
IST-3 the Third International Stroke Trial
IVT intravenous thrombolysis
HMCAS the hyperdense MCA sign
M1 M1 segment of the middle cerebral artery
M1D distal M1 segment of the middle cerebral artery
M1P proximal M1 segment of the middle cerebral artery
M2 M2 segment of the middle cerebral artery
M3 M3 segment of the middle cerebral artery
MCA middle cerebral artery
MERCI Mechanical Embolus Removal in Cerebral Ischemia
MIP maximum intensity projection
MRI magnetic resonance imaging
MTT mean transit time
NCCT non-contrast (enhanced) computed tomography
NIHSS National Institutes of Health stroke scale
NINDS National Institute of Neurological Disorders and Stroke
NNT number needed to treat
mRS modified Rankin Scale
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MRS Merci Retrieval System
OR odds ratio
PCA posterior cerebral artery
PComm posterior communicating artery
PET positron emission tomography
PROACT Prolyse in Acute Cerebral Thromboembolism
PS Penumbra System
PWI perfusion-weighted imaging
ROC receiver-operating characteristic curve
r-proUK recombinant prourokinase
RR risk ratio
r-tPA recombinant tissue plasminogen activator
SARIS Stent-Assisted Recanalization in Acute Ischemic Stroke
sICH symptomatic intracranial hemorrhage
SITS-ISTR Safe Implementation of Thrombolysis in Stroke–International Stroke
Treatment Registry
SSS Scandinavian stroke scale
TOAST trial of org 10172 acute stroke treatment
tPA tissue plasminogen activator
TTP time to peak
VOF venous output function
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1. INTRODUCTION
Stroke is the second-leading cause of death in adults aged 15 years and over
worldwide, the fourth-leading cause of disease burden as measured in disability-
adjusted life years, and the leading cause of acquired disability in adults in most
regions 1, 2. Globally, an estimated 5.7 million people died as a result of a stroke in
2005 2. The estimated direct medical cost of stroke in the United States was $25
billion in 2007 3. In Finland, the yearly medical expenses caused by stroke care are
estimated to be $1.6 billion, which is 7% of all healthcare expenditures 4.
Ischemic stroke is a vascular disease that is caused by insufficient flow of blood to
the brain tissue. In general, stroke results from a thrombotic occlusion of an
intracranial artery. Reperfusion following recanalization or bypass of the occlusion,
or improved collateral flow is a necessary but not sufficient condition for a
favorable clinical outcome with the time from the onset of ischemia to the
reperfusion being a pivotal determinant 5. Thus, therapies that target the
prerequisites of reperfusion, such as intravenous thrombolysis (IVT) and intra-
arterial interventions, are of special interest.
Imaging has a central role in the evaluation of patients with acute stroke. Typically,
a multimodal CT or stroke MRI is performed. Both methods enable the detection of
intracranial hemorrhage, allow the approximation of the extent of reversible and
irreversible ischemic changes and provide anatomical information on the cerebral
and cervical vasculature 6, 7. These data can be used to predict the clinical outcome
and the risk of hemorrhagic complications and to triage the patients to different
therapeutic approaches. Multimodal CT, especially parameters derived from CT
angiography (CTA) and CT perfusion (CTP) studies, holds promise in achieving
these goals with increased accuracy 8, 9.
15
This thesis examines, in a retrospective, observational cohort, the utility and the
prognostic performance of imaging parameters derived from CTA and CTP studies
in the evaluation of acute (< 3 h) ischemic stroke patients receiving IVT. These
parameters include ASPECTS assigned to different CTP maps, the Boston Acute
Stroke Imaging Scale (BASIS), the Clot Burden Score (CBS) and the location of the
clot. Two modified imaging parameters are introduced. The quality of CTP studies
with scanners of different detector widths is also investigated.
16
2. REVIEW OF THE LITERATURE
2.1 Acute ischemic stroke
2.1.1 Pathophysiology and etiology
The symptoms and the imaging and histopathologic findings following ischemic
stroke result from insufficient flow of blood to the brain parenchyma. Most
commonly, this reduction in blood flow is caused by an occlusion of an arterial
branch supplying a part of the brain in the absence of adequate collateral circulation.
Systemic factors, such as hypoperfusion because of sustained severe hypotension,
can also lead to irreversible ischemic damage in the brain tissue. An occlusion of a
blood vessel is typically due to arterial or paradoxical embolism, due to a local
thrombotic event that is triggered by rupture of an atherosclerotic plaque or due to
prothrombotic conditions (Figure 1). The Trial of Org 10172 Acute Stroke
Treatment (TOAST) classification and its variants (SSS-TOAST, CCS) define five
major etiological subtypes of ischemic stroke 10-12:
1. large-artery atherosclerosis (19%)
2. cardioembolism (9%)
3. small-vessel occlusion (44%)
4. stroke of another determined etiology (5%)
5. stroke of an undetermined etiology (22%)
The proportion of patients in each etiological category varies greatly between
different reports and depends on the population studied and the sophistication of the
diagnostic procedures. The above percentages are averages based on a large,
worldwide study 13. When only high-income countries are considered, the
proportion of cardioembolism is higher (26%), whereas that of small-vessel disease
is lower (30%). Overall there is a trend toward a higher incidence of
17
cardioembolism and large-artery atherosclerosis (including arterio-arterial
embolism) in Western countries.
If the reduction in blood flow is of sufficient severity and duration, a series of events
occurs at the cellular level that leads to irreversible changes. These events include
the release of excitatory neurotransmitters and inflammatory mediators, influx of
calcium to the cells, the generation of free-oxygen radicals, the depolarization of the
cellular membrane, and the loss of the membrane integrity 14, 15. A concept of the
neurovascular unit comprising neurons, astrocytes, microglial cells, and
microvascular structures has emerged recently in the study of ischemic injury 15.
The interactions and signaling between these components appears to play a pivotal
role in the response of the tissue to the ischemic insult 16. If adequate blood supply is
not restored in the appropriate time, the affected tissue becomes infarcted,
undergoes necrosis and shows scarring with accompanying, potentially permanent
neurological deficits 17.
Figure 1: A thrombotic mass (black arrow) occluding the distal M1 segment of the
middle cerebral artery. Adapted from the Heart and Stroke Foundation of Canada,
www.heartandstroke.ca.
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2.1.2 Risk factors
Numerous risk factors for stroke have been identified. The main risk factor is age
with each year of age after the age of 19 showing an increased risk of stroke of 9%
for men and 10% for women, on average 18. Other key non-preventable risk factors
include the male gender, a family history of strokes and a previous stroke. In a large
worldwide study, ten preventable risk factors— hypertension, current smoking, high
waist-to-hip ratio, poor diet, lack of physical activity, diabetes mellitus, high alcohol
intake, psychosocial stress and depression, cardiac disease (especially atrial
fibrillation) and an unfavorable lipid profile— contributed 90.3% of the total risk in
a multivariate model 13. In general, risk factors tend to have a greater impact at
younger ages 18.
2.1.3 Vascular anatomy and vascular territories
The cerebral vasculature is divided into the anterior circulation, which is formed
intracranially by the middle cerebral arteries (MCA) and the anterior cerebral
arteries (ACA), and the posterior circulation that comprises the basilar artery, its
end-arteries in the posterior fossa and the posterior cerebral arteries (PCA) in the
supratentorial space (Figure 2). The vessels are often divided into numbered
segments on the basis of their branching pattern, as demonstrated for MCA in
Figure 2D. The anterior circulation is supplied by the internal carotid arteries (ICA),
and the posterior circulation is supplied by the vertebral arteries (VA). Typically,
there are several interconnecting vessels that allow collateral flow between the
anterior and the posterior circulation, most notably the anterior and the posterior
communicating arteries (AComm and PComm) that form the circle of Willis
together with parts of the ACA, ICA and PCA vessels 19. The vascular anatomy
gives rise to vascular territories, i.e., volumes of brain tissue supplied by a certain
vascular trunk in near end-artery fashion (Figure 3). Stroke symptoms correlate with
the vascular territories affected by the stroke 20-23.
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Figure 2: CT angiography maximum-intensity projection (MIP) images of the main
blood vessels of the brain. The anterior circulation is demonstrated in panels A
through D. Panel A depicts the anterior cerebral arteries (small arrows); Panels B
and C, the middle cerebral arteries (large arrows). Panel D is an inset to Panel C
featuring the left middle cerebral artery (MCA). The posterior circulation is
demonstrated in Panels E and F with Panel E depicting the distal parts of the right
distal posterior cerebral artery and Panel F, the proximal parts along with the basilar
artery (dashed arrows). In panel D, the left MCA is divided into segments
comprising the proximal M1 segment (M1P), the distal M1 segment (M1D), the M2
20
segment (M2) and the M3 segment (M3). The supraclinoid portion of the internal
carotid artery (ICA) is also marked.
Figure  3: The supratentorial vascular territories of the brain. Image adapted from
www.eMedicine.com.
2.1.4 Epidemiology and socioeconomic impact
Epidemiological and health economics data often do not differentiate ischemic from
hemorrhagic stroke. According to a recent global study, 87% of strokes are ischemic
in origin 3. In the following text, both stroke subtypes are addressed together unless
stated otherwise.
As stated above, stroke is the second-leading cause of death (10% of all deaths) in
adults aged 15 years and over worldwide, the fourth-leading cause of disease burden
as measured in disability-adjusted life years, and the leading cause of acquired
disability in adults in most regions 1,  2. An estimated 5.7 million people died as a
21
result of a stroke in 2005 2. Stroke accounts for approximately 6% of deaths in the
United States and 8% of male and 12% of female deaths in Finland 3, 24. The mean
early (one month) case fatality was 14.3% in developed countries in the years 2000
through 2008 25. During extended follow-up, other causes of death then begin to
take precedence 26.
In a meta-analysis by Feigin et al., the age-standardized prevalence of stroke for
people aged 65 years or older ranged from 46 to 73 per 1000 (men: 59 to 93 per
1000; women: 32 to 62 per 1000) 25. The authors reported that the incidence
increased progressively with each decade of life. The age-standardized incidence for
people aged 55 years or older was in the range of 4.2 to 6.5 per 1000 person-years.
In Finland, the incidences in the year 2002 were 2 per 1000 person-years for people
aged 25 to 74 years, 16 per 1000 person-years for people aged 75 to 84 years, and
30 per 1000 person-years for people aged 85 years and over 24. In developed
countries, the incidence has declined in recent decades, whereas developing
countries are experiencing a stroke epidemic 25.
The estimated direct medical cost of stroke in the United States was $25 billion in
2007 3. In Finland, every fourth stroke patient belongs to the labor force, which
incurs an annual loss of 16500 labor-years 27. The yearly medical expenses caused
by stroke care are estimated to be $1.6 billion, which is 7% of all healthcare
expenditures 4. The estimated mean lifetime costs of ischemic stroke are $130000 4.
2.1.5 Functional outcome measures
The majority (64%) of the contemporary stroke trials use modified Rankin scale
(mRS) evaluations at different time points (1-, 3-, or 6-month mRS) as the
functional outcome measure 28. This scoring system is depicted in Table 1. The
score is often dichotomized using the threshold ? 2 (“good clinical outcome”) or ? 1
(“excellent clinical outcome”) to facilitate statistical analyses. Another commonly
used (41%) outcome measure is the Barthel activities of daily living (ADL) index 28.
The dichotomization cut-off for the Barthel index is typically ? 90 points.
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Table 1: The modified Rankin scale (mRS). mRS is a 6-point scale, with higher
scores indicating a worse functional outcome.
2.1.6 Symptoms, signs and diagnosis
A diagnosis of acute ischemic stroke is based on history, general physical and
neurological examination and imaging findings 24, 29. Laboratory and cardiac tests
have a minor role in diagnostics and are typically used to rule out stroke mimics, to
detect comorbid conditions and in part to determine eligibility for revascularization
therapies. The symptoms and findings of the neurological examination are best
evaluated, quantified and communicated when using a standardized, formal stroke
scale 30-32. The National Institutes of Health Stroke Scale (NIHSS) is the most
widely used formal scoring system 33. NIHSS essentially captures and quantifies the
stroke symptoms and the neurological signs and findings (Table 2). The role of CT
imaging in the diagnosis of acute stroke is detailed in section 2.2.
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Category Score/Description
1a. Level of Consciousness (LOC) 0 = Alert
1 = Drowsy
2 = Stuporous
3 = Coma
1b. LOC Questions
(Month, age)
0 = Answers both correctly
1 = Answers one correctly
2 = Incorrect
1c. LOC Commands
(Open/close eyes, make fist/let go)
0 = Obeys both correctly
1 = Obeys one correctly
2 = Incorrect
2. Best Gaze
(Eyes open – patient follows examiner’s finger
or face)
0 = Normal
1 = Partial gaze palsy
2 = Forced deviation
3. Visual Fields
(Introduce visual stimulus/threat to patient’s
visual field quadrants
0 = No visual loss
1 = Partial hemianopia
2 = Complete hemianopia
3 = Bilateral hemianopia (blind)
4. Facial Paresis
(Show teeth, raise eyebrows and squeeze eyes
shut)
0 = Normal
1 = Minor
2 = Partial
3 = Complete
5a. Motor Arm – Left
5b. Motor Arm – Right
(Elevate arm to 90 degrees if patient is sitting,
45 degrees if supine)
0 = No drift
1 = Drift
2 = Can’t resist gravity
3 = No effort against gravity
4 = No movement
X = Untestable (limb amputation etc.)
6a. Motor Leg – Left
6b. Motor Leg – Right
(Elevate leg to 30 degrees with patient supine)
0 = No drift
1 = Drift
2 = Can’t resist gravity
3 = No effort against gravity
4 = No movement
X = Untestable (limb amputation etc.)
7. Limb Ataxia
(Finger-nose, heel down shin)
0 = No ataxia
1 = Present in one limb
2 = Present in two limbs
8. Sensory
(Pin prick to face, arm, trunk, and leg – compare
side to side)
0 = Normal
1 = Partial loss
2 = Severe loss
9. Best Language
(Name item, describe a picture and read
sentences)
0 = No aphasia
1 = Mild to moderate aphasia
2 = Severe aphasia
3 = Mute
10. Dysarthria
(Evaluate speech clarity by patient repeating
listed words)
0 = Normal articulation
1 = Mild to moderate slurring of words
2 = Near unintelligible or worse
X = Intubated or other physical barrier
11. Extinction and Inattention
(Use information from prior testing to identify
neglect or double simultaneous stimuli testing)
0 = No neglect
1 = Partial neglect
2 = Complete neglect
Table  2: The National Institutes of Health Stroke Scale (NIHSS). NIHSS is a 42-
point scale that quantifies neurological deficits in 11 categories. Higher scores
indicate more severe deficits. Adapted from Richardson et al. 34
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2.1.7 Acute management and therapies
The aims of acute stroke therapy are 1) to restore the perfusion of the ischemic brain
tissue as rapidly as possible, 2) to limit the amount of damage to the ischemic tissue
whether caused by primary (hypoperfusion) or secondary (for example,
hyperglycemia or hyperthermia) mechanisms, and 3) to decrease the probability of
complications (such as hemorrhagic transformation, aspiration). Both in
experimental models and clinical trials, the duration and severity of ischemia
determines the extent of irreversible damage 17, 35. However, potentially viable
ischemic tissue (penumbra) has been demonstrated to exist for at least 24 h after
symptom onset 36, 37. Overall, the time elapsed from the onset of the symptoms to
treatment is a critical determinant of the outcome that guides decision making and
pre- and in-hospital management 38.
Four interventions have been unanimously proven to improve the outcome of
ischemic stroke: 1) the management of patients in a stroke unit, 2) the use of aspirin
within 48 h of stroke onset, 3) decompressive surgery (hemicraniectomy) for
supratentorial malignant hemispheric cerebral infarction, and 4) the use of an
intravenous thrombolytic within 4.5 h of symptom onset 39-43. Therapeutic
interventions that directly address revascularization— the reperfusion of the
ischemic tissue by recanalization of the occluded vessel or by other means— are of
particular importance because they could reverse the disease process. Currently
available revascularization therapies include intravenous thrombolysis (IVT),
sonothrombolysis, intra-arterial thrombolysis (IAT) possibly assisted with balloon
angioplasty, IVT followed by an intra-arterial intervention, mechanical
thrombectomy using aspiration, stent retrievers, other specific retrieval devices or a
combination of these therapies, and bypass stenting 44-47.
For a comprehensive review of the early management of adults with ischemic
stroke, see the current United States and Finnish guidelines 24, 29.
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2.1.7.1 Intravenous thrombolytic therapy
Tissue plasminogen activator (tPA) is a serine protease that enhances the conversion
of plasminogen to active plasmin that acts on fibrin clots to dissolve the clot 48. This
interaction has been targeted for pharmacotherapy. First-generation therapeutic
plasminogen activators— streptokinase and urokinase— have been gradually
replaced by different recombinant tissue plasminogen activators (r-tPAs) that
preferentially activate fibrin-bound plasminogen and thus have better spatial
specificity 49. r-tPA can be administered intravenously or intra-arterially, but only
the intravenous administration route has been approved by the Food and Drug
Administration (FDA). An obvious systemic and local adverse side effect is the
increased risk of bleeding.
In 1996, the FDA approved the use of intravenous r-tPA for the treatment of acute
ischemic stroke. The approval was based on the results of the National Institute of
Neurological Disorders and Stroke trial (NINDS) 43. This trial established a time
window for the therapy to within 3 h from symptom onset. This time limit was
supported by a meta-analysis of all trials up to 2004 50. The other relevant trials
included the European Cooperative Acute Stroke Study (ECASS), ECASS II and
the Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic
Stroke (ATLANTIS) study 51-53. These trials allowed patients to be enrolled for up
to 6 h after the stroke onset and, in this setting, showed no benefit of the intravenous
r-tPA compared to placebo. However, in 2008, the ECASS III trial and evaluation of
the Safe Implementation of Thrombolysis in Stroke–International Stroke Treatment
Registry (SITS-ISTR) provided evidence that a time window of 4.5 h was safe and
effective 54, 55. This time window has since been adopted into most current treatment
guidelines 24, 56.
Recently, three trials have studied the IVT beyond the 4.5 h window. These trials
utilized MRI to measure the mismatch between diffusion-weighted imaging and
perfusion-weighted imaging findings (DWI-PWI mismatch, see section 2.2.4),
which can be used to approximate the ischemic penumbra 57, 58. In the Desmoteplase
in Acute Ischemic Stroke (DIAS) series of trials, the decision to treat with r-tPA was
based on non-quantitatively defined mismatch criteria, and the time window was
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extended to 9 h 59-61. The phase III trial failed to show a benefit of r-tPA treatment.
In the open-label, non-randomized Diffusion-weighted imaging Evaluation For
Understanding Stroke Evolution (DEFUSE) study, patients received r-tPA at up to 6
h after symptom onset 62. A close relationship between a favorable clinical response,
and the DWI-PWI mismatch was observed. The Echoplanar Imaging Thrombolytic
Evaluation Trial (EPITHET) investigators conducted a double-blinded, randomized,
controlled trial using intravenous tPA from 3 to 6 h after stroke onset 63, 64. They
found a significant trend toward attenuation of infarct growth on DWI and a
significant increase in reperfusion that was detected with PWI. Further trials
addressing a treatment time window of beyond 4.5 h are being conducted. The
largest of these trials is the Third International Stroke Trial (IST-3) 65.
According to a meta-analysis of intravenous r-tPA trials by Lees et al., the odds ratio
(OR) of an excellent outcome (mRS ? 1) was 2.4 if the treatment was administered
during the first 90 min and declined steadily to 1.4 during the 3.0-4.5 h time epoch
35. These data are reflected in the number needed to treat (NNT) figures that
increased proportionally with time (Figure 4). Symptomatic intracranial hemorrhage
(sICH), which has potentially deleterious effects on the short- and long-term clinical
outcome, occurs in 1.7-8.0% of patients receiving intravenous r-tPA 43, 54, 66-68.
Numerous risk factors for sICH have been identified. Patients with severe stroke
(NIHSS ? 20) have a greater likelihood of hemorrhage 69. Advanced age alone does
not increase the probability of hemorrhagic complication, but the outcomes are
worse 70. Hyperglycemia and sustained hypertension have been linked with an
increased risk of sICH 71-75. The numerous CT imaging findings that are associated
with an increased risk of hemorrhage are described in section 2.2. MRI findings that
predict hemorrhagic complications include a profound reduction of cerebral blood
volume, large diffusion or perfusion abnormalities upon baseline imaging (? 100
ml), low apparent diffusion coefficient (ADC) values, signs of early blood-brain
barrier disruption, and leukoaraiosis of the deep white matter 75-81. Some of the
absolute and relative contraindications to intravenous r-tPA are due to the increased
probability of hemorrhage. The exact inclusion and exclusion criteria for
intravenous r-tPA vary somewhat between institutions and countries. For a typical
treatment protocol, see Wechsler 49.
27
Figure  4:  NNT to  reach  a  mRS score  of  0-1  for  all  trials  of  intravenous  r-tPA in
acute ischemic stroke prior to 2010. NNT is almost doubled with each additional 90
min after stroke onset. Adapted from Donnan et al. 39
2.1.7.2 Intra-arterial interventions
The two largest trials that have studied intra-arterial administration of a
thrombolytic agent are the phase II Prolyse in Acute Cerebral Thromboembolism
(PROACT) and the PROACT II trials 82, 83. In both studies, the pharmacological
intervention was intra-arterial recombinant prourokinase (r-proUK) with intravenous
heparin, which were both administered within 6 h of symptom onset. Patients
receiving IAT had increased vessel recanalization rates (58-66% vs. 14-18%) and
better clinical outcomes although the probability of intracranial hemorrhage was
increased. The Emergency Management of Stroke (EMS) trial and the Interventional
Management of Stroke (IMS) trials I and II studied a combined intra-arterial and
intravenous thrombolysis with r-tPA administered within a 3 h time window 30, 84, 85.
Combined IV-IA strategies are collectively called bridging therapies. The
investigators reported that there was a significantly improved 3-month outcome
compared with the NINDS placebo arm, whereas there was only a trend toward
improved outcomes when compared with the NINDS r-tPA arm. Other studies with
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more heterogeneous setups have shown better functional outcomes in combined IV-
IA treatment groups 47. IAT can be assisted with balloon angioplasty.
During the last decade, different methods and devices have been introduced to
perform mechanical thrombectomy. Two of these devices, the Merci Retrieval
System (MRS) and the Penumbra System (PS), have been approved by the FDA for
the treatment of acute ischemic stroke. The Mechanical Embolus Removal in
Cerebral Ischemia (MERCI) trial was a single-arm study that included patients
presenting between 3-8 h from symptom onset or within 3 h if there was a
contraindication to IVT or if the treatment failed 86. This trial was extended in the
Multi MERCI study 87. In a pooled analysis, recanalization, which was achieved in
65% of patients, significantly predicted improved 3-month outcome 88. Higher
degrees of recanalization were associated with improved outcome and decreased
mortality 89. In the Phase II Penumbra Pivotal Stroke Trial, the time window for
treatment was 8 h. Eighty-one percent of the patients showed recanalization, 42%
showed an improvement of at least 4 points in NIHSS scores and a 1-month mRS
score ? 2 90. There are several case reports and retrospective study series showing
high recanalization rates when using intracranial stents as an emergency
revascularization strategy 47. However, the Stent-Assisted Recanalization in Acute
Ischemic Stroke (SARIS) trial is the only high-quality prospective study 91. In this
study, following intervention, 100% of occlusions were recanalized. At one-month
follow-up, 65% of patients showed an improvement of at least 4 points in NIHSS
scores, and 62% had mRS ? 3. Recanalization with retrievable, unfolded stents
(stent retrievers) and temporary stent placement is currently being investigated and
has shown promising preliminary results 92-95.
2.2 Multimodal computed tomography
Traditionally CT examinations of the brain have been performed by imaging
sequential axial slices with or without intravenously administered iodinated
contrast-agent. These imaging modalities are called contrast-enhanced computed
tomography (CECT) and non-contrast (enhanced) computed tomography (NCCT).
Both of these modalities provide anatomical and structural information on the
29
intracranial space. CECT is not typically included in the acute ischemic stroke
imaging protocols. The introduction of multidetector technology in the past two
decades has enabled the use of thinner section-widths and rapid coverage of large
imaging volumes. This technology has resulted in the development of computed
tomography angiography (CTA) and computed tomography perfusion (CTP). CTA
provides detailed anatomical information on the cerebral vasculature. CTP conveys
functional information on the hemodynamic status of the vasculature at the tissue
(capillary) level and allows the detection and characterization of ischemic brain
parenchyma. Together, the three modalities— NCCT, CTA and CTP— are referred
to as multimodal computed tomography.
2.2.1 Non-contrast computed tomography
The first scan obtained when using a multimodal CT imaging protocol is NCCT. It
is used to exclude etiologies that cause symptoms mimicking those of ischemic
stroke, the most important of which are intracranial hemorrhage and neoplasms, to
detect possible early or irreversible ischemic changes in the brain parenchyma and
to assess the risk of post-treatment bleeding complications, especially in the context
of revascularization therapy 7, 43, 50, 71.
Early ischemic changes (EICs) observed using NCCT within 6 h of symptom onset
include 1) subtle parenchymal hypoattenuation with or without swelling that often
manifests as a loss of visualization of the gray-white matter interface and 2) isolated
parenchymal swelling without hypoattenuation. Focal hyperattenuation of an arterial
trunk is an additional sign that can be considered a surrogate for ongoing
parenchymal ischemia. In some specific locations, these findings have been given
names including the insular ribbon sign, obscuration of the lentiform nucleus, the
MCA dot sign, and the dense media sign or the hyperdense MCA sign (HMCAS).
The EICs are insensitive for detecting acute ischemic processes and show, at best,
moderate interobserver agreement and reproducibility. In general, they indicate an
increased risk of poor clinical and imaging outcomes. The presence of HMCAS is
associated with a major neurologic deficit, and it predicts poor clinical and
radiologic outcomes after IVT 96. For a review, see 7, 97.
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The duration and degree of hypoperfusion determines the presence of EICs 98.
Although the presence or absence of different types of EICs cannot reliably
differentiate between irreversibly damaged brain tissue and penumbra, the isolated
focal swelling is associated with the penumbra and the parenchymal
hypoattenuation with the infarct core and a poor functional outcome 99-103. Frank
parenchymal hypoattenuation indicates irreversible ischemic damage 101. The extent
of these changes is predictive of the risk of hemorrhagic transformation 71, 73, 104, 105.
Evaluation of this risk is especially important when deciding whether a patient is
eligible for revascularization therapies. In the ECASS I and II trials, the
involvement of more than one-third of the MCA territory with EICs and/or frank
hypoattenuation was considered a contraindication for reperfusion therapy due to an
increased risk of hemorrhagic transformation 51. This rather arbitrary criterion that is
challenging to interpret has been widely adopted 106-108. However, the relationship
between EICs and adverse outcomes following IVT is not straightforward. It
appears that IVT administered in the presence of early infarction signs does not
induce a poorer outcome than that predicted by the early signs alone 97.
2.2.1.1 Alberta Stroke Program Early CT Score
To overcome the issues associated with the “one-third of the MCA territory”
criterion, an algorithmic, topographic system called the Alberta Stroke Program
Early CT Score (ASPECTS) was developed 104, 109, 110. ASPECTS is a weighted
scoring scheme that allows quantitative assessment of the extent of acute ischemic
changes in the anterior circulation. Only parenchymal hypoattenuation is considered
a finding in the scoring process. Each hemisphere is divided into 10 regions (Figure
5) comprising the caudate nucleus, lenticular nucleus, insula, internal capsule,
inferior anterior MCA territory, inferior middle MCA territory, inferior posterior
MCA territory, superior anterior MCA territory, superior middle MCA territory, and
the superior posterior MCA territory in two axial sections at the level of the basal
ganglia (the ganglionic level) and the corona radiata (the supraganglionic level).
Each of these regions is given a score of 1 point. This point is deducted if the region
shows acute ischemic changes. Thus, negative findings yield a score of 10, and
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extensive ischemia covering the entire MCA region yields a score of 0. On the basis
of a volumetric assessment, if the ASPECTS score is ? 6, then more than one-third
of the MCA territory is affected, on average. When 3 or more of the ASPECTS
regions show ischemic changes (ASPECTS ? 7), the patient is unlikely to achieve
an independent functional outcome. Overall, ASPECTS applied to NCCT images is
predictive of the clinical outcome, the effectiveness of IVT and IAT and the rate of
hemorrhagic complications but is not sufficiently accurate for triaging IVT
candidates 110-115. The ASPECTS paradigm has also been adapted to the posterior
circulation 116. However, when applied to NCCT, this score did not predict
functional independence 116.
Figure  5: Axial NCCT images showing the MCA territory regions as defined by
ASPECTS. The ganglionic and the supraganglionic levels are indicated using white
32
brackets. C- Caudate, I- Insular ribbon, IC- Internal Capsule, L- Lentiform nucleus,
M1- Anterior MCA cortex, M2- MCA cortex lateral to the insular ribbon, M3-
Posterior MCA cortex, M4, M5, and M6 are the anterior, lateral and posterior MCA
territories immediately superior to M1, M2 and M3, rostral to the basal ganglia.
Subcortical structures are allotted 3 points (C, L, and IC). The MCA cortex is
allotted 7 points (insular cortex, M1, M2, M3, M4, M5 and M6). The image is
adapted from www.aspectsinstroke.com.
2.2.2 Computed tomography angiography
The second modality acquired in a multimodal protocol is typically the CTA. In
general, a volume from the aortic arch up to the vertex of the skull is covered, and
thin-section slices of isotropic spatial resolution are calculated 117. This method
enables the reconstruction of two-dimensional (2D) reformatted images in arbitrary
planes, maximum intensity projection (MIP) images and three-dimensional (3D)
images and provides detailed information on the cerebral vasculature that is
comparable with that obtained using digital-subtraction angiography (DSA) 118-122.
Both intracranial and extracranial vessels can be evaluated in a single study. Thus,
the vascular anatomy and the collateral circulation can be visualized, the pathology
of the vessel wall that alters the diameter of the vessel lumen can be evaluated, and
intravascular thrombi can be identified 117, 123. CTA can detect large- and small-
vessel occlusions and stenoses highly accurately (95-99%) both intracranially and
extracranially 123-126. The location and the volume of the thrombi are independent
prognostic factors in acute ischemic stroke with proximal, high-volume clots
predicting poor clinical outcomes compared with distal, low-volume clots. This
finding is related to the rate of recanalization, which is lower in proximal-vessel
positions. In addition, the location and volume of the clot limits the effectiveness of
IVT in dissolving the occluding thrombus 127-138. This information can be used to
guide therapeutic decision making and the choice between IVT, intra-arterial
interventions or refraining from revascularization therapy.
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2.2.2.1 Clot Burden Score
The Clot Burden Score (CBS) is an imaging score based on the location and the
extent of the thrombus detected using CTA 135, 139. In this scoring scheme, a score of
0 to 10 is assigned on the basis of the number and location of arterial segments
affected in the anterior circulation (Figure 6). Similar to ASPECTS, the absence of
an occlusion is scored with 10 points and points are deducted if non-opaque arterial
segments are shown by the contrast agent. CBS is correlated with the clinical and
radiological outcomes 134, 135, 139. Patients with higher CBS values are more likely to
experience independent functional outcomes and less likely to die. Correspondingly,
the final infarct volumes are smaller and the rates of hemorrhagic transformation
lower.
Figure  6: Schematic representation of the Clot Burden Score (CBS). One or two
points each are subtracted from a total score of 10 when no contrast opacity is
detected using CTA in the infraclinoid ICA (1 point), supraclinoid ICA (2 points),
proximal M1 segment (2 points), distal M1 segment (2 points), M2 segment
branches (1 point each) and the A1 segment (1 point), as indicated by the numbers
next to the corresponding vessel segments. CBS applies only to the symptomatic
hemisphere. From Puetz et al. 135
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2.2.2.2 Boston Acute Stroke Imaging Scale
The Boston Acute Stroke Imaging Scale (BASIS) is an imaging score that combines
arterial and parenchymal imaging findings 140. BASIS is a binary, 2-step
classification scheme where patients are designated as having either a major or
minor stroke. If the distal ICA, the proximal MCA (segments M1 and M2) or the
basilar artery is occluded or if there is a significant ischemic lesion either in NCCT
or DWI based on the one-third of the MCA rule, ASPECTS or bilateral pons or
bithalamic involvement, the stroke is considered major. Otherwise, the stroke is
designated as minor. BASIS is correlated with mortality, short-term clinical
outcome evaluated at discharge from the hospital, and the length and costs of
hospitalization with major stroke predicting poor outcomes and higher costs 133, 140.
2.2.2.3 Evaluation of the leptomeningeal collateral circulation
Leptomeningeal collateral circulation occurs due to the arterio-arterioral
connections between the major cerebral artery systems that enable the filling of pial
arteries distal to the site of vessel occlusion. Sufficient flow through the collaterals
allows the brain tissue to remain viable even if the normal antegrade flow supplying
the tissue volume is diminished or interrupted 141-143. This additional blood flow
reduces the baseline infarct core and the expansion of the core, decreases the risk of
hemorrhagic transformation and increases the odds of a good clinical outcome in-
hospital, at discharge and six months after the stroke 123, 144-152. A multitude of
heterogeneous methods have been used to identify and score collateral circulation
including classification schemes utilizing CTA 123, 138, 148, 152, 153. However, currently,
a systematic evaluation of the extent of the collateral pathways is seldom performed
in the acute-stroke imaging workup.
2.2.2.4 Computed tomography angiography source images
Unprocessed CTA source images (CTA-SI) can be used to predict whether the
tissue volume will infarct regardless of whether recanalization is achieved 154. CTA-
SI is clearly superior to NCCT in the detection of the infarct core and in the
prediction of infarct extension, symptomatic hemorrhagic complications and clinical
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outcomes 60, 112, 126, 155-159. CTA-SI obtained using a 16-row or shorter detector-
length scanners essentially capture the steady state of the contrast agent, which
approximates the cerebral blood volume and irreversible ischemic changes 160, 161.
Wider detector lengths and faster image-acquisition times make CTA-SI more
blood-flow weighted, and thus, it increasingly reflects the at-risk tissue rather than
only the tissue that will undergo necrosis 112, 162-164.
2.2.3 Computed tomography perfusion
The final imaging modality obtained in a typical multimodal protocol is CTP. A
perfusion study enables the quantification of capillary, tissue-level blood flow. CTP
is a dynamic imaging modality where the first pass of a bolus of iodinated contrast-
agent is traced though the brain parenchyma by repeated scanning of the volume of
interest immediately following the injection 165. This method provides insight into
the physiology and pathophysiology of cerebral hemodynamics. Based on a multi-
compartmental tracer kinetic model, CTP allows the calculation of a variety of
parameters that reflect different aspects of the hemodynamic state 7, 166, 167:
1. Cerebral Blood Flow (CBF) indicates the volume of blood moving through
a brain volume (mass) of interest per unit time ([CBF] = ml/100 g/min).
2. Cerebral Blood Volume (CBV) describes the total volume of blood in a
given brain volume (mass) of interest ([CBV] = ml/100 g). This volume
includes the intracellular, intravascular and extravascular interstitial spaces.
3. Mean Transit Time (MTT) describes the average difference in time
between the arterial inflow and the venous outflow of a brain region-of-
interest ([MTT] = s). This time is dependent on the average distance
travelled. MTT can be calculated from the CBF and CBV with the central
volume principle 168: MTT = CBV/CBF.
4. Time to Peak (TTP) is defined as the time from the beginning of the arterial
enhancement to the peak of the enhancement curve ([TTP] = s).
In essence, two mathematical approaches have been applied in calculating the CBF
and MTT from raw measurement data obtained using a CT scanner: the
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deconvolution and non-deconvolution methods 166. Non-deconvolution methods are
based on the application of Fick’s principle of conservation of mass to a given
region of interest. The CBF can be calculated using the maximum slope technique.
Non-deconvolution methods make use of simplifying assumptions that decrease the
accuracy of the results. Deconvolution methods attempt to correct the effect of
contrast delay and dispersion. There are multiple deconvolution techniques, and the
singular value decomposition (SVD) has gained widespread acceptance.
Deconvolution methods enable the creation of accurate, quantitative perfusion
parametric maps. The concept and calculations have been validated in humans using
xenon-CT, positron emission tomography (PET) and MRI and in animals, using
microsphere studies. For a comprehensive theoretical and technical analysis, see the
series of reviews by Konstas et al. 166, 167, 169.
The main goal of a stroke perfusion study is to provide an assessment of the
viability of the ischemic tissue, i.e., to identify the irreversibly damaged tissue (the
infarct core), the tissue that is at risk for progression to infarction if reperfusion is
not achieved (the penumbra) and the normally perfused or hyperemic tissue 167, 170,
171. This classification stems from experimental studies that characterized two
functional thresholds for CBF: 1) below which cortical function ceases without an
increase in extracellular potassium or reduction in pH (the penumbra) and 2) below
which there is disruption of cellular integrity (the core) 172. These thresholds have
been correlated with advanced neuroimaging findings— the perfusion parametric
maps— to define a more clinically relevant operational penumbra, which identifies
hypoperfused but potentially salvageable tissue 170, 173, 174. In the simplest terms, the
operational penumbra is the mismatch (subtraction) volume between the CBF or
MTT (or TTP) and the CBV (or DWI), in which the CBV (or DWI) lesion reflects
the infarct core and the CBF or MTT (or TTP) lesion reflects the boundaries of the
hypoperfused penumbral tissue (Figure 7) 167. This concept was initially validated
for MRI, and later MRI and CT results were correlated (see section 2.2.4 for a
discussion of the DWI-PWI mismatch in MRI) 154, 175. However, standardization or
validation of the quantitative perfusion parameter map values has not been achieved
for acquisition and postprocessing across different vendor platforms or even across
different platforms from the same vendor 176, 177. Thus, numerous absolute threshold
values have been proposed for different perfusion parameters in multiple studies.
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The use of relative values obtained by comparing to the contralateral, uninvolved
side can, in part, circumvent this problem 178-180. However, even the relative values
vary with postprocessing technique, and the interpreter must be familiar with the
software and hardware used 179, 180. The perfusion parameters that best define the
core and the penumbra remain under discussion. This task is challenging, as both
regions are dynamic in character because of the nature of the disease process.
Recent reports suggest that appropriately thresholded relative and absolute MTT
values optimally distinguish the at-risk penumbra and that thresholded CBF values
may assess the core more accurately than CBV cut-offs 176, 179, 180. Depending on the
postprocessing technique used, relative MTT thresholds ranged between 150 and
249% and relative CBF values were between 16 and 44%. Relative CBVs ranged
between 56 and 60% 179. ASPECTS has been validated for CTP parametric maps,
which provides another method for quantifying CTP findings in the anterior
circulation including calculation of the perfusion mismatch 113, 181, 182.
Figure  7: A patient suffering from an acute stroke of the left MCA region who
displays both MTT and CBF–CBV mismatch. The CBV lesion is obviously smaller
than the MTT or the CBF lesion. Arrows mark the boundaries of the perfusion
defect in the three parametric maps.
CTP has the potential to serve as a surrogate marker for stroke severity and as an
independent predictor of clinical outcome. Multiple studies utilizing a variety of
imaging methods have established a strong correlation between the size of the core
upon admission and the clinical outcome 167, 183. Patients with a core lesion volume
? 70-100 ml show poor outcomes regardless of therapy or recanalization status 184-
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186. It is unclear how large a clinically significant penumbra should be. An arbitrary
mismatch ratio (for example, defined as VolumeMTT/VolumeCBV) –cut-off of 1.2 or
2.0 has been used in most studies 167. The degree of early reduction in CBF and
CBV and, interestingly, the size and severity of the DWI lesion are correlated with
the risk of a hemorrhagic complication 76, 77, 187-189. CTP can identify potentially
salvageable brain tissue in the context of IVT 190.
A major disadvantage of CTP in most currently used scanners is the limited z-axis
coverage. According to a recent report, 75 mm of z-axis coverage was required to
reliably detect a perfusion mismatch ratio of 2.0 in the anterior circulation, whereas
50 mm was sufficient when a ratio of 1.2 was used 191. Newer 256- and 320-row
scanners can achieve whole-brain coverage 192, 193. CTP is insensitive to acute
lacunar and small, deep white-matter lesions 194, 195. CTP may overestimate the size
of the CBV lesion 190, 196. In contrast, CBV and CBF may underestimate the core
due to post-ischemic hyperperfusion 197. If not properly thresholded, the MTT and
CBF defects include a region of reactive benign oligemia that is not at risk of
progressing to infarction 180, 198-200. CTP involves an intravenous injection of 35-60
ml of iodinated contrast material. However, this procedure does not appear to
increase the incidence of contrast-induced nephropathy 201. The patient also receives
a dose of ionizing radiation. If the CTP protocol has been set-up correctly, the dose
is slightly higher than that used for NCCT 167. The complex post-processing may be
prone to operator errors 202, which can be counteracted with training and quality
control 203.
2.2.4 Comparison of multimodal CT and stroke MRI
Multimodal MRI offers an alternative method to study acute stroke. A typical stroke
MRI protocol includes diffusion-weighted imaging (DWI), perfusion-weighted
imaging (PWI), MR angiography (MRA), gradient-echo (GRE) and fluid-attenuated
inversion recovery (FLAIR) imaging 204, 205. GRE and FLAIR are used to detect
intracranial hemorrhage, and MRA provides information on major-vessel patency.
DWI is used to detect the ischemic process and to characterize the extent of the
infarct core 206, 207. PWI allows the assessment of cerebral hemodynamics using the
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perfusion parameters described in section 2.2.3 208, 209. The DWI-PWI mismatch
estimates the size of the operational penumbra 209-211.
MRI is superior to NCCT in sensitivity and accuracy of detection of acute ischemia
and hemorrhage 212, 213. The anatomical and pathophysiological information
obtained with CTA and CTP and the clinical utility of these data are comparable to
MRI 160, 175, 214-217. Theoretically, CTP provides better approximation of the true
quantitative perfusion values 117, 205. As with CTP parameters, DWI can
overestimate the size of the infarct core but appears superior to any CT option 205,
218. Multimodal CT is readily available, is faster and cheaper to perform, is less
sensitive to motion artifacts and has fewer contraindications 7, 117, 205. However, MRI
typically has better z-axis coverage and does not involve exposure to ionizing
radiation or iodinated contrast-agents 117, 205.
2.2.5 The role of multimodal CT in acute ischemic stroke
Imaging plays a central role in the evaluation of patients with acute stroke. The
current American Heart Association (AHA) guidelines for imaging of acute
ischemic stroke recommend the use of NCCT or MRI to detect ICH and frank
ischemic changes 219. However, the guidelines state that in patients presenting
within 3 h of symptom onset, NCCT alone shows suboptimal detection rates of
ischemic changes and that more definitive diagnoses can be obtained using DWI or
CTA-SI if they do not unduly delay the timely administration of r-tPA. A
multimodal protocol takes 2 to 10 min to complete and does not significantly delay
the administration of IVT 220, 221. In addition, the authors of the guidelines reported
that a vascular study— CTA, MR angiography (MRA) or DSA— is “probably
indicated” and that patients who are more than 3 h from symptom onset should be
examined using a DWI or a CTA-SI and also using vascular imaging and perfusion
studies, particularly if an intra-arterial intervention is contemplated. Furthermore, an
incremental protocol that includes CTP enhances stroke diagnostics and inter- and
intraobserver agreement 8. Overall, the guidelines assert that progress in the
treatment of the acute-stroke patient has been modest, and it is apparent that the use
of NCCT alone is insufficient to properly triage patients to different treatments.
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A multimodal protocol enables diagnostics beyond excluding intracranial
hemorrhage and provides information that allows more diverse clinical decision
making with the intention of selecting patients for different revascularization
therapies 7, 45, 117, 166, 167, 219. A multimodal protocol enables questions, such as
whether there are intravascular thrombi that can be targeted for thrombolysis,
whether there is a sizable core of critically ischemic tissue that is irreversibly
infarcted, whether there is adequate collateral circulation, and whether there is a
penumbra of severely ischemic but potentially salvageable tissue, to be answered.
Patients outside the currently accepted therapeutic time window for
revascularization therapies or who have an unknown duration of symptoms can
potentially be treated. The risk of a hemorrhagic complication can be evaluated
more accurately. Patients can be more sensibly triaged in trials of experimental
therapies, such as sonothrombolysis, mechanical thrombectomy using new devices,
induced hypertension therapy and different neuroprotective strategies. One report
suggests that it may be possible to increase the proportion of good functional
outcomes among IVT patients by using multimodal CT upon admission 222.
Multimodal imaging is an essential component in the shift from time window-based
decision making to management based on the characterization of the ischemic
tissue. The steps to reach this paradigm change have been traced in a recent
multidisciplinary consensus statement 223.
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3. AIMS OF THE STUDY
The aims of this study are as follows:
1) To study the potential of ASPECTS as applied to CTP parametric maps in
the characterization of acute ischemic stroke and the prediction of clinical
and imaging outcomes. In particular, to test the hypothesis that the CTP
ASPECTS mismatch, which is the difference between MTT and CBV
ASPECTS scores, may be useful for identifying patients that could benefit
from IVT [I].
2) To correlate the anatomical information conveyed by BASIS and CBS to the
dynamic information of the CTP parameters in order to determine how these
variables predict the clinical outcome and whether a derived parameter
combining both CTA and CTP data could provide increased value for the
prediction of the clinical outcome of acute ischemic stroke in the context of
IVT [II].
3) To analyze in depth the impact of the location of the clot, visualized in the
anterior circulation using CTA, on the clinical outcome in acute ischemic-
stroke patients treated with IVT [III].
4) To compare the technical quality of the CTP studies performed using a 64-
row or a 16-row scanner and to analyze the differences in the ability to
detect perfusion defects between the two scanners in the context of acute
ischemic stroke [IV].
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4. SUBJECTS, MATERIALS AND
METHODS
4.1 Overview
All studies [I-IV] had retrospective observational cohort design. The clinical and
imaging data of consecutive patients, who were admitted to Tampere University
Hospital between January 2004 and December 2007 because of acute (duration < 3
h) stroke symptoms and who after evaluation received IVT to treat acute ischemic
stroke, were collected and analyzed.
The initial imaging evaluation consisted of NCCT, CTA and CTP. The selection of
patients to receive thrombolytic therapy was based on institutional guidelines, which
did not have CTP or CTA parameters as exclusion or inclusion criteria. To rule out
possible selection bias caused by CTA and CTP studies, a sample population of 179
acute-stroke patients who did not receive IVT in 2007 was reviewed. The indication
to exclude a patient from IVT was documented carefully. In one case, the decision
to exclude a patient was based on the results of a CTP study (extremely poor
technical quality of the admission NCCT and over one-third MCA lesion in the
CBV map). In addition, we discovered three cases in which the admission NCCT
was initially erroneously interpreted as negative, the results reported orally to the
stroke neurologist, a review and a correction was conducted after the CTP maps had
been calculated and analyzed some minutes later, and the decision to administer
thrombolytic therapy was withdrawn. A follow-up NCCT was performed for all
patients at 24 h after the administration of the thrombolytic agent.
IVT was administered according to guidelines from the American Heart Association
(AHA) 224: Actilyse (Boehringer-Ingelheim, Ingelheim, Germany), total dose 0.9
mg/kg, was administered in a 10% bolus with the remaining 90% administered as a
continuous infusion over 1 h.
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4.2 Subjects, study population and baseline
characteristics
4.2.1 Patients who received IVT to treat acute ischemic stroke in
2007 [I and II]
The clinical and imaging data from 92 consecutive patients, who were admitted to
Tampere University Hospital between January 2007 and December 2007 due to
acute (duration < 3 h) stroke symptoms and who received intravenous r-tPA to treat
acute ischemic stroke after evaluation, were collected. In total, 271 patients
suffering from acute ischemic stroke were evaluated as candidates for thrombolytic
therapy during this period. A full multimodal imaging evaluation was successfully
completed in 72 of the 92 patients (78%) who received thrombolytic therapy. Nine
patients (10%) were evaluated using NCCT alone, and 11 patients (12%) were
evaluated using NCCT and CTA due to a previously known hypersensitivity to the
contrast agent, chronic renal failure, imminent closure of the three-hour time
window or movement artifacts that rendered some of the imaging data
uninterpretable (Figure 8). Altogether, 83 patients (90%) were imaged using CTA.
The median age of the patients was 71 years (interquartile range 58-80 years, 42
female). Based on the clinical features and the imaging studies, in 11 of the 92
patients evaluated, the ischemic episode involved the posterior circulation (8 cases
of thrombosis of the basilar artery). The other episodes were considered to involve
the anterior circulation. The thrombosis was demonstrated with CTA in 37 cases
(45% of the CTA studies and 40% of all patients). In 40 cases (56%) of the 72
evaluated using CTP, a perfusion defect was detected in the ASPECTS levels. An
additional 6 perfusion defects were found outside the ASPECTS levels. A perfusion
pattern implying acute ischemia was detected in half of the cases involving the
posterior circulation when CTP was conducted. In total, a perfusion defect was
demonstrated in 64% of the CTP scans (50% of all patients). The median NIHSS
upon admission was 7 points (56.0% < 8, 18.7% > 15; interquartile range 4-12). The
median mRS was 1 point preictally.
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Figure 8: The population and subpopulations of studies I and II.
4.2.2 Patients who received IVT to treat acute ischemic stroke
from 2004 to 2007 [III]
Altogether, 313 anterior- or posterior-circulation ischemic-stroke patients from
January 2004 to December 2007 were treated with IVT and had a 3-month follow-
up after thrombolysis. CTA was performed on 283 patients (90%). The inclusion
criteria were acute anterior-circulation vessel occlusion confirmed with CTA and
IVT treatment. There were 105 (37%) patients who met the inclusion criteria.
Thrombi were not detected in 140 (50%) cases, and 38 (13%) patients showed a
posterior-circulation clot. The median age of the patients was 69 years (interquartile
range 54-83 years; 45 female). The median NIHSS upon admission was 13 points
(interquartile range 4-12) and 6 points (interquartile range 0-20) at 24 h after IVT
administration. The median NCCT ASPECTS upon admission was 10 points
(interquartile range 8-10). The median time from imaging to the initiation of IVT
was 35 minutes. The median preictal mRS was 1. A 3-month mRS was missing
from one patient who was discharged to another district and was not contacted for
phone interview. At 24 h, a local hemorrhagic complication or parenchymal
hemorrhage distant to the site of the infarct was detected in 7 cases (7%). According
to the 5-subtype Causative Classification of Stroke (CCS) scheme 12, large-artery
atherosclerosis was the etiology in 23 (22%) cases; cardiac embolism in 55 (52%)
cases; and other uncommon cause in 6 (6%) patients. There were no cases of small-
artery occlusion, and 21 (20%) patients had an ischemic stroke of undetermined
cause. Sixty-nine percent of the patients had hypertension, 17% suffered from
diabetes, 41% had atrial fibrillation, and 33% had coronary artery disease.
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4.2.3 Patients who received IVT to treat acute ischemic stroke
from 2006 to 2007 [IV]
Clinical and imaging data were analyzed of 140 consecutive patients who were
admitted to Tampere Hospital between January 2006 and December 2007 due to
acute (duration < 3 h) stroke symptoms, who were imaged with NCCT and CTP and
who subsequently received intravenous r-tPA. The patients were scanned using
either a 64-row or a 16-row scanner located in neighboring rooms. Although the
patients were not explicitly randomized for imaging with either scanner, the
selection of the scanner was effectively random. The median age of the patients was
71 years (interquartile range 58–80 years; 45% female). Based on the clinical
features and the imaging data, in 16 of the 140 patients evaluated (11%), the
ischemic episode involved the posterior circulation. The median NIHSS score upon
admission was 7 (interquartile range 4-12; 54% < 8, 13% > 15). The median mRS
was 1 preictally. There were no significant differences in age, admission NIHSS,
prestroke mRS or onset-to-treatment times between the patients imaged with the 64-
row and those examined with the 16-row scanner. There were significantly fewer
females in the 16-row group (36% vs. 55%).
4.3 Clinical variables
Baseline characteristics included antiplatelet therapy (aspirin, dipyridamole or
clopidogrel) prior to stroke, age, gender, prestroke functional status, time from both
symptom onset and imaging to the initiation of IVT and the stroke clinical risk
factors hypertension, diabetes, coronary heart disease, and atrial fibrillation. These
data were collected from patient records. Admission clinical evaluation results had
been prospectively stored according to a specific protocol and comprised blood
pressure, the NIHSS score at the time of initiation of IVT and whether an
intravenous antihypertensive was used. The admission hemoglobin, glucose and
glycated hemoglobin were obtained from the laboratory database. Systematic ECG
monitoring and further vascular and heart imaging were performed in the stroke unit
and the neurology ward, and the results of these studies were retrieved. A follow-up
NIHSS score was determined for all patients at 24 h after the administration of the
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thrombolytic agent. The CCS scheme was used by a certified CCS-rater to assess
stroke etiology.
A Modified Rankin Scale (mRS) score, which was scored three months after the
stroke, was the primary clinical outcome measure in all studies. In the years from
2004 to 2005, the three-month mRS score was prospectively recorded by a
neurologist experienced in stroke management during a follow-up visit, and from
2006 to 2007, the three-month mRS score was prospectively recorded by a stroke
neurologist during a phone interview. Death during the primary hospitalization and
discharge from the neurology ward to a rehabilitation facility were both considered
to signify unfavorable clinical outcomes upon discharge. These data were used as
secondary clinical outcome measures in study III.
4.4 Imaging parameters
NCCT scans were obtained using two different multidetector scanners: a General
Electric LightSpeed 16-slice scanner (GE Healthcare, Milwaukee, WI) and a Philips
Brilliance 64-slice scanner (Philips, Cleveland, OH). Brain NCCT was performed
using the following parameters: 64-row, 120 kV, 430 mAs, collimation 12 x 1.25
mm, rotation 1.5 s and 16-row, 120 kV, 320 mAs, collimation 16 x 1.25 mm,
rotation 1s. Contiguous slices were reconstructed to the thickness of 5 mm over the
entire scanning range (64-row) or to the thickness of 5 mm in the skull base and 7.5
mm in the supratentorial region (16-row).
CTA was performed using a scanning range extending from the C2-vertebra to the
vertex of the skull. The imaging parameters were 120 kV, 212 mAs (using dynamic
tube current modulation), collimation 64 x 0.625 mm, rotation 0.75 s, pitch factor
0.923 (64-row) or 120 kV, 160 mAs, collimation 16 x 0.625 mm, rotation 0.8 s,
pitch factor 0.938 (16-row). Contiguous slices were reconstructed to the thickness of
0.9 mm with a 0.45 mm overlap (64-row) or to the thickness of 1.25 mm (16-row).
The contrast agent (iobitridol, Xenetix, 350 mgI/ml, Aulnay-sous-Bois, France) was
administered via an antecubital 18G cannula using a double-piston power injector at
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a flow rate of 4 ml/s using 70 ml of contrast agent followed by a 50-ml saline flush.
Manual bolus triggering was used.
CTP was performed using the parameters 80 kV, 200 mAs (effective), collimation
32 x 1.25 mm, rotation 0.4 s (64-row) or 80 kV, 200 mAs, collimation 8 x 2.5 mm,
and rotation 1s (16-row). A total of 120 slices covering a range of 80 mm were
generated in 55 s using a protocol that utilized two alternating table positions to
increase the z-axis coverage, i.e., a “shuttle mode” (64-row), or 200 slices covering
a range of 20 mm were generated in 50 s in a stationary table position (16-row).
Contiguous slices were reconstructed to the thickness of 10 mm (64-row) or to the
thickness of 5 mm (16-row) at even time intervals. The imaging range was
positioned such that the ASPECTS levels were covered. The remaining 80 mm
range (64-row) was positioned both cranial and caudal to the ASPECTS levels with
the exact balance dependent upon the clinical presentation. The contrast agent
(Xenetix, 350 mgI/ml) was administered via an antecubital 18G cannula using a
double-piston power injector at a flow rate of 5 ml/s using 60 ml of contrast agent
followed by a 40 ml saline flush.
4.5 Image analysis
NCCT examinations were reviewed using dedicated medical-imaging workstations.
CTA and CTP images were analyzed and areas and volumes were measured using
the Advantage Workstation version 3.2 (GE Healthcare, Milwaukee, WI). CTA
images were reviewed by examining both the raw data and the MIP images.
Parametric perfusion maps were generated using the CT Perfusion 3 software,
which uses a deconvolution-based algorithm. The ACA was used as a source for the
arterial input function (AIF), and the region of interest for the venous output
function (VOF) was positioned in the superior sagittal sinus. These curves were
considered noisy if there was a clear dip or spike in the curve that could affect the
calculations. Minor rippling of the signal, although a phenomenon caused by noise
sources, was not recorded as noise in this context. Persistently poor image quality
was corrected when feasible by manually adjusting the parameters that control the
motion artifact correction algorithm in the software.
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The principles of the ASPECTS scoring of NCCT and CTP maps are described in
section 2.2.1.1. The location of the image section closest to an ASPECTS level was
considered suboptimal if the location did not exactly correspond with the reference
level described in the literature 109 but did allow reliable scoring. ASPECTS was
considered uninterpretable if the section was obviously a different anatomic region,
for example, the cranial parts of the basal ganglia when evaluating the upper level.
MTT maps were used to detect at-risk tissue, and CBV maps were used to
approximate the infarct core. The perfusion mismatch was calculated as the
difference between ASPECTS scored for the maps. When characterizing a perfusion
defect, we used a semiquantitative approach where the presence of a perfusion
defect was determined visually from color-coded maps by comparing the
appearance of the affected location to that of the healthy tissue on the contralateral
hemisphere. On the basis of theoretical considerations and to increase measurement
accuracy, we required the area measured in the visually identified location to be
larger than 25 mm2 with a mean MTT > 7s (or mean CBV < 2.5 mL/100 g; adapted
from Wintermark et al. 225). Further validation was performed by requiring the mean
relative MTT > 249% for the penumbra and the mean relative CBF < 31% and the
mean relative CBV < 58% for the infarct core compared with the contralateral side
179, 180.
The location of the clot was recorded on the basis of the most-proximal position of
the occlusion. The M1 segment of the MCA was divided into two parts of equal
length: the proximal and the distal half. The principles of the Clot Burden Score
(CBS) scoring system and the assignment of BASIS are described in sections 2.2.2.1
and 2.2.2.2.
The examinations were reviewed in the order NCCT, CTA and finally CTP, which
parallels the clinical work flow. The reviewers were blinded to the clinical data
apart from the side and nature of the acute symptoms. The location of the clot was
determined, the CBS was scored, and BASIS, NCCT and CTP ASPECTS were
assigned by two radiologists (N.S. and A.L. or J.H., see study I). In cases where the
scoring differed, a consensus score was agreed upon. The overall consensus opinion
was compared in general terms to the original report by an experienced
49
neuroradiologist, and if significant discrepancies were present, that neuroradiologist
was further consulted. Perfusion-defect areas and final infarct volumes were
measured by one radiologist (N.S.). The boundaries of the affected areas were
determined visually, and absolute- and relative-value thresholds described above
were applied. Volumes were calculated by multiplying the measured area by the
slice thickness.
Intraclass correlation coefficients (ICC) between a staff radiologist (N.S.) and an
experienced neuroradiologist (J.H.) were calculated for CBS and ASPECTS
assignments in a test sample (n=20): ICCCBS=0.86, ICCNCCT0h=0.86, ICCMTT=0.79,
ICCCBV=0.73 and ICCNCCT24h=0.93. The median interobserver agreement indices for
areas and volumes were AREAMTT: 68%, AREACBV: 90% and VOLUMEINFARCT:
80%. The interobserver agreement index for BASIS was 95%. Cohen´s kappa for
the location of the clot was 0.94.
4.6 Statistical analyses
Data were analyzed using SPSS versions 17 and 18 (SPSS Inc., Chicago, IL). A
biostatistician was consulted where deemed necessary. Patients with mRS ? 2
(primary clinical outcome measure) at the 3-month follow-up or those discharged to
home from the neurology ward (secondary clinical outcome measure) were
considered to have experienced favorable clinical outcomes. P-values of less than
0.05 were considered statistically significant. In study I, the difference between the
3-month postictal and the preictal mRS was used as an indicator of a good clinical
outcome, as it more accurately reflects the disease load inflicted by the current
episode. As expected from the definitions, ?mRS and mRS were highly correlated
(r = 0.85), and the offset between ?mRS and mRS was generally very small or
nonexistent. The median preictal mRS in the research population was 1. The
threshold for a good clinical outcome was deemed to be ?mRS ? 1 to enable
comparison with the mRS ? 2 threshold.
Group comparisons were performed using Fisher’s exact test [I]; the Mann-Whitney
U test and Fisher’s exact test [II]; Student’s t-test, the Chi-squared test, the Kruskal-
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Wallis, and Fisher’s exact test [III]; and Student’s t-test, the Mann-Whitney U test,
the Chi-squared test and Fisher’s exact test [IV].
Binary logistic regression modeling using either the primary or secondary clinical
outcome measures as the dependent variable was repeated for different variables of
interest. In study II, age and gender were treated as potential confounders and were
controlled for by treating them as covariates. One variable of interest was included
in the model at a time. In study III, NIHSS, age, gender, time from onset to
treatment and clinical risk-factors were examined as potential confounders and were
tested both in univariate models and with the location of clot in the model. The final
regression model retained the statistically significant and theoretically relevant
confounders. The calibration of the models was evaluated using the Hosmer-
Lemeshow test and the discrimination using the C statistic. The odds ratio (OR) at a
95% confidence interval (CI) was calculated for each covariate.
Pearson correlation coefficients and 2-tailed significance levels were calculated in
all correlation analyses. Differences between correlation coefficients were examined
using Steiger's Z-test.
After excluding cases of thrombosis of the basilar artery, receiver-operating
characteristic curves (ROC) were computed and Youden indices were evaluated to
select optimal threshold values for imaging parameters in predicting the
dichotomized good clinical outcome [I, II]. Differences between areas under the
curves (AUCs) of ROCs were tested using the Hanley-McNeil procedure.
Diagnostic sensitivities and specificities and confidence intervals were calculated
according to their textbook definitions. Normal and extended McNemar tests were
used to compare the overall diagnostic performance, the sensitivities and the
specificities.
Where necessary, the Bonferroni correction was applied to adjust for multiple
comparisons.
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5. RESULTS
5.1 CTP ASPECTS, CBS, and BASIS in the evaluation
of acute ischemic stroke [I, II]
The diagnostic performances of ASPECTS applied to CTP parametric maps, BASIS
and CBS were studied in the context of IVT. It was further hypothesized that CTP
ASPECTS mismatch may be useful in identifying patients that potentially benefit
from thrombolytic therapy and that a derived parameter combining both CTA and
CTP data may best predict clinical outcomes.
5.1.1 CTP ASPECTS parameters predict the final infarct volume
and the clinical outcome [I]
To assess the prognostic performance, the correlations between different ASPECTS
parameters, the final infarct volume and the clinical outcome (measured by the
?mRS, which is the difference between the postictal and preictal mRS scores) were
studied. When both anterior- and posterior-circulation strokes were included in the
analysis (n = 92 for NCCT and n = 72 for CTP), the final infarct volume correlated
inversely with all ASPECTS scores, and the absolute values of the correlation
coefficients having the order 24 h follow-up NCCT (NCCT 24 h) > CBV >
admission NCCT (NCCT 0 h) > MTT. In the case of the clinical outcome, the
correlations were ordered NCCT 24 h > CBV > MTT > NCCT 0 h. When the
anterior-circulation ischemic events were included in the analysis (n = 81 for NCCT
and n = 66 for CTP), correlations between the ASPECTS scores and the clinical
outcome were strengthened, although a similar order was maintained. This change is
due primarily to the generally poor prognosis of the posterior-circulation events that
were excluded and the definition of ASPECTS addressing only the anterior
circulation. In the CTP ASPECTS mismatch subgroup (n = 36), the correlation
coefficients between the ASPECTS scores and the clinical outcome were higher,
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whereas the correlations between the ASPECTS scores and infarct volume remained
essentially unchanged. All correlations described were statistically significant.
Overall, the correlations between the MTT and CBV scores and the clinical outcome
were stronger than that of the admission NCCT score and the clinical outcome,
suggesting that the CTP parameters may classify the patients more accurately.
However, only the CBV score displayed a statistically significant difference from
the admission NCCT score in all subgroups studied (p = 0.01-0.02).
The dichotomized thresholds for a good clinical outcome (?mRS ? 1) in anterior-
circulation stroke were calculated for the CTP and NCCT ASPECTS scores using
ROC curves. CBV ? 7 (AUC = 0.72) was the most accurate in identifying patients
with a good clinical outcome and thus those who potentially benefited from IVT.
This parameter showed 100% sensitivity and 44% specificity, and no patients with a
good clinical outcome were in the CBV < 7 group. Although statistically robust, the
MTT ? 4 (AUC = 0.68) and NCCT 0 h ? 10 (AUC = 0.66) thresholds were
outperformed. However, the differences between the AUCs were not statistically
significant.
5.1.2 CTP ASPECTS mismatch identifies potentially
salvageable ischemic tissue [I]
A mismatch between the NCCT 24 h and the MTT ASPECTS scores may be used to
estimate the amount of tissue salvaged because MTT approximates the extent of at-
risk tissue and the NCCT 24 h depicts the infarct volume. Going upstream in the
pathophysiological chain of events, this mismatch parameter is related to
reperfusion and vessel recanalization. Dichotomizing ?mRS using the threshold
?mRS ? 1 to signify a good clinical outcome, the lowest statistically significant
threshold for the MTT–NCCT 24 h ASPECTS mismatch that was related with a
favorable clinical outcome was 2 (p = 0.04). Using this threshold as an indicator for
total or partial timely tissue reperfusion, in the subgroup of patients showing MTT–
NCCT 24 h ASPECTS mismatch ? 2 (n = 17), this parameter and the CTP
ASPECTS mismatch were highly correlated (r = 0.83) and showed a strong linear
relationship (R2 = 0.70, Figure 9). These data suggest that the CTP ASPECTS
mismatch adequately predicts the amount of potentially salvageable tissue.
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Figure 9: The relationship between the MTT–CBV ASPECTS and the MTT–NCCT
24 h ASPECTS mismatches.
5.1.3 CBS, BASIS and CBV ASPECTS as prognostic classifiers
[II]
CBS and CBV ASPECTS were dichotomized using the thresholds (CBS > 6 and
CBV ASPECTS ? 7) that most accurately differentiated favorable from poor clinical
outcomes in study I and previous studies 111, 113, 114, 139, 182. By definition, BASIS is a
dichotomous variable. When the subgroups, which were defined by the
dichotomizations, were compared separately for each variable, patients with low
CBS or CBV ASPECTS scores or with major strokes had significantly higher
admission-NIHSS scores, larger perfusion defects in the CBV and MTT maps and
more findings of acute ischemic processes in the admission NCCT. A low CBS
score correlated with a low CBV ASPECTS score and major stroke. All these
properties significantly predicted poor clinical outcomes and larger infarct volume.
The accuracy of CBS and CBV ASPECTS in the prediction of the clinical outcome
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was enhanced when only anterior circulation strokes were included in the analysis,
whereas the predictive power of BASIS improved when all vascular territories were
included in the analysis. The performance of BASIS also improved if patients with
occlusion of the M2 segment were classified as having a minor stroke. This
modification was named M1-BASIS. An imaging parameter that combines CBS and
CBV ASPECTS was also devised by calculating an unweighted sum of the scores.
This parameter was named CBSV. An optimal threshold for dichotomization was
calculated for CBSV using ROC analysis where the 3-month clinical outcome was
used as the state variable (> 15, AUC = 0.72).
The prognostic value of these dichotomous imaging parameters was further assessed
using binary logistic regression analyses having functional independence (mRS ? 2)
at three months after the stroke as the dependent variable. Age and gender were
considered potential confounders and were controlled for by treating them as
covariates. When all vascular territories were included in the analysis, CBV
ASPECTS, CBS, CBSV, BASIS and M1-BASIS were all significant predictors of
good clinical outcome. CBV ASPECTS displayed the largest OR (13.3, CI 95% =
2.2-79.7). NCCT 0 h ASPECTS was not significantly associated with the clinical
outcome. When only anterior-circulation strokes were considered, CBSV was the
most robust predictor (OR = 16.3, CI 95% = 2.7-98.8, p = 0.002), whereas BASIS
did not reach statistical significance.
Sensitivities and specificities for detecting good clinical outcome (mRS ? 2) were
calculated for the dichotomized imaging parameters. When all vascular territories
were included in the analysis, CBV ASPECTS was the most sensitive predictor of
good clinical outcome (0.96, CI 95% = 0.86-0.99), whereas BASIS showed the most
accurate specificity (0.57, CI 95% = 0.34-0.77). BASIS was significantly less
sensitive than any of the other parameters. When only the anterior circulation was
considered, CBV ASPECTS was the most sensitive (0.96, CI 95% = 0.86-0.99)
predictor, and CBSV was the most specific (0.47, CI 95% = 0.22-0.73) predictor,
and again, BASIS was significantly less sensitive when compared to all other
parameters. CBV ASPECTS showed the best overall diagnostic accuracy in both
setups (0.82 for all vascular territories and 0.83 for the anterior circulation).
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5.2 The location of the thrombus in the prediction of the
clinical outcome [III]
The location of the clot is one of the components used in the calculation of the CBS.
The impact of the location of the clot only on the clinical outcome of anterior-
circulation stroke patients treated with IVT was studied. An assumption was made
that dividing the M1 segment of the MCA into proximal (M1P) and distal (M1D)
parts would provide increased accuracy in predicting the clinical outcome.
5.2.1 The location of the clot predicts the clinical outcome in a
dose-response manner
Patients with more proximal clots showed a poorer functional outcome at three
months after their stroke (Figure 10). When adjoining clot locations (ICA-M1P,
M1P-M1D, M1D-M2, M2-M3) were compared in pairs to determine differences in
the rate of good clinical outcome, the largest difference in prognosis (2.5-fold)
between adjoining clot locations was found between M1P and M1D where 24% and
59% showed a good clinical outcome, respectively. This measurement was the only
difference that was statistically significant (p = 0.01). There was a significant
increase in mortality (32% vs. 3%, p < 0.001) and functional dependency (82% vs.
29%, p < 0.001) in patients with an ICA or M1P occlusion compared with patients
with a more distal occlusion.
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Figure 10: Clinical outcome (3-month mRS) for different clot locations. A
favorable clinical outcome was defined as mRS ? 2 (functional independence).
Only one patient (6%) with an ICA and one patient (5%) with a M1P occlusion were
discharged to home, whereas 13 (45%) patients with an M1D clot, 15 (48%) patients
with an M2 clot and 5 (71%) patients with an M3 clot returned to home from the
primary hospital episode. Similar to the 3-month outcome, in a pairwise comparison
between the adjoining clot locations, the difference in favorable outcomes between
M1P (5%) and M1D (45%) was the only statistically significant difference (p =
0.003).
Binary logistic regression analysis was performed using functional independence
(mRS ? 2) at three months after the stroke as the dependent variable. When the clot
location was included in the model, the onset-to-treatment time (OTT), the gender,
presence of diabetes or hypertension or atrial fibrillation or coronary heart disease,
tested one at a time, were not statistically significant covariates. Age, NIHSS,
gender and OTT were retained in the final multivariate regression model as potential
confounders. Gender and OTT were selected for theoretical reasons, although they
did not reach statistical significance. The clot location was a highly significant
independent predictor of good clinical outcome in this model that was adjusted for
NIHSS (Table 3). When the ICA was set as the reference for the clot location, the
OR for a good clinical outcome at three months increased when moving from a
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proximal vessel position to a more distal one. The difference between ICA and M1P
was not statistically significant, whereas the differences to more distal locations
were highly significant, implying that the two proximal and the two distal vessel
positions form separate groups. The largest difference in the ORs of adjoining vessel
positions was between M1P and M1D (6.5-fold). A higher NIHSS score and
advanced age were both significantly associated with poorer outcome.
Odds
ratio CI 95% p value
Clot location - - 0.001
   ICA Ref Ref -
   M1 Proximal 4.2 0.45 - 38.2 0.21
   M1 Distal 27.4 2.9 - 257.9 0.004
   M2 and M3 (combined) 57.3 6.0 - 549.0 0.001
Onset-to-treatment time 1.0 0.98 - 1.02 0.81
Gender 0.49 0.15 - 1.6 0.23
Age 0.94 0.90 - 0.98 0.005
Admission NIHSS 0.82 0.74 - 0.92 0.001
Table 3: Binary logistic regression analysis for 3-month favorable clinical outcome
(mRS ? 2). Odds ratios are per minute for onset-to-treatment time, per year for age
and per one point for NIHSS. Ref = reference location.
5.2.2 A cut-off between M1P and M1D best differentiates
between good and poor clinical outcomes
On the basis of the above analyses, the clot location was dichotomized using three
cut-offs: ICA-M1P, M1P-M1D, M1D-M2 and M3 combined to simulate location-
based decision making. These dichotomized variables were entered into the
regression model one at a time instead of the clot-location variable. When the 3-
month outcome was the dependent variable, ICA-M1P and M1P-M1D showed
almost equal ORs (17.1 vs. 16.0), with the latter having a narrower 95% CI (2.3-
129.5 vs. 3.9-66.2). The most distal cut-off clearly showed a smaller OR (5.5, 95%
CI 1.8-16.8). When using the discharge status as the dependent variable, the cut-off
M1P-M1D yielded the largest OR (31.0, 95% CI 4.5-215.3). Overall, the increase in
the odds of a favorable outcome was clearly dampened when distal to M1P-M1D.
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Sensitivities and specificities for detecting good clinical outcomes were calculated
for these cut-offs. A clot distal to the cut-off location constituted a positive test
result. The cut-off M1P-M1D showed the highest diagnostic accuracy (0.75) in
predicting good clinical outcome at three months after the stroke. When the cut-offs
were tested in pairs, the overall diagnostic performance was significantly different
in every pair (p < 0.001 for each pair).
5.3 The technical quality and perfusion-defect detection
properties of CTP studies performed using a 16-row
or a 64-row multidetector CT scanner [IV]
The technical quality of the perfusion studies performed using 16-row or 64-row
scanners were compared and the differences in the ability to detect perfusion defects
were analyzed. The hypothesis was that the 16-row scanner would miss information
that is potentially critical for clinical decision making when compared with the 64-
row scanner.
The 64-row scanner was used to perform a perfusion study with 67 of the 140
patients (48%). A perfusion defect was demonstrated in 56% of the CTP studies.
Seventy-seven percent of the patients experienced a favorable clinical outcome at 3
months (mRS ? 2). The clinical outcome was not significantly different between
patients evaluated using different scanners.
5.3.1 The 16-row CTP scans show poorer technical quality
There were more motion artifacts in the 16-row group (Table 4). The artifacts
appeared to be due to the capture of small-scale periodic patient movements, such as
tremor, swallowing, nodding and minor swinging of the head. Correspondingly, the
AIF and the VOF curves were significantly noisier when calculated from the 16-row
scans. The analysis software completely corrected significantly fewer of these
artifacts. Both ASPECTS levels were optimally covered in only 29% of the 16-row
scans, whereas in the 64-row scans, both levels were optimally included in the
imaging volume in every case. In 46 of the 16-row scans (63%), only the lower level
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was optimally covered. Because of this lack of coverage, ASPECTS could not be
reliably assigned for the upper level in 26 cases (34%). Furthermore, because of its
larger z-axis coverage, the 64-row scanner fully or partially visualized the
subtentorial compartment significantly more often.
64-row
(n = 67)
16-row
(n = 73) p
Both ASPECTS levels optimally covered 67 (100%) 21 (29%) < 0.001
Motion artifacts 36 (54%) 52 (71%) 0.04
Incompletely corrected motion artifacts 8 (12%) 33 (42%) 0.001
Noisy AIF and/or VOF 1 (1%) 28 (38%) < 0.001
Subtentorial parenchyma not visualized 1 (1%) 31 (42%) < 0.001
ASPECTS score uninterpretable 0 (0%) 31 (42%) < 0.001
Scan not reliably interpretable 0 (0%) 6 (8%) 0.03
Table  4: Comparison of the technical quality of the 64-row and 16-row perfusion
scans.
5.3.2 The 16-row CTP studies suffer from decreased sensitivity
in the detection of perfusion defects in the cranial parts of
the middle cerebral artery region
The overall ASPECTS scores for MTT and CBV maps and the ASPECTS mismatch
scores were not significantly different between scanners. When the ASPECTS
regions that were missed by the 16-row scanner because of limited anatomic
coverage were scored as normal and were included in the analysis, the average
number of regions affected in the upper ASPECTS level was reduced. This
reduction reflects the decreased sensitivity for detecting perfusion defects. In the
case of MTT, this difference between the scanners became statistically significant
(Table 5). However, there were no significant differences in the total MTT and CBV
scores or the mean and number of ASPECTS mismatches. There were 9 patients
(6%) who showed perfusion defects that were located entirely outside the regions
covered by the ASPECTS levels and the volume between these levels. Eight were
detected by the 64-row scanner (p = 0.03).
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ASPECTS regions affected
64-row
(n = 67)
16-row
(n = 42) p1
16-row
(n = 67) p2
MTT lower ASPECTS level 1.4 ± 2.0 1.1 ± 1.6 0.74 1.5 ± 2.0 0.74
MTT upper ASPECTS level 0.9 ± 1.1 0.7 ± 1.1 0.54 0.5 ± 1.0 0.02
CBV lower ASPECTS level 0.7 ± 1.4 0.5 ± 1.2 0.35 0.6 ± 1.2 0.77
CBV upper ASPECTS level 0.3 ± 0.7 0.3 ± 0.7 0.87 0.2 ± 0.6 0.25
Table 5: Comparison of the perfusion-defect detection properties at different
ASPECTS levels. The 16-row (n = 67) column heading refers to the inclusion of
patients with ASPECTS regions that were missed by the 16-row scanner due to its
limited anatomic coverage. These regions were scored as normal. In the n = 42
population, these patients were excluded. p1: 64-row (n = 67) vs. 16-row (n = 42),
p2: 64-row (n = 67) vs. 16-row (n = 67). All values are of the mean ± SD.
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6. DISCUSSION
6.1 Predicting the outcome of acute ischemic stroke
using CTA and CTP
Predicting the clinical outcome is perilous. Ischemic stroke is a highly dynamic
condition comprising interplay between multiple different pathophysiological and
possibly also interventional processes that influence the eventual outcome. Some of
the most important of these factors include the coagulation cascade, the endogenous
fibrinolytic system, the exogenous drug effects, re-embolization, tissue
susceptibility to ischemic damage, the processes that modify the infarct threshold,
the collateral circulation, and the duration and the severity of the ischemia. The clot
may undergo complete or partial dissolution resulting in vessel recanalization,
undergo stabilization resulting in persistent occlusion, or progress to a more
extensive thrombosis. No single clinical or imaging variable sampled at the time of
admission to the hospital can capture these phenomena sufficiently to enable
deterministic prediction of the outcome. However, parameters derived from CTA
and CTP imaging potentially provide improved accuracy in the evaluation of the
prognosis and enable more precise risk stratification and decision making for
treatment 8, 9.
In study I, the ASPECTS scoring scheme was applied to CTP maps and the
association of these scores with the clinical and the imaging outcomes was
examined. The limited z-axis coverage of the majority of CT scanners that are
currently in use means that CTP images cannot cover the entire brain volume with a
single contrast bolus. Furthermore, exact volumetric analysis of the perfusion maps
requires user supervision and is too slow to be used in the context of acute stroke
imaging. Thus, applying the ASPECTS scoring scheme to the perfusion images
becomes an appealing alternative. This method has been validated by previous
investigators 111-114.
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The initial analyses in study I included all patients who received IVT within a
period of one year regardless of the vascular territory affected to provide a realistic
estimate of the overall performance in a clinical setting. A perfusion defect was
detected in 50% of these patients implying that with limited z-axis coverage, a CTP
study could affect approximately half of the positive thrombolytic treatment
decisions. Correlation analyses including all patients, patients with an anterior-
circulation stroke, and patients with a CTP ASPECTS mismatch revealed that the
CTP ASPECTS scores correlated more closely with the clinical outcome than the
findings from the admission NCCT. However, only CBV displayed a statistically
significant difference from the NCCT, whereas the MTT did not reach statistical
significance. This result appears to be due to the heterogeneity introduced by cases
where timely reperfusion occurred and the MTT defect was completely or partially
reversed. These findings are similar to previous reports in which the CTP ASPECTS
scores, especially the CBV ASPECTS, better predicted the clinical outcome of IVT
patients compared with the admission NCCT and CTA-SI 111-114, 181. Using ROC
analysis, Kloska et al. suggested that an optimal threshold value for CBV ASPECTS
that best differentiated between good and poor clinical outcomes was ? 7, whereas
Aviv et al. found that no patients with CBV ASPECTS ? 7 achieved a good clinical
outcome 113, 114. In study I, the threshold that performed best in ROC analyses was
CBV ASPECTS ? 7, which agrees closely with these reports.
The perfusion mismatch concept has also been adapted to CTP ASPECTS 182. CTP
ASPECTS mismatch has been used as a criterion to extend the time window of IVT
to  6  h 226. In study I, 39% of patients presented with such a mismatch. It was
demonstrated that the CTP ASPECTS mismatch identified the amount of potentially
salvageable tissue adequately and described the spectrum of possible imaging
outcomes. Small mismatches (? 1 ASPECTS points) were difficult to assess because
of noise introduced by the dynamic stroke pathophysiology and interpretation issues
during image analysis. A threshold of ? 2 salvaged ASPECTS regions was
correlated with a favorable clinical outcome, suggesting that reversal of smaller
perfusion defects are unlikely to benefit the patient. This threshold corresponds
approximately to a mismatch ratio of 2.0 182. This result prompted Sztriha et al. to
use this CTP ASPECTS threshold in the classification of patients who presented
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between 3 and 6 h from symptom onset 226. They reported that this threshold
performed adequately in identifying patients who could benefit from IVT.
Building on and expanding these concepts, in study II, we examined the
performance of two CTA-based classification schemes, BASIS and CBS, and one
perfusion parameter, CBV ASPECTS, and a combination of these variables in the
prediction of clinical outcomes in the same IVT cohort as in study I. Both BASIS
and CBS address the location of the clot, whereas CBS also takes the volume of the
clot into account. CBV ASPECTS provides an approximation of the size of the
infarct core. Thus, these parameters provide information on markedly different
aspects of the stroke pathophysiology.
Patients with low CBS and CBV ASPECTS scores and with major strokes
according to BASIS experienced poor clinical outcomes more often, which is
consistent with recent studies 111-114, 134, 135, 139, 181, 227. As expected from their
definition, which does not address the posterior circulation, CBS and CBV
ASPECTS predicted the clinical outcome with greater accuracy when only anterior-
circulation strokes were analyzed. In contrast, BASIS encompasses both the anterior
and posterior circulation and correspondingly performed better when all vascular
territories were included in the analysis. However, BASIS did not reach statistical
significance when only patients with anterior-circulation strokes were analyzed (p =
0.23). This finding was reversed if patients with thrombosis of the M2 segment were
classified as having a minor stroke (p = 0.002). This modified BASIS performed
better than the original and was named M1-BASIS. This finding is likely due to the
effect of IVT and supports the notion that patients with a clot in the M2 segment
often benefit from IVT, whereas when the clot is more proximal, a limited response
is more likely 131, 134, 136, 228. Only a minority of patients (8%) received IVT in the
cohort that was originally used to validate BASIS 140. In the logistic regression
analysis, BASIS, M1-BASIS and dichotomized CBV ASPECTS and CBS were all
significant predictors of the clinical outcome.
A new, derived imaging parameter was created by calculating the sum of a
parameter from the CTA and one from the CTP, the CBS and CBV ASPECTS. This
variable was named CBSV. When only anterior-circulation strokes were considered,
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CBSV proved to be, statistically, the most robust predictor of favorable clinical
outcome (OR = 16.3, CI 95% = 2.7-98.8, p = 0.002). In view of the fact that the
CBSV combines two independent predictors of the clinical outcome that both reflect
different pathophysiological aspects of stroke, in theory, the CBSV should have
better predictive power than either of its components, which is supported by the
results of study II. An imaging score resembling CBSV but utilizing CTA-SI instead
of CBV was introduced recently 134. This scoring scheme improved the
identification of patients with high mortality rates or poor functional outcomes
despite early IVT.
CBV ASPECTS, CBS, CBSV and M1-BASIS all had high sensitivity (85-96%) but
moderate to poor specificity (24-52%) for predicting good clinical outcome. BASIS
was only moderately sensitive (70-71%). This rather low specificity is to be
expected because not all patients experience reperfusion, and although strategic
infarcts may cause a serious functional deficit, they may show minimal imaging
findings. Tan et al. found CBS to be less sensitive but more specific when compared
with our results 139. This inconsistency is likely due to the higher median NIHSS
score and lower proportion of patients treated with r-tPA (71%) in their study
population.
The location of the clot is one of the main components of CBS and BASIS. Study
III examined the ability of the location of the clot alone in predicting the clinical
outcome. The results revealed that the location was an independent predictor of the
clinical outcome even when the NIHSS score was controlled for. The odds ratios for
a good clinical outcome increased and the mortality decreased consistently when
moving from a proximal to a more distal vessel position. When adjoining vessel
positions were tested in pairs, only the difference between M1P and M1D was
statistically significant. Following dichotomization of the clot location, a cut-point
between the M1P and M1D was associated with the largest increase in the odds of a
favorable outcome and showed the highest diagnostic accuracy. This cut-point is
likely due to specific anatomic and pathophysiological factors. The lenticulostriate
arteries, which supply blood to the basal ganglia, originate primarily from the
proximal M1 segment. A lesion in this region affects gait and other motor functions
and has direct consequences for functional independence. The mean diameter of the
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vessel, and thus the volume of the clot, is larger in the proximal segment, which
potentially decreases the effectiveness of IVT. Moreover, proximal thrombi tend to
propagate distally, which can also increase the total volume of the clot.
Some studies have previously addressed the effect of the clot location on
recanalization and clinical outcomes in the context of IVT. Del Zoppo et  al.  used
DSA to reveal that thrombi situated in the M2 and M3 segments are more likely to
undergo recanalization than those in the M1 segment and the ICA 127. Consistent
with these results, in a more recent study, Saqqur et al. utilized repeated transcranial
Doppler ultrasonography to detect recanalization where the main end-point was the
clinical outcome at 3 months 129. Different subareas of the M1 segment were not
addressed in either of these studies. However, the rate of good outcomes at M1P in
study III was comparable to that of the proximal MCA and the M1D to that of the
distal MCA in these published reports. Furthermore, other studies with more
heterogeneous setups have corroborated that large-vessel occlusions are less likely
to recanalize and that they predict unfavorable clinical outcomes 128, 131, 132.
Overall, the findings of study III and the previously published research support the
notion that alternatives to IVT, which are chiefly primary intra-arterial or bridging
therapy, should be considered if the thrombus is located in the ICA or in the
proximal M1 segment.
6.2 The 16-row scanner is inferior to the 64-row
scanner in the CTP evaluation of acute ischemic
stroke
The differences in the technical quality and the perfusion-defect detection properties
between CTP studies performed using a 16-row or a 64-row scanner were compared
in a clinically managed IVT cohort. The 64-row scanner covered 80 mm of the z-
axis, whereas the 16-row scanner covered 20 mm. The coverage of the 64-row
scanner was increased by alternating the table between two positions. This
procedure can also be utilized with 16-row scanners. Typically, 40-mm coverage is
achieved. Another method to double the imaging range is to use two contrast
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injections and to image adjoining 20 mm slabs separately. Although these
techniques increase the number of perfusion defects detected, the results remain
inferior compared with z-axis ranges larger than 40 mm 191, 193.
Some studies have addressed the impact of different z-axis ranges in the detection of
perfusion defects. Using a 320-row scanner, Page et al. reported that 160-mm
coverage better defined the extent of the infarct core and the penumbra compared
with 40-mm coverage 193. Morhard et al. observed that 20-mm coverage missed
24% of pathological findings when compared with 96-mm coverage 229. Furtado et
al. noted that 75 mm of z-axis coverage was required to reliably detect a perfusion
mismatch ratio of 2.0, whereas 50 mm was sufficient when a ratio of 1.2 was used
191. Fifty-five millimeters must be covered to provide sufficiently accurate
estimations whether more than one-third of the MCA region is irreversibly
damaged. Interestingly, rules based on ASPECTS provide potential alternatives for
excluding patients from thrombolytic therapy and require less extensive coverage
109, 112. Youn et al. reported that 80-mm coverage was associated with a significantly
higher lesion-detection rate compared with 20-mm coverage 230. The results
presented in this thesis are consistent with these findings. All previous studies
contained somewhat heterogeneous populations and simulated narrower coverage
by selecting ranges of larger volumes that were imaged using one scanner, whereas
in study IV, all patients received IVT and two scanners with different detection
widths were used.
In study IV, the 16-row examinations suffered from limited anatomic coverage that
often resulted in inadequate visualization of the cranial MCA region. ASPECTS
could not be assigned to the upper, supraganglionic level in one-third (34%) of these
scans, which significantly decreased the detection sensitivity of perfusion defects in
the upper level (Table 5). The impact on the overall ASPECTS score was limited
because the lower ganglionic level is given considerably heavier weight (7 vs. 3
regions). However, in study I, the threshold for salvaged ASPECTS regions (and
hence the CTP ASPECTS mismatch) that was associated with a favorable outcome
was 2 points. Thus, the supraganglionic level alone is potentially critical in the
evaluation of the mismatch. Furthermore, the 64-row scanner was capable of
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discovering a significantly larger number of perfusion defects entirely outside the
volume limited by the ASPECTS levels.
The number of movement artifacts was significantly greater in the 16-row group.
This increase may be due to the higher sampling frequency (1/s vs. 0.27/s) and the
smaller slice thickness (5 mm vs. 10 mm), which appeared to capture small-scale
periodic patient movements more frequently. This type of movement was poorly
corrected by the analysis software. Although this feature does not typically render
the scan uninterpretable, it introduces inaccuracies to the measurement of absolute
values of the perfusion parameters. However, a lower sampling frequency could
result in the same effect and a larger slice thickness may decrease the sensitivity in
detecting small perfusion defects due to averaging.
Overall, the 16-row scanner was inferior to the 64-row scanner in the CTP
evaluation of acute ischemic stroke. However, there was no significant difference in
the clinical outcome between the study groups. This finding is to be expected
because the institutional guidelines on stroke management did not define any
specific role for the CTP findings at the time; thus, stroke management was
essentially similar between the both groups.
6.3 Limitations
All studies were limited methodologically by the retrospective single center design.
The sample size is a potential limitation in particular for the subgroup analyses.
Because of the design of the studies, direct data on vessel recanalization or
reperfusion were not available for the majority of patients. However, a low
ASPECTS score at the 24 h NCCT and poor clinical outcomes are closely correlated
with delayed or failed reperfusion and can be used as a surrogate. The craniocaudal
coverage of the CTP was, at a minimum, 20 mm. Thus, the size of the perfusion
defect was estimated using ASPECTS scoring and area measurements in the
ASPECTS levels. It should be noted that MTT maps potentially overestimate the
size of the perfusion defect, whereas CBV maps may overestimate or underestimate
the volume of the irreversibly damaged parenchyma, and CTP results may vary with
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machine 177. Interobserver agreement in some imaging parameters was not perfect,
although this finding is consistent with previous reports 113. M1-BASIS was created
based on a post hoc analysis of the data set and should be further validated in other
thrombolytic therapy cohorts. In study III, the distribution of patients based on clot
locations was uneven because 63% of patients showed a clot distal to the mid M1
segment. The only confounding variable between these two groups (proximal and
distal to the mid M1 segment) that was significantly different was gender. However,
gender was not a significant predictor of the clinical outcome. The Pearson
correlation coefficient for gender and the clot location was 0.18. The Kruskal-Wallis
test for gender did not reveal significant differences between clot locations. The
disparity in gender distribution could be attributed to chance because no selection
process was identified that would potentially produce this result.
6.4 Multimodal CT-based evaluation protocol for acute
stroke
Multimodal CT is fast, increasingly available, safe when performed correctly, and
affordable 167. There is an accumulating body of evidence that multimodal CT can
provide diagnostic information comparable to that of MRI, which can aid in clinical
decision making, in particular in the selection of different revascularization
therapies. Thus, CT-only imaging protocols in the evaluation of acute stroke have
been proposed 167.
Distal ICA occlusions, proximal MCA-branch occlusions or a considerable thrombi
burden may be poor candidates for IVT and may be better candidates for intra-
arterial thrombolysis or mechanical interventions 137, 231, 232. An observational study
by Mattle et al. compared IAT to IVT in patients with hyperdense MCA sign and
noted that IAT was more beneficial 233. The findings of study III are consistent with
these reports, and the results provide improved spatial resolution in the M1 segment.
In a recent study, multimodal intra-arterial therapy resulted in the highest
recanalization rates of anterior-circulation clots 233, 234. Furthermore, intra-arterial
therapies have a potential role when IVT fails, if there is contraindication to IVT, in
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the extension of the treatment time window and in the treatment of wake-up strokes
47.
Drawing from the previously published research and the results of studies I-IV, a
multimodal CT-based evaluation and treatment triage protocol for acute stroke is
proposed (Figure 11) 49, 167, 235. This protocol demonstrates how the findings of this
thesis can be integrated to the emerging, imaging-oriented, time-independent
concept of acute stroke evaluation and management outlined in section 2.2.4. The
overall level of evidence on the use of intra-arterial stroke interventions remains
suboptimal and does not permit definitive recommendations. The recanalization
strategy for thrombosis of the basilar artery remains an open issue, and the cut-off
location for intra-arterial or bridging therapy suggested in Figure 11 is largely
speculative 236. Although the time from the onset of the symptoms has no explicit
role in the proposed protocol, when a perfusion defect is undetected in the presence
of significant symptoms and more than 4.5 h has elapsed from the symptom onset,
DWI imaging may detect a possible acute lacunar ischemic event.
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Figure 11: An imaging-oriented evaluation protocol for acute stroke based on the
use of multimodal CT.
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7. SUMMARY AND CONCLUSIONS
This thesis investigated the utility and the prognostic performance of imaging
parameters derived from CTA and CTP scans in the evaluation of acute ischemic-
stroke patients receiving intravenous thrombolytic therapy and the quality of CTP
studies with scanners of different detector widths.
The main findings and conclusions are as follows:
1. Parameters derived using ASPECTS scores of CTP maps obtained upon
admission to the hospital can detect reversible ischemia and are correlated
with the clinical outcome. CBV ASPECTS best differentiates between good
and poor outcomes in anterior-circulation strokes and is superior to NCCT
ASPECTS. CTP ASPECTS mismatch adequately identifies the amount of
potentially salvageable tissue and describes the spectrum of possible imaging
outcomes.
2. CBS, BASIS and CBV ASPECTS are statistically robust and sensitive but
unspecific predictors of good clinical outcomes among patients receiving
IVT. Two derived imaging parameters, CBSV and M1-BASIS, essentially
share these same properties but appear to provide slightly better prognostic
accuracy.
3. The functional outcome of acute ICA or proximal M1 segment occlusion is
generally poor even if treated with intravenous thrombolytic therapy. A cut-
point between the proximal and the distal M1 segment best differentiates
between good and poor clinical outcomes and provides the highest accuracy
in predicting favorable clinical outcomes.
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4. CTP studies performed using a 16-row scanner suffer from limited z-axis
coverage that significantly decreases the sensitivity for detecting perfusion
defects in the cranial parts of the MCA region compared with a 64-row
scanner. The 16-row scans show more motion artifacts that result from
small-scale periodic patient movements.
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 Abstract 
 Background and Purpose: Advances in the management of acute ischemic stroke and medical 
imaging are creating pressure to replace the rigid one-third middle cerebral artery (MCA) and 
non-contrast-enhanced CT (NCCT) Alberta Stroke Program Early CT Score (ASPECTS) thresholds 
used for the selection of patients eligible for intravenous thrombolytic therapy. The identifica-
tion of potentially salvageable ischemic brain tissue lies at the core of this issue. In this study, 
the role of CT perfusion ASPECTS in the detection of reversible ischemia was analyzed.  Materi-
als and Methods: We retrospectively reviewed the clinical and imaging data of 92 consecutive 
patients who received intravenous thrombolytic therapy for acute (duration  ! 3 h) ischemic 
stroke. Most of the patients underwent admission multimodal CT, and all patients had follow-
up NCCT at 24 h. ASPECTS was assigned to all modalities and correlated with clinical and imag-
ing parameters. Receiver-operating characteristic curve analysis was performed to determine 
optimal thresholds for different parameters to predict clinical outcome.  Results: A perfusion 
defect could be detected in 50% of the patients. ASPECTS correlated inversely with the clinical 
outcome in the following order: follow-up NCCT  1 cerebral blood volume (CBV)  1 mean transit 
time (MTT)  1 admission NCCT. The follow-up NCCT and the CBV displayed a statistically signifi-
cant difference from the admission NCCT, while the MTT did not reach statistical significance. 
The threshold that best differentiated between good and bad clinical outcome on admission 
was CBV ASPECTS  6 7. In patients with CT perfusion ASPECTS mismatch, MTT and CBV ASPECTS 
 Published online: February 17, 2011 
 Niko Sillanpaa, MD 
This is an Open Access article licensed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online 
version of the article only. Distribution for non-commercial purposes only.
 Medical Imaging Center, Tampere University Hospital, PL 2000 
 FI–33521 Tampere (Finland) 
 Tel. +358 3 311 64628, E-Mail niko.sillanpaa   @   pshp.fi 
 
www.karger.com/cee
 DOI: 10.1159/000324324 
E X T R A
7Cerebrovasc Dis Extra 2011;1:6–16
 DOI: 10.1159/000324324 
 Sillanpaa et al.: CT Perfusion ASPECTS in the Evaluation of Stroke 
www.karger.com/cee
 © 2011 S. Karger AG, Basel 
 Published online: February 17, 2011 
E X T R A
essentially provided the lower and upper limits for the follow-up NCCT ASPECTS, thus defining 
the spectrum of possible outcomes. Furthermore, CT perfusion ASPECTS mismatch strongly 
correlated (r = 0.83) with the mismatch between the tissue at risk and the final infarct, i.e. the 
amount of salvaged tissue. This finding suggests that the CT perfusion ASPECTS mismatch ad-
equately identifies the amount of potentially salvageable ischemic brain tissue.  Conclusions: 
Parameters derived from the use of CT perfusion ASPECTS can detect reversible ischemia and 
are correlated with clinical outcome.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 The role of CT perfusion (CTP) in the decision to administer thrombolytic therapy with 
intravenous recombinant tissue plasminogen activator (rtPA) remains controversial. Re-
search initiatives have been proposed to establish a sufficient body of evidence that would 
allow formal clinical guidelines to be composed  [1] . At the core of this dilemma lie the detec-
tion of the ischemic penumbra and the infarct core and the implications this information 
should have for clinical decision making. Previous studies suggest that CTP can provide an 
estimate of the amount of potentially salvageable, acutely ischemic brain tissue and that the 
resulting CTP parameters provide an independent prognostic factor of the clinical outcome 
 [2–6] . CTP also seems to increase diagnostic performance in stroke diagnosis and inter- and 
intraobserver agreement  [7] .
 The Alberta Stroke Program Early CT Score (ASPECTS) is a semiquantitative, weighted 
scoring system that was developed to overcome the difficulties in the application of the non-
contrast-enhanced CT (NCCT) one-third middle cerebral artery (MCA) rule that is used to 
select patients eligible for intravenous thrombolytic therapy  [8] . ASPECTS is predictive of 
clinical outcome and hemorrhagic complications but is not sufficiently accurate in the triage 
of thrombolysis candidates  [9–11] . Applying ASPECTS to CTP parametric maps has been 
suggested to be more reliable in both detecting reversible ischemia and predicting clinical 
outcome  [12–15] .
 We retrospectively reviewed the clinical and imaging data of 92 consecutive patients 
who received intravenous thrombolytic therapy for acute (duration  ! 3 h) ischemic stroke in 
order to study the potential of CTP ASPECTS in the detection of reversible ischemia. We 
hypothesized that CTP ASPECTS mismatch  [16] , the difference between the mean transit 
time (MTT) and cerebral blood volume (CBV) map scores, might be useful in identifying 
patients who potentially benefit from thrombolytic therapy.
 Materials and Methods 
 Overview 
 We retrospectively analyzed the clinical and imaging data of 92 consecutive patients who 
were admitted to Tampere University Hospital between January 2007 and December 2007 
because of acute (duration  ! 3 h) stroke symptoms and who received intravenous rtPA for the 
treatment of acute ischemic stroke after evaluation. In total, 271 patients suffering from acute 
ischemic stroke were evaluated as candidates for thrombolytic therapy during this period of 
time. The initial imaging evaluation of stroke patients consisted of NCCT, CT angiography 
(CTA) and CTP. The selection of patients eligible for thrombolytic therapy was based on in-
stitutional guidelines that did not have CTP or CTA parameters as exclusion or inclusion cri-
teria. Still, we reviewed patient records of 179 patients who did not receive thrombolytic ther-
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apy in order to detect possible selection bias caused by CTP studies. The indications to exclude 
a patient from thrombolytic therapy had been carefully documented. In 1 case, the decision 
to exclude the patient was based on the results of a CTP study (extremely poor technical qual-
ity of the admission NCCT and over one third MCA lesions in the CBV map). In addition, we 
discovered 3 cases in which the admission NCCT was initially erroneously interpreted as 
negative and the results were reported orally to the stroke neurologist, followed by a review 
and a correction after the CTP maps had been calculated and analyzed some minutes later, 
with the result that the decision to administer thrombolytic therapy was withdrawn.
 A full multimodal imaging evaluation was successfully completed in 72 of the 92 pa-
tients who received thrombolytic therapy. Nine patients were evaluated with NCCT alone 
and 11 patients with NCCT and CTA because of previously known contrast agent hypersen-
sitivity, chronic renal failure, imminent closure of the 3-hour time window, or movement 
artifacts that rendered some of the imaging data not evaluable. A standard rtPA administra-
tion scheme was used: a total dose of 0.9 mg/kg Actilyse (Boehringer-Ingelheim, Ingelheim, 
Germany) was administered, with 10% given as a bolus and the remaining 90% as a contin-
uous infusion for 1 h. A follow-up NCCT was performed for all patients 24 h after the ad-
ministration of the thrombolytic agent. National Institutes of Health Stroke Scale (NIHSS) 
scores were assessed on admission and 24 h after the thrombolytic therapy. The modified 
Rankin Scale (mRS) was evaluated preictally and on day 90. The clinical data were stored 
(prospectively) in the patient records during the hospital stay and on day 90 after the ictus, 
the latter following a phone interview. These data were collected from the patient records and 
critically reviewed for errors using the data available from all medical and related disciplines 
(J.T.S.). The study was approved by the Tampere University Hospital Ethics Committee.
 Imaging Parameters 
 CT scans were obtained using two different multidetector scanners: the General Electrics 
LightSpeed 16-slice scanner (GE Healthcare, Milwaukee, Wisc., USA) and the Philips Bril-
liance 64-slice scanner (Philips, Cleveland, Ohio, USA). Brain NCCT was performed using the 
parameters 120 kV, 430 mA, collimation 12  ! 1.25 mm, and rotation 1.5 s (64-slice scanner), 
or 120 kV, 320 mA, collimation 16  ! 1.25 mm, and rotation 1 s (16-slice scanner). Contiguous 
slices were reconstructed to the thickness of 5 mm in the whole scanning range (64-slice scan-
ner) or to the thickness of 5 mm in the skull base and 7.5 mm in the supratentorial region 
(16-slice scanner). CTA was performed using a scanning range extending from the C2 vertebra 
to the vertex of the skull. The imaging parameters were 120 kV, 212 mA (using dynamic tube 
current modulation), collimation 64  ! 0.625 mm, rotation 0.75 s, and pitch factor 0.923 
(64-slice scanner), or 120 kV, 160 mA, collimation 16  ! 0.625 mm, rotation 0.8 s, and pitch 
factor 0.938 (16-slice scanner). Contiguous slices were reconstructed to the thickness of 0.9 mm 
with a 0.45-mm overlap (64-slice scanner) or to the thickness of 1.25 mm (16-slice scanner). 
The contrast agent (iobitridol 350 mg I/ml; Xenetix, Aulnay-sous-Bois, France) was adminis-
tered via an antecubital vein with an 18-gauge cannula using a double-piston power injector 
with a flow rate of 4 ml/s and 70 ml of contrast agent followed by a 50-ml saline flush. Manu-
al bolus triggering was used. CTP was performed using the parameters 80 kV, 200 mA (effec-
tive), collimation 32  ! 1.25 mm, and rotation 0.4 s (64-slice scanner), or 80 kV, 200 mA, col-
limation 8  ! 2.5 mm, and rotation 1 s (16-slice scanner). 120 slices covering a range of 80 mm 
were generated in 55 s using an alternating jog protocol, i.e. shuttle mode (64-slice scanner), or 
200 slices covering a range of 20 mm were generated in 50 s with a stationary gantry position 
(16-slice scanner). Contiguous slices were reconstructed to a thickness of 10 mm (64-slice scan-
ner) or 5 mm (16-slice scanner) at even time intervals. The imaging range was positioned so 
that the ASPECTS planes  [8] were always covered. The rest of the 80-mm range (64-slice scan-
ner) was positioned both cranial and caudal to the ASPECTS planes with the exact balancing 
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depending on the clinical presentation. The contrast agent (Xenetix 350 mg I/ml) was admin-
istered via an antecubital vein with an 18-gauge cannula using a double-piston power injector 
with a flow rate of 5 ml/s and 60 ml of contrast agent followed by a 40-ml saline flush.
 Image Analysis 
 NCCT examinations were reviewed using dedicated medical imaging workstations. 
CTA and CTP images were analyzed, and areas and volumes were measured with Advantage 
Workstation version 3.2 (GE Healthcare). Parametric perfusion maps – MTT, cerebral blood 
flow, and CBV – were generated with the CT Perfusion 3 software that uses a deconvolution-
based algorithm. CTA images were reviewed by examining both the raw data and maximum 
intensity projection images.
 The principles of ASPECTS scoring in NCCT and CTP maps and the evaluation of CTP 
ASPECTS mismatch have been described in previous studies  [8, 12, 15] . In short, each hemi-
sphere is divided into 10 regions in 2 axial planes at the level of the basal ganglia and corona 
radiata ( fig. 1 ). Each of these regions has a score of 1 point. This point is deducted if that re-
gion has ischemic changes. Thus, a negative finding yields a score of 10, and extensive isch-
emia covering the whole MCA region yields a score of 0.
 MTT maps were used to detect tissue at risk, and CBV maps were used to approximate 
the infarct core  [4] . The calculation of CTP ASPECTS mismatch is described in  figure 1 . We 
adopted a semiquantitative approach where the presence of a perfusion defect was deter-
mined visually from color-coded maps by comparing the appearance of the affected location 
with that of the healthy tissue on the contralateral side. In order to increase measurement 
 Fig. 1. CTP ASPECTS mis-
match in a patient suffering 
from acute ischemia in the right 
MCA  ter ritory. In the CBV maps, 
 ASPECTS areas I, M2, and M5 
are affected (CBV ASPECTS = 
7), whereas in the MTT maps 
 areas I, M1, M2, M4, M5, and 
M6 display a perfusion defect 
(MTT ASPECTS = 4). Thus, 
CTP  ASPECTS mismatch = 3. 
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accuracy and based on theoretical considerations, the area in the visually identified location 
was required to measure  1 25 mm 2 with a mean MTT  1 7 s (or mean CBV  ! 2.5 ml/100 g, cor-
respondingly). NCCT and CTP ASPECTS were assigned by two radiologists (N.S. and A.L.). 
In cases where the scoring differed, a consensus score was agreed on. This score was corre-
lated with the original findings of an experienced neuroradiologist, and if significant dis-
crepancies were present, this neuroradiologist was further consulted. The examinations were 
reviewed in the order NCCT, CTA, and finally CTP, paralleling that of the clinical work flow. 
The reviewers were blinded to the clinical data apart from the side and nature of the acute 
symptoms. Perfusion defect areas and final infarct volumes were measured by one radiolo-
gist (N.S.). The boundaries of the affected areas were determined visually, and absolute val-
ue thresholds described above were applied. Volume was calculated by multiplying the mea-
sured area with the slice thickness. Intraclass correlation coefficients (ICC) between a staff 
radiologist (N.S.) and an experienced neuroradiologist (J.H.) were calculated for ASPECTS 
assignments in a test sample (n = 20): ICC NCCT = 0.86, ICC MTT = 0.79, ICC CBV = 0.73, and 
ICC NCCT 24 h = 0.93. Median interobserver agreement indices for areas and volumes were 
Area MTT : 68%, Area CBV : 90%, and Volume INFARCT : 80%.
 Statistics 
 Data were analyzed with SPSS version 17 (SPSS Inc., Chicago, Ill., USA). Pearson correla-
tion coefficients and 2-tailed significance levels were calculated in all correlation analyses. 
Receiver-operating characteristic curves (ROC) were computed and Youden indices were eval-
uated to select optimal threshold values for imaging parameters to predict dichotomized good 
clinical outcome. After the dichotomization of the imaging parameters based on the threshold 
values, the data were cross tabulated and significance levels were calculated using Fisher’s exact 
test. Differences between correlation coefficients and ROC area under the curves (AUCs) were 
studied with Steiger’s Z test and the Hanley-McNeil procedure, respectively. Sensitivity, speci-
ficity, and confidence interval calculations were performed using standard procedures. In the 
text and the illustrations, the following notation is used to denote the level of statistical sig-
nificance:  *  p  ! 0.05,  * *  p  ! 0.01 and  * * *  p  ! 0.001. If p  6 0.01, the precise p value is given.
 Results 
 Baseline Characteristics and Validation of the Scoring System 
 The median age of the patients was 71 years (interquartile range 58–80 years, 42 female). 
Based on the clinical features and the imaging studies, in 11 of the 92 patients evaluated, the 
ischemic episode involved the posterior circulation (8 cases of thrombosis of the basilar ar-
tery). The rest of the episodes were considered to involve the anterior circulation. The throm-
bosis could be demonstrated with CTA in 37 cases (45% of the CTA studies and 40% of all 
patients). In 40 (56%) of the 72 patients evaluated with CTP, a perfusion defect could be de-
tected in the ASPECTS planes. An additional 6 perfusion defects were found outside the 
 ASPECTS planes. A perfusion pattern implying acute ischemia could be detected in half of the 
cases involving the posterior circulation when CTP was performed. In total, a perfusion defect 
could be demonstrated in 64% of the CTP studies (50% of all patients). The median NIHSS on 
admission was 7 points (56.0% had NIHSS  ! 8, 18.7% had NIHSS  1 15, interquartile range 
4–12), and 24 h later the median NIHSS was 2 points. The median mRS was 1 point preictal-
ly and 2 points 3 months later. The median change in mRS (  mRS) was 1 point. 74.4% of the 
patients experienced a favorable clinical outcome at 3 months (mRS  ^  2). At 24 h, a local hem-
orrhagic complication (HI1, HI2, PH1, or PH2) was detected in 6 cases (6.5%), and 4 patients 
(4.4%) had parenchymal hemorrhage distant to the site of the infarct (PHr1 or PHr2). In order 
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to validate the ASPECTS scoring method, we studied the correlations between CTP and 
NCCT ASPECTS, and the area and the volumetric data acquired from the perfusion maps and 
the NCCT images. ASPECTS for CBV and MTT were inversely correlated with the perfusion 
defect areas with r = –0.87 * * * and r = –0.91 * * * , respectively. The correlation between the CTP 
ASPECTS mismatch and the measured mismatch area was r = 0.77 * * * . As expected, the infarct 
volume correlated with   mRS (r = 0.54 * * * ) as did NIHSS on admission (r = 0.35 * * ).
 CTP ASPECTS Parameters Correlate with Final Infarct Volume and Clinical Outcome 
 In order to assess the prognostic performance, we studied the correlations between dif-
ferent ASPECTS parameters, the final infarct volume, and the clinical outcome, which we 
measured with   mRS. First, we studied the overall performance of the ASPECTS scoring 
method systematically applied to all patients identified as candidates for thrombolytic ther-
apy based on clinical features, including patients with a subsequently diagnosed posterior 
circulation stroke ( table 1 , ‘all patients’). The final infarct volume correlated inversely with 
all ASPECTS, with the 24-hour follow-up NCCT having the highest correlation, as expected. 
Also the other scores displayed statistically significant correlations in the order CBV  1 
NCCT 0 h  1 MTT, with NCCT 0 h and MTT having close to equal correlation coefficients. This 
pattern is reflected in the clinical outcome, where the correlations were ordered NCCT 24 h  1 
CBV  1 MTT  1 NCCT 0 h , with CBV having a correlation coefficient almost equal to that of 
NCCT 24 h . In general, the correlations between ASPECTS and   mRS were weaker than those 
between ASPECTS and the infarct volume but still highly statistically significant. This pat-
Table 1. C orrelations between the NCCT and CTP ASPECTS scores and the final infarct volume and the 
clinical outcome (mRS) for all patients, patients with anterior circulation ischemia, and patients with 
CTP ASPECTS mismatch
Infarct volume  mRS
corr. coeff. vs. NCCT0 h corr . coeff. vs. NCCT0 h
All patients (n = 92 for NCCT and n = 72 for CTP)
NCCT0 h r = –0.56*** – r = –0.25* –
MTT r = –0.56*** p = 1.0 r = –0.34** p = 0.40
CBV r = –0.69*** p = 0.07 r = –0.48*** p = 0.01*
NCCT24 h r = –0.82*** p < 0.001*** r = –0.49*** p = 0.01*
Anterior circulation (n = 81 for NCCT and n = 66 for CTP)
NCCT0 h r = –0.57*** – r = –0.34** –
MTT r = –0.58*** p = 0.91 r = –0.43*** p = 0.41
CBV r = –0.70*** p = 0.08 r = –0.55*** p = 0.02*
NCCT24 h r = –0.85*** p < 0.001*** r = –0.65*** p < 0.001***
Patients with CTP ASPECTS mismatch (n = 36)
NCCT0 h r = –0.55** – r = –0.39* –
MTT r = –0.48** p = 0.63 r = –0.57*** p = 0.12
CBV r = –0.66*** p = 0.33 r = –0.69*** p = 0.01*
NCCT24 h r = –0.84*** p = 0.003** r = –0.85*** p < 0.001***
The final infarct volume and the clinical outcome correlated inversely with all ASPECTS scores, with 
the 24-hour follow-up NCCT having the highest correlation. All the correlation coefficients (corr. coeff.) 
were statistically significant. The correlations between the MTT and CBV ASPECTS scores and the clin-
ical outcome are stronger than the correlation of the admission NCCT score and the clinical outcome, 
suggesting that CTP parameters may better classify reversible and non-reversible ischemia. However, only 
the CBV score displayed a statistically significant difference (p < 0.05) from the admission NCCT score 
in all the subgroups (vs. the NCCT0 h columns). * p < 0.05; ** p < 0.01; *** p < 0.001.
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tern is mostly due to the inclusion of the ischemic events of the posterior circulation in the 
analysis, as the prognosis of these events is generally worse and ASPECTS is designed to de-
tect disturbances in the anterior circulation. When only anterior circulation events are in-
cluded in the analysis, the correlations between ASPECTS and   mRS are strengthened, 
while the order remains unchanged ( table 1 , ‘anterior circulation’).
 CTP ASPECTS mismatch gives a single-digit estimate of the extent of reversible isch-
emia ( fig. 1 ). In our data, a mismatch was present in 36 cases (39%). In an additional 4  patients, 
a perfusion mismatch was present in the ASPECTS planes but not within any ASPECTS sub-
territory. In the ASPECTS mismatch subgroup, the correlations between ASPECTS and the 
clinical outcome were higher than in the case of all patients or all anterior circulation events, 
while the correlations between ASPECTS and infarct volume remained similar ( table 1 , ‘pa-
tients with CTP ASPECTS mismatch’).
 Overall, the correlations between the MTT and CBV scores and the clinical outcome are 
stronger than the correlation of the admission NCCT score and the clinical outcome, sug-
gesting that CTP parameters may better classify reversible and non-reversible ischemia. 
However, only the CBV score displayed a statistically significant difference (p  ! 0.05) from 
the admission NCCT score in all the subgroups studied ( table 1 ).
 CTP ASPECTS Mismatch Identifies Potentially Salvageable Ischemic Tissue 
 In  figure 2 , the MTT, CBV, and NCCT 24 h ASPECTS scores and   mRS are plotted for 
each of the 36 patients with a CTP ASPECTS mismatch and sorted according to the NCCT 24 h 
ASPECTS in descending order along the x-axis. Essentially, MTT and CBV provide the low-
er and upper limits for NCCT 24 h , thus defining the spectrum of possible outcomes. The 
  mRS curve traces the contour of all the other curves; it lies most closely to the NCCT 24 h 
curve, which can be expected considering the results of the correlation analysis.
 A mismatch between the NCCT 24 h and the MTT ASPECTS scores can be used to esti-
mate the amount of tissue salvaged, as MTT gives an estimate on the amount of tissue at risk 
and NCCT 24 h depicts the size of the actual infarct. Thus, this mismatch parameter can be 
used as a surrogate for vessel recanalization. Dichotomizing   mRS with the condition   mRS 
 ^  1 to signify good clinical outcome, the lowest statistically significant threshold for the 
MTT-NCCT 24 h ASPECTS mismatch that predicted good clinical outcome was 2 (p = 0.04). 
Using this threshold as an indicator for total or partial vessel recanalization, in the subgroup 
of patients with MTT-NCCT 24 h ASPECTS mismatch  6 2 (n = 17), this parameter and CTP 
ASPECTS mismatch are highly correlated (r = 0.83 * * * ) and have a strong linear relationship 
(R 2 = 0.70,  fig. 3 ). Overall, these findings suggest that the CTP ASPECTS mismatch ade-
quately predicts the amount of potentially salvageable ischemic brain tissue.
 CBV ASPECTS  6 7 Identifies Patients with Good Clinical Outcome 
 Table 2 demonstrates the thresholds for good clinical outcome (  mRS  ^  1) for the CTP 
and NCCT ASPECTS scores derived from ROC. Overall, the most robust predictor of a 
good clinical outcome was the 24-hour follow-up NCCT score  6 8, which had 94% sensitiv-
ity and 65% specificity. However, CBV  6 7 performed well in identifying patients who had 
good clinical outcome and who potentially benefited from thrombolytic therapy. This 
threshold had 100% sensitivity, 44% specificity, and no patients with good clinical outcome 
in the CBV  ! 7 partition. The thresholds MTT  6 4 (AUC = 0.68) and NCCT 0 h  6 10 (AUC = 
0.66), although statistically robust, were outperformed by CBV  6 7 (AUC = 0.72). The dif-
ferences between AUCs did not yield statistical significance. However, in the case of MTT 
and NCCT 0 h , the AUCs were below the 0.70 threshold, which is often considered as a cutoff 
value for an adequately performing diagnostic test. Patients with thrombosis of the basilar 
artery in the admission CTA were excluded from the analysis.
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 Fig. 2. The MTT, CBV, and NCCT 24 h ASPECTS scores and   mRS are plotted for each of the 36 patients 
with a CTP ASPECTS mismatch  1 0 according to the NCCT 24 h ASPECTS in descending order along the 
x-axis. The   mRS curve traces the contour of all the other curves; it lies most closely to the NCCT 24 h 
curve. Essentially, MTT and CBV provide the lower and upper limits for NCCT 24 h , thus defining the 
spectrum of possible outcomes. 
 Fig. 3. The lowest statistically significant threshold for the MTT-NCCT 24 h ASPECTS mismatch that pre-
dicted good clinical outcome was 2. Using this threshold as a marker indicating total or partial vessel re-
canalization, in the subgroup of patients with MTT-NCCT 24 h ASPECTS mismatch  6 2 (n = 17), this mis-
match and CTP ASPECTS mismatch are highly correlated (r = 0.83 * * * ) and have a strong linear relation-
ship (R 2 = 0.70). In the case of the outlier in the top left corner of the graph, the recanalization was partial 
or too late, allowing part of the tissue at risk to become infarcted, while the rest of the tissue at risk was 
salvaged. 
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 Discussion 
 We set off to study the performance of different quantitative parameters obtained using 
CTP ASPECTS that potentially have an impact on the choice of treatment in acute stroke. 
With 16- and 64-slice scanners, the axial dimension of the imaging volume is limited
to 20–80 mm depending on the protocol used. This is not enough to cover the whole brain. 
Further, exact volumetric analysis of the perfusion maps requires user supervision, espe-
cially in the case of CBV, and is too slow a procedure to be used in the context of acute stroke 
imaging, which requires rapid online interpretation of the images. Thus, applying the 
 ASPECTS scoring system to the perfusion images becomes an attractive option  [12] .
 We decided to use the difference between the postictal and the preictal mRS as the indi-
cator of good clinical outcome, as this better reflects the disease load inflicted by the current 
episode. As expected from the definitions,   mRS and 3-month mRS are highly correlated
(r = 0.85 * * * ). Since poor preictal functional status is essentially a contraindication to throm-
bolytic therapy, the offset between   mRS and 3-month mRS is generally very small or non-
existent. The median preictal mRS in our research population was 1. The threshold for good 
clinical outcome was chosen to be   mRS  ^  1 in order to maintain comparability to the tra-
ditional 3-month mRS  ^  2 threshold.
 All patients who received intravenous thrombolytic therapy in a period of 1 year were 
included in the baseline analysis regardless of the vascular territory affected in order to gain 
a realistic idea of the performance of the multimodal CT evaluation of stroke in a clinical 
setting. A perfusion defect could be detected in 50% of these patients, implying that with the 
technology used, a CT perfusion study could have an impact on half of the positive throm-
bolytic treatment decisions at the maximum. In total, 87% of the perfusion defects were pres-
ent in either or both of the two ASPECTS planes. Those located outside the ASPECTS planes 
were detected by the 64-slice scanner in all but 1 case. The acute ischemic lesions that escape 
detection by CTP are mostly lacunar processes or are localized infratentorially or cranially 
to the perfusion study volume  [17] .
 We hypothesized that CTP ASPECTS parameters predict the clinical outcome of pa-
tients who receive intravenous thrombolytic therapy better than the traditional admission 
NCCT. Correlation analyses with all patients and relevant subgroups support this hypoth-
esis, as the CTP parameters correlate more closely with the clinical outcome when compared 
Table 2.  Threshold values for dichotomized NCCT and CTP ASPECTS parameters that best differentiate 
between good (mRS ≤1) and bad clinical outcome
Threshold Good 
outcome
p
value
RR
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
AUC
CBV ≥7 vs. <7 74 vs. 0% <0.001 n/a 1.00 (0.93–1.00) 0.44 (0.25–0.66) 0.72
MTT ≥4 vs. <4 68 vs. 6% <0.001 11.5 (2.9–45.6) 0.92 (0.81–0.97) 0.5 (0.29–0.71) 0.68
NCCT0 h ≥10 vs. <10 65 vs. 11% 0.01 6.0 (3.2–11.3) 0.86 (0.75–0.92) 0.45 (0.26–0.66) 0.66
NCCT0 h ≥7 vs. <7 75 vs. 1% 0.04 62.0 (8.8–436.7) 0.98 (0.92–1.00) 0.15 (0.05–0.36) 0.66
NCCT24 h ≥8 vs. <8 71 vs. 5% <0.001 27.4 (7.0–107.5) 0.94 (0.85–0.98) 0.65 (0.43–0.82) 0.83
R OC were devised to find the optimal threshold values. Overall, the most robust predictor of good 
clinical outcome was the 24-hour follow-up NCCT score ≥8. CBV ≥7 performed well in identifying 
 patients who had good clinical outcome and who potentially benefited from thrombolytic therapy. The 
differences between the AUCs did not yield statistical significance for the admission imaging studies 
(CBV, MTT, and NCCT0 h). Patients with thrombosis of the basilar artery were excluded from the analysis. 
RR = Risk ratio; CI = confidence interval; n/a = not available.
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to the NCCT findings ( table 1 ). However, only CBV displayed a statistically significant dif-
ference from NCCT, while MTT did not reach statistical significance. This is probably due 
to the heterogeneity introduced by cases in which thrombolytic therapy was effective and the 
MTT defect was totally or partially reversed. There was no statistically significant difference 
in the correlations between the admission CTP and NCCT parameters and the total infarct 
volume. This finding can be expected as the strength of the correlation between the infarct 
volume and the clinical outcome was only moderate (r = 0.54 * * * ), which probably reflects 
the presence of strategic infarcts that have a relatively small volume but have a considerable 
impact on the clinical outcome and often escape detection by the follow-up NCCT.
 Optimally, the decision of administering thrombolytic therapy is based on the amount 
of salvageable brain tissue present. In the MCA region, this tissue volume is correlated with 
CTP ASPECTS mismatch  [16] . In total, 39% of the patients presented with such a mismatch. 
We demonstrated that in patients who received thrombolytic therapy CTP ASPECTS mis-
match adequately identifies the amount of potentially salvageable tissue ( fig. 2 ,  3 ). However, 
small mismatches are difficult to interpret because of noise introduced by biological hetero-
geneity and errors in image analysis. In our data, a mismatch  6 2 was linked with good clin-
ical outcome. A larger sample size is needed for a more accurate analysis.
 Other notable limitations of this study are its retrospective design and non-excellent in-
terobserver agreement in some imaging parameters, which, however, is comparable to that 
previously reported  [13] .
 Finally, in the footsteps of previous investigators, we identified threshold values for di-
chotomized NCCT and CTP ASPECTS parameters that would best differentiate between 
good and bad clinical outcome. Our approach emphasized the sensitivity of identifying pa-
tients with potentially good outcome. While a statistically robust threshold could be devised 
for all the parameters studied, the threshold that performed best at presentation was CBV  6 7, 
which is in accordance with previous findings  [12–15] . However, thresholds 6 and 8 per-
formed almost equally well, implying that relying on a single threshold value in decision mak-
ing is probably ill advised. We also tested the established admission NCCT ASPECTS  6 7 
threshold. This threshold proved to be very unspecific (Specificity 15%), which is to be ex-
pected as there were only patients who received thrombolytic therapy in our study population.
 In conclusion, advances in the management of acute ischemic stroke and medical imag-
ing and the extension of the time window for thrombolytic therapy are creating pressure to 
replace the rigid one-third MCA rule and non-contrast-enhanced CT ASPECTS thresholds 
in selecting patients to receive thrombolytic therapy with a shift toward identifying patients 
with potentially salvageable ischemic brain tissue. Our data suggest that parameters derived 
using ASPECTS scoring of CT perfusion images, especially the CTP ASPECTS mismatch, 
can in part answer these demands. Further, on admission, the ASPECTS of the CBV map 
correlates more strongly with clinical outcome than the NCCT ASPECTS.
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Abstract 
Purpose: Recently two classification methods based on the location and the extent of thrombosis 
detected with CT angiography have been introduced:  the Boston Acute Stroke Imaging Scale 
(BASIS) and the clot burden score (CBS). We studied the performance of BASIS and CBS in 
predicting good clinical outcome (mRS ≤2 at 90 days) in an acute (<3h) stroke cohort treated with 
intravenous thrombolytic therapy. 
Methods: 83 consecutive patients who underwent multimodal CT were analyzed.  Binary logistic 
regression model was used to assess how BASIS, CBS and cerebral blood volume (CBV) ASPECTS 
predict favorable clinical outcome. Diagnostic sensitivities and specificities were calculated and 
compared. 
Results: Patients with low CBS and CBV ASPECTS scores and major strokes according to BASIS had 
significantly higher admission NIHSS scores, larger perfusion defects and more often poor clinical 
outcome. In logistic regression analysis CBV ASPECTS, CBS and BASIS were significantly associated 
with the clinical outcome. The performance of BASIS improved when patients with thrombosis of 
the M2 segment of the middle cerebral artery were classified as having minor stroke (M1-BASIS). 
In the anterior circulation the sum of CBS and CBV ASPECTS (CBSV) proved to be the most robust 
predictor of favorable outcome. CBV ASPECTS and CBS had high sensitivity but moderate to poor 
specificity while BASIS was only moderately sensitive and specific. 
Conclusions: CBS, BASIS and CBV ASPECTS are statistically robust and sensitive but unspecific 
predictors of good clinical outcome. Two new derived imaging parameters, CBSV and M1-BASIS, 
share these properties and may have increased prognostic value.  
 
Abbreviation key: ASPECTS = Alberta Stroke Program Early CT Score, AUC = area under the curve, 
BASIS = Boston Acute Stroke Imaging Scale, CBV = cerebral blood volume, C = C statistic, CBS = clot 
burden score, CI = confidence interval, CTA = computed tomography angiography, CTP = computed 
tomography perfusion, H-L = Hosmer-Lemeshow , MTT = mean transit time, MCA = middle 
cerebral artery, NCCT = non-contrast-enhanced computed tomography, NIHSS = National 
Institutes of Health Stroke Scale, mRS = modified Rankin Scale, ROC = receiver-operating 
characteristic, RR = risk ratio, rtPA = recombinant tissue plasminogen activator 
 
Key words: computed tomography angiography, Boston Acute Stroke Imaging Scale, clot burden 
score, computed tomography perfusion, thrombolytic therapy, stroke, ASPECTS
Introduction 
Computed tomography angiography (CTA) of the intracranial vessels is increasingly being 
performed either separately or as part of multimodal CT evaluation of acute ischemic stroke to 
detect intravascular occlusion by clots, hemodynamically significant stenotic atherosclerotic 
lesions, arterial dissection and other arteriopathies. CTA provides an independent prognostic 
factor with proximal, high volume clots predicting poor clinical outcome when compared to distal, 
low volume clots [1-9].  
Recently two classification methods based on the location and the extent of the thrombus 
detected with CTA have been introduced. BASIS (Boston Acute Stroke Imaging Scale) is a binary 
classification scheme where patients are designated to have either major or minor stroke [5]. In 
short, if the distal internal carotid artery (ICA), the proximal (segments M1 and M2) middle 
cerebral artery (MCA) or the basilar artery is occluded or if there is a significant ischemic lesion  
either in non-contrast CT (NCCT) or diffusion weighted MRI, the stroke is considered major, 
otherwise the stroke is considered minor [5]. BASIS is correlated to short-term clinical outcome 
evaluated at discharge from the hospital and the length and the costs of hospitalization [5, 6]. Clot 
burden score (CBS) is a more elaborate scheme in which a score from 0 to 10 is given based on the 
extent of arterial segments affected in the anterior circulation [7, 8]. The scoring system has been 
pictorially demonstrated by Puetz et al. [8]. CBS is correlated to the clinical and radiological 
outcomes [7-9]. 
We reviewed retrospectively the clinical and imaging data of 83 consecutive patients who 
underwent multimodal CT assessment and received intravenous thrombolytic therapy to treat 
acute (<3h) ischemic stroke in order to study the performance of BASIS and CBS in predicting the 
clinical outcome. Further, we correlated the anatomical information conveyed by BASIS and CBS 
with CT perfusion (CTP) parameters that reflect the hemodynamic state in the cerebral vasculature 
and hypothesized that a derived parameter combining both CTA and CTP data might best predict 
the clinical outcome. 
 
Materials and Methods 
Overview 
We analyzed retrospectively the clinical and imaging data of 380 consecutive patients who were 
admitted to Tampere University Hospital between January  2007 and December 2007 because of 
acute (duration <3h) strokelike symptoms. After clinical and imaging evaluation 92 patients 
received intravenous rtPA to treat acute ischemic stroke. Among these patients full admission 
multimodal (NCCT, CTA and CTP) imaging evaluation was successfully completed with 72 patients 
while an additional 11 patients were evaluated with just NCCT and CTA because of chronic renal 
failure, imminent closure of the 3h time window or movement artifacts that rendered some of the 
imaging data uninterpretable. These 83 patients were selected to this study. The selection of 
patients to receive thrombolytic therapy was based on institutional guidelines that did not have 
CTP or CTA derived parameters as exclusion or inclusion criteria. Standard intravenous rtPA 
adminstration scheme was used: Actilyse (Boehringer-Ingelheim, Ingelheim, Germany), total dose 
0.9 mg/kg from which 10% given as a bolus and the remaining 90% as a continuous infusion for 1h. 
Stable access to an emergency angiography suite was not available at the time so intra-arterial 
interventions were not included in the treatment protocol. A follow-up NCCT was performed for 
all patients 24h after the administration of the thrombolytic agent. National Institutes of Health 
Stroke Scale (NIHSS) was assessed at the admission and 24h after the thrombolytic therapy. 
Modified Rankin Scale (mRS) was evaluated preictally and on day 90. The clinical data was stored 
prospectively to the patient records during the hospital stay and on day 90 after the ictus, the 
latter following a phone interview. This data was collected from the patient records and critically 
reviewed for errors using the data available from all medical and related disciplines (J.T.S.). The 
study was approved by Tampere University Hospital ethics committee. 
 
Imaging parameters 
Computed tomography scans were obtained using two different multidetector scanners:  General 
Electrics LightSpeed 16-slice (GE Healthcare, Milwaukee, Wis) and Philips Brilliance 64-slice 
(Philips, Cleveland, Oh). The imaging procedures and the parameters used are described 
thoroughly in our previous study available online as an open-access article at the website of the 
publisher [10].  
 
Image analysis 
NCCT examinations were reviewed using dedicated medical imaging workstations. CTA and CTP 
images were analyzed with Advantage Workstation version 3.2 (GE Healthcare). The examinations 
were reviewed in the order NCCT, CTA and finally CTP paralleling that of the clinical work flow. The 
reviewers were blinded to the clinical data apart from the side and nature of the acute symptoms.  
The analysis of the NCCT and the CTP images is detailed in our previous article [10]. CTA images 
were studied by examining the raw data and maximum intensity projection images.  The principles 
of the CBS scoring system and the assignment of BASIS have been described in recent studies [5, 
7]. CBS was scored and BASIS was assigned independently by two radiologists (N.S. and A.L.). In 
cases where the scoring or the assignment differed, a consensus opinion was agreed on. These 
results were correlated with the original neuroradiological report. If significant discrepancies were 
present the neuroradiologist that had issued the report was further consulted. Intraclass 
correlation coefficient (ICC) between a staff radiologist (N.S.) and an experienced neuroradiologist 
(J.H.) for a test sample (n=20) for CBS was 0.87.  The interobserver agreement index for BASIS was 
95%. The interobserver variability statistics for the other imaging parameters used are described in 
our previous article [10]. 
 
Statistics 
The data was analyzed with SPSS version 18 (SPSS Inc., Chicago, Ill). Group comparisons were 
performed by using the Mann-Whitney U test and the Fisher exact test. Patients with mRS ≤2 at 90 
days were considered to have experienced good clinical outcome. After excluding cases with 
thrombosis of the basilar artery Receiver-operating characteristic curves (ROC) were computed for 
the imaging parameters studied using dichotomized clinical outcome as the state variable. Youden 
index was evaluated to select for optimal threshold value. A binary logistic regression model using 
the clinical outcome as the dependent variable was repeated for different variables of interest. 
Age and gender were treated as potential confounders and were controlled for by treating them 
as covariates. One variable of interest was included in the model at a time.  The calibration of the 
models was evaluated with the Hosmer-Lemeshow test and the discrimination with the C statistic. 
Odds ratio (OR) with 95% confidence interval (CI) was calculated for each covariate. Sensitivity, 
specificity and confidence interval calculations were performed using standard procedures. The 
McNemar test was used to compare the sensitivities and specificities calculated. The Bonferoni 
correction was applied to adjust for multiple comparisons. 
 
Results 
Baseline characteristics 
The median age of the patients was 71 years (interquartile range 62-80 years, 40 female). Based 
on the clinical features and the imaging studies, in 11 of the 83 patients evaluated (13%) the 
ischemic episode involved the posterior circulation. The rest of the episodes were considered to 
involve the anterior circulation. Thrombosis could be demonstrated with CTA in 37 cases (45%). 
The locations of the thrombi are described in Table 1. In 40 cases (56%) of the 72 evaluated with 
CTP a perfusion defect could be detected in the ASPECTS planes. An additional 6 perfusion defects 
were found outside the ASPECTS planes. In total, a perfusion defect could be demonstrated in 64% 
of the CTP studies (50% of all patients).  The median NIHSS score at the admission was 7 
(interquartile range 4-12, 54% had NIHSS <8, 18% had NIHSS >15) and 24h later the score was 2. 
The median time from symptom onset to treatment was 138 minutes (interquartile range 114-
162). The median mRS was 1 preictally and 2 90 days later. The median change in mRS (∆mRS) was 
1 point. 74% of the patients experienced favorable clinical outcome at 90 days (mRS ≤2). At 24h a 
local hemorrhagic complication (HI1, HI2, PH1 or PH2) was detected in 5 cases (6.0%) and 4 
patients (4.8%) had parenchymal hemorrhage distant to the site of the infarct (PHr1 or PHr2). The 
validation of the ASPECTS scoring method for CTP is depicted in our previous study [10]. 
 
CBS, BASIS and CBV ASPECTS as prognostic classifiers  
CBS and CBV ASPECTS were dichotomized using the thresholds (CBS >6 and CBV ASPECTS >6) that 
best differentiated good from poor clinical outcome in the previous studies [7, 10-14]. BASIS is by 
definition a dichotomous variable that classifies strokes as either major or minor. Table 2 
summarizes the comparison of patients in the subgroups so formed for all intracranial vascular 
territories (n=83) whereas in Table 3 only patients suffering from anterior circulation stroke were 
included in the analysis (n=72). There was no significant difference in age between the patients in 
the different subgroups. There were more female patients with major strokes and more male 
patients with minor strokes according to the BASIS classification (p=0.01). As expected, patients 
with low CBS and CBV ASPECTS scores and patients with major strokes had significantly higher 
admission NIHSS scores, significantly larger perfusion defects in the CBV and MTT maps and more 
findings related to acute ischemic process in the admission NCCT. Patients in the low CBS and low 
CBV ASPECTS subgroups invariably had major stroke according to BASIS. Patients with low CBV 
ASPECTS and major stroke had more proximal and higher volume thrombi shown by significantly 
lower CBS. Low CBS and CBV ASPECTS and major stroke significantly predicted poor clinical 
outcome and larger infarct volume 24 hours after the administration of thrombolytic therapy. The 
ability of CBS and CBV ASPECTS to predict the clinical outcome was enhanced when only anterior 
circulation strokes were included in the analysis, whereas the predictive power of BASIS improved 
when all vascular territories were included in the analysis. BASIS did not reach statistical 
significance when only patients with anterior circulation strokes were analyzed (p=0.23). This is 
because patients with thrombosis in the M2 segment of the MCA are classified as having major 
stroke and yet in the study population 83% of these patients had good clinical outcome. If these 
patients were classified as having minor stroke, BASIS performed considerably better (Table 4). 
This modification is referred to as M1-BASIS in Tables 4, 5 and 6 and in the following paragraphs. 
There were eight cases of local and/or peripheral hemorrhagic complications in the study 
population. In four patients the hemorrhages were mild and did not produce any symptoms. In the 
other four patients a notable space occupying effect was present. When cross-tabulated with the 
dichotomized imaging parameters, none of the parameters predicted hemorrhagic transformation 
statistically significantly. 
In order to further assess the prognostic value of these dichotomous imaging parameters we 
performed binary logistic regression analysis using the mRS at 90 days dichotomized with the 
threshold ≤2 as the dependent variable (Table 5). We also devised a novel parameter which 
combines CBS and CBV ASPECTS by calculating an unweighted sum of the scores for each patient. 
This parameter was named CBSV. Using ROC analysis with clinical outcome as the state variable, 
an optimal threshold for dichotomization was calculated for CBSV (>15, AUC=0.72, Figure 1) and 
this dichotomized variable was entered into the regression analysis. Figure 1 also shows ROC 
curves for CBS (AUC=0.69) and CBV ASPECTS (AUC=0.70). Age and gender were treated as 
potential confounders and were controlled for by treating them as covariates. When all vascular 
territories were included in the analysis, CBV ASPECTS, CBS, CBSV, BASIS and M1-BASIS were all 
significantly associated with the clinical outcome. CBV ASPECTS displayed the largest odds ratio for 
good clinical outcome (p=0.005, OR=13.3). NCCT ASPECTS and gender were not significantly 
associated with the clinical outcome whereas a low NIHSS score at presentation significantly 
predicted good clinical outcome (p=0.007). Age had a modest effect with old age being a risk 
factor for poor outcome (p=0.02). When only anterior circulation strokes were considered, CBV 
ASPECTS, CBS, CBSV and M1-BASIS were significantly associated with the clinical outcome with 
CBSV having the best statistical confidence level (p=0.002, OR=16.3). CBS displayed the largest 
odds ratio (p=0.005, OR=25.1). BASIS did not reach statistical significance.  
Sensitivities and specificities for detecting good clinical outcome were calculated for all the 
imaging parameters that achieved statistical significance in the regression analysis (Table 6). When 
all vascular territories were included in the analysis, CBV ASPECTS was the most sensitive predictor 
of good clinical outcome (0.96, CI 95% = 0.86-0.99) while BASIS had the best specificity (0.57, CI 
95% = 0.34-0.77). In the case of sensitivity, the differences between CBV ASPECTS, CBS and CBSV 
were not statistically significant while BASIS was significantly less sensitive than any of the other 
parameters.  M1-BASIS was less sensitive than CBV ASPECTS (p=0.03). In the case of specificity, 
BASIS and M1-BASIS were significantly more specific when compared to CBS (p=0.02 and p=0.04, 
respectively). Otherwise there were no statistically significant differences. When only the anterior 
circulation was considered, CBV ASPECTS was the most sensitive (0.96, CI 95% = 0.86-0.99) and 
CBSV the most specific (0.47, CI 95% = 0.22-0.73) predictor. BASIS proved to be significantly less 
sensitive when compared to all the other parameters (p=0.001-0.008). There were no statistically 
significant differences between specificities.  When the Bonferoni correction was applied to adjust 
for multiple comparisons, BASIS remained to be significantly less sensitive than other parameters 
both in the case of all vascular territories and the anterior circulation while all other differences 
were rendered statistically non-significant. 
 
Discussion 
Recently a number of imaging parameters have been introduced that may be useful in the risk 
stratification and the treatment decision making in acute ischemic stroke. We studied the 
performance of two CTA-based classification schemes, BASIS and CBS, and one perfusion 
parameter, CBV ASPECTS, in a thrombolytic therapy cohort. 
In the absence of adequate collateral circulation vessel recanalization is a necessary condition to 
favorable clinical outcome. The location, the volume and the composition of the clot essentially 
determine the effectiveness of intravenous rtPA in dissolving the occluding thrombus [1-9, 15]. 
The time from the onset of the symptoms to the possible recanalization largely determines the 
functional outcome as the duration of parenchymal ischemia dictates the progression of the 
irreversible changes, i.e. the size of the infarct core [16]. Both BASIS and CBS address the location 
of the clot while CBS also takes into account the volume. CBV ASPECTS estimates the size of the 
infarct core. 
Patients with low CBS and CBV ASPECTS scores and with major strokes according to BASIS had 
significantly higher admission NIHSS scores, larger perfusion defects, larger infarct volumes, more 
findings related to acute ischemic process in the admission NCCT and more often poor clinical 
outcome. CBS and CBV ASPECTS predicted the clinical outcome more accurately when only 
anterior circulation strokes were analyzed which is to be expected as these scoring schemes do 
not include data from the posterior circulation. BASIS, on the other hand, also takes into account 
the posterior circulation.  Thus it performs better when all vascular territories are included in the 
analysis as patients with occlusion of the basilar artery are correctly classified as having major 
stroke. However, BASIS did not reach statistical significance when only patients with anterior 
circulation stroke were analyzed. This is remedied if patients with thrombosis of the M2 segment 
are classified as having minor stroke (p=0.23 vs. p=0.002). This modified BASIS, which we named 
M1-BASIS, seems to perform slightly better than BASIS also when all vascular territories are 
included in the analysis. These findings probably reflect the effect of the thrombolytic therapy and 
support the notion that patients with thrombosis of the M2 segment of the MCA benefit from 
intravenous thrombolytic therapy whereas a more proximal clot location predicts limited response 
[1, 3, 9, 17]. Only a minority of patients (8%) received thrombolytic therapy in the study 
population that was originally used to validate BASIS [5]. 
In the logistic regression analysis dichotomized M1-BASIS, CBV ASPECTS, CBS and BASIS were all 
significantly associated with the clinical outcome (p=0.001, p=0.005, p=0.02 and p=0.01, 
respectively). When only anterior circulation strokes were considered, the sum of CBS and CBV 
ASPECTS, a novel variable which we named CBSV, proved to be the most robust predictor of 
favorable outcome (p=0.002, OR=16.3). CBSV combines two independent predictors of clinical 
outcome that reflect different pathophysiological processes: CBV ASPECTS that approximates the 
volume of already irreversibly damaged brain tissue and CBS that provides information about clot 
extent and location [7, 8, 10]. Thus, theoretically CBSV should have better predictive power than 
either of its components. This is supported by our results. 
CBV ASPECTS, CBS, CBSV and M1-BASIS all had high sensitivity (85-96%) but moderate to poor 
specificity (24-52%) in predicting good clinical outcome. The rather modest specificity is to be 
expected as not all patients with potentially favorable profile experience recanalization and as 
strategic infarcts may cause serious functional deficit with minimal imaging findings.  Further, 
there were 4 patients (2 with anterior circulation strokes) with prestroke mRS >2 that were 
classified as low risk patients by CBS, CBV ASPECTS and CBSV, which decreases the specificity of 
these parameters somewhat. BASIS was only moderately sensitive (70-71%). There were no 
statistically significant differences between specificities after the Bonferoni correction was applied 
to adjust for multiple comparisons. Tan et al. found CBS to be less sensitive but more specific 
when compared to our findings [7]. This is probably due to considerably higher median NIHSS 
score (16) and lower proportion of patients treated with rtPA (70.5%) in their study population.  
Our study is limited by retrospective design and sample size. There was some heterogeneity in the 
details of treatment and variation in onset-to-needle times which are to be expected in a clinically 
managed population. Because of the study design data on vessel recanalization was not available 
for the majority of the patients. However, a large final infarct volume is intimately related to 
delayed or failed recanalization and can be used as a surrogate. M1-BASIS was created based on a 
post hoc analysis of the data set and should be further validated in other thrombolytic therapy 
cohorts. 
In conclusion, novel imaging parameters that lie upstream to clinical parameters (NIHSS) in the 
pathophysiological chain of ischemic stroke potentially allow higher resolution in the risk 
stratification and the treatment decision making. Optimally a selection of markers portraying 
different aspects of the disease state and having independent prognostic value would be utilized. 
These markers include anatomical angiographic data revealing the location and the extent of the 
clot (CBS and BASIS) and dynamic perfusion data enabling the detection of irreversibly damaged 
and potentially salvageable brain tissue (CBV ASPECTS and CTP ASPECTS mismatch) [10]. We 
demonstrated that CBS, BASIS and CBV ASPECTS are statistically robust and sensitive but 
unspecific predictors of good clinical outcome among patients receiving intravenous thrombolytic 
therapy. We introduced two derived imaging parameters, CBSV and M1-BASIS, that essentially 
share these same properties but seem to have slightly better prognostic accuracy. BASIS was 
significantly less sensitive than the other parameters studied. 
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 Table 1. The location of the clot in CT angiography. A thrombus could be detected in 44.6% of the 
studies. The most common locations were the M2 and the M1 segments of the MCA. There were 8 
cases of thrombosis of the basilar artery. The most distant thrombi detected were situated in the 
M3 segment.  
Thrombus location n % 
Basilar artery 8 9.6 
PCA P2 segment 2 2.4 
SCA 1 1.2 
MCA M1 segment 10 12.0 
MCA M2 segment 12 14.5 
MCA M3 segment 3 3.6 
ICA 1 1.2 
Total detected 37 44.6 
Not detected 46 55.4 
 
 
Table 2. All patients arranged into subgroups according to dichotomized CBS, CBV ASPECTS and 
BASIS. Patients with low CBS and CBV ASPECTS scores and with major strokes according to BASIS 
had significantly higher admission NIHSS scores, larger perfusion defects, larger infarct volumes 
and more often poor clinical outcome. Patients in the low CBS and low CBV ASPECTS subgroups 
invariably had major stroke according to BASIS. Patients with low CBV ASPECTS and major stroke 
had more proximal and higher volume thrombi as reflected by significantly lower CBS. All values 
mean ± 1SD unless otherwise noted. ∆mRS = mRS at 90 days – prestroke mRS. 
 All Vascular Territories 
 Clot Burden Score  CBV ASPECTS  BASIS   
 CBS ≤ 6 CBS > 6  CBV ≤ 6 CBV  > 6  major minor  
 n = 9 n = 74 p value n = 8 n = 64 p value n = 32 n = 51 p value 
mRS at 90 days  3.0 ± 2.0 2.0 ± 1.6 0.05 4.0 ± 1.3 1.8 ± 1.4 0.002 3.0 ± 1.9 1.7 ± 1.3 0.04 
∆mRS  2.6 ± 1.9 1.1 ± 1.4 0.01 3.3 ± 0.9 0.9 ± 1.3 < 0.001 2.1 ± 1.8 0.8 ± 1.1 0.004 
Infarct volume (cm3) 60.1 ± 66.2 9.4 ± 21.5 0.001 87.5 ± 60.1 7.6 ± 16.3 < 0.001 33.1 ± 47.5 3.5 ± 7.8 < 0.001 
CBS 5.2 ± 1.7 9.7 ± 0.6 - 6.9 ± 1.6 9.5 ± 1.4 < 0.001 8.0 ± 2.1 10.0 ± 0.0 < 0.001 
BASIS (major/minor) 9 / 0 23 / 51 < 0.001 8 / 0 18 / 46 < 0.001 32 / 0 0 / 51 - 
CBV ASPECTS 6.8 ± 2.8 9.4 ± 1.5 0.001 4.4 ± 0.7 9.7 ± 0.7 - 7.6 ± 2.4 10.0 ± 0.2 < 0.001 
MTT ASPECTS 2.4 ± 1.1 8.3 ± 2.5 < 0.001 2.9 ± 1.5 8.3 ± 2.6 < 0.001 4.6 ± 2.7 9.4 ± 1.2 < 0.001 
NCCT ASPECTS 8.6 ± 1.7 9.6 ± 1.2 0.04 7.4 ± 2.6 9.7 ± 0.9 0.001 8.8 ± 1.9 9.9 ± 0.5 < 0.001 
Admission NIHSS 13.6 ± 4.4 8.2 ± 6.4 0.008 15.5 ± 3.2 7.6 ± 5.6 0.001 13.3 ± 7.0 6.1 ± 4.3 < 0.001 
Gender (female/male) 7 / 2 33 / 41 0.08 5 / 3 30 / 34 0.47 21 / 11 19 / 32 0.01 
Age 63.3 ± 17.8 69.4 ± 13.5 0.34 74.1 ± 11.4 68.0 ± 14.8 0.24 69.5 ± 13.2 68.3 ± 14.7 0.81 
 
 
Table 3. Patients with anterior circulation stroke arranged into subgroups according to 
dichotomized CBS, CBV ASPECTS and BASIS. The ability of CBS and CBV ASPECTS to predict the 
clinical outcome improved when only anterior circulation strokes were included in the analysis. 
Interestingly, BASIS did not reach statistical significance when only patients with anterior 
circulation stroke were analyzed. All values mean ± 1SD unless otherwise noted. ∆mRS = mRS at 90 
days – prestroke mRS. 
 Anterior Circulation  
 Clot Burden Score  CBV ASPECTS  BASIS   
 CBS ≤ 6 CBS > 6  CBV ≤ 6 CBV  > 6  major minor  
 n = 9 n = 63 p value n = 8 n = 58 p value n = 24 n = 48 p value 
mRS at 90 days  3.0 ± 2.0 1.7 ± 1.4 0.02 4.0 ± 1.3 1.7 ± 1.4 0.001 2.5 ± 1.6 1.6 ± 1.4 0.23 
∆mRS  2.6 ± 1.9 0.9 ± 1.1 0.005 3.3 ± 0.9 0.8 ± 1.2 < 0.001 1.8 ± 1.5 0.7 ± 1.1 0.02 
Infarct volume (cm3) 60.1 ± 66.2 8.9 ± 22.2 0.001 87.5 ± 60.1 6.8 ± 15.5 < 0.001 40.0 ± 52.1 3.2 ± 7.3 < 0.001 
CBS 5.2 ± 1.7 9.7 ± 0.6 - 6.9 ± 1.6 9.4 ± 1.5 < 0.001 7.4 ± 2.0 10.0 ± 0.0 < 0.001 
BASIS (major/minor) 9 / 0 15 / 48 < 0.001 8 / 0 15 / 43 < 0.001 24 / 0 0 / 48 - 
CBV ASPECTS 6.8 ± 2.8 9.3 ± 1.5 0.001 4.4 ± 0.7 9.7 ± 0.7 - 7.3 ± 2.4 10.0 ± 0.2 < 0.001 
MTT ASPECTS 2.4 ± 1.1 8.2 ± 2.5 < 0.001 2.9 ± 1.5 8.1 ± 2.7 < 0.001 4.0 ± 2.2 9.4 ± 1.3 < 0.001 
NCCT ASPECTS 8.6 ± 1.7 9.5 ± 1.3 0.01 7.4 ± 2.6 9.7 ± 0.9 0.001 8.4 ± 2.0 9.9 ± 0.5 < 0.001 
Admission NIHSS 13.6 ± 4.4 7.4 ± 5.1 0.003 15.5 ± 3.2 7.0 ± 4.7 < 0.001 11.7 ± 5.5 6.3 ± 4.4 < 0.001 
Gender (female/male) 7 / 2 25 / 38 0.07 5 / 3 25 / 33 0.45 16 / 8 16 / 32 0.01 
Age 63.3 ± 17.8 68.8 ± 13.9 0.41 74.1 ± 11.4 67.6 ± 15.0 0.20 68.3 ± 13.9 68.0 ± 14.8 0.98 
 
Table 4. Patients arranged into subgroups according to M1-BASIS, all vascular territories and the 
anterior circulation. If patients with thrombosis in the M2 segment of the MCA were classified as 
having minor stroke, BASIS had considerably better prognostic value. This modification was named 
M1-BASIS. All values mean ± 1SD unless otherwise noted. ∆mRS = mRS at 90 days – prestroke mRS. 
 M1-BASIS 
 All Vascular Territories Anterior Circulation 
 major minor  major minor  
 n = 21 n = 62 p value n = 13 n = 59 p value 
mRS at 90 days  2.9 ± 1.9 1.7 ± 1.3 0.02 3.5 ± 2.1 1.7 ± 1.3 0.002 
∆mRS  2.3 ± 1.8 0.8 ± 1.1 0.001 2.6 ± 2.0 0.8 ± 1.1 < 0.001 
Infarct volume (cm3) 54.4 ± 59.3 6.6 ± 18.3 < 0.001 39.0 ± 51.9 6.8 ± 17.9 0.001 
CBS 6.2 ± 2.2 9.8 ± 0.5 < 0.001 7.7 ± 2.5 9.8 ± 0.5 < 0.001 
BASIS (major/minor) 13 / 0 9 / 50 < 0.001 21 / 0 11 / 51 < 0.001 
CBV ASPECTS 6.6 ± 2.7 9.6 ± 1.1 < 0.001 7.3 ± 2.8 9.6 ± 1.1 < 0.001 
MTT ASPECTS 2.8 ± 1.6 8.5 ± 2.3 < 0.001 4.1 ± 3.1 8.6 ± 2.2 < 0.001 
NCCT ASPECTS 8.0 ± 2.2 9.7 ± 1.0 < 0.001 8.7 ± 2.0 9.7 ± 0.9 0.005 
Admission NIHSS 13.5 ± 4.5 6.9 ± 4.8 < 0.001 15.4 ± 6.7 6.7 ± 4.7 < 0.001 
Gender (female/male) 8 / 5 24 / 35 0.22 13 / 8 27 / 35 0.21 
Age 66.3 ± 15.6 68.5 ± 14.2 0.71 68.8 ± 14.0 68.7 ± 14.2 0.97 
 
Table 5. Binary logistic regression analysis for favorable clinical outcome (mRS ≤2 at 90 days), all 
vascular territories and the anterior circulation. CBV ASPECTS, CBS and BASIS were all significantly 
associated with the clinical outcome with M1-BASIS having the best statistical confidence level in 
predicting of good clinical outcome when all vascular territories were included in the analysis. 
When only anterior circulation strokes were considered, the sum of CBS and CBV ASPECTS (CBSV) 
proved to be the most robust predictor. CI = Confidence Interval, H-L = Hosmer-Lemeshow 
significance, C = C statistic. 
 All Vascular Territories Anterior Circulation  
 
Odds 
ratio CI 95% 
p 
value H-L C 
Odds 
ratio CI 95% 
p 
value H-L C 
CBV ASPECTS > 6 13.3 2.2 - 79.7 0.005 0.51 0.75 15.3 2.4 - 98.8 0.004 0.88 0.79 
CBS > 6 11.6 1.7 - 77.1 0.01 0.36 0.74 25.1 2.6 - 240 0.005 0.16 0.80 
M1-BASIS (minor) 8.7 2.4 - 31.6 0.001 0.92 0.80 7.3 1.5 - 34.0 0.01 0.70 0.78 
BASIS (minor) 3.9 1.2 - 12.9 0.02 0.23 0.74 2.6 0.66 - 10.2 0.17 0.83 0.73 
CBSV > 15 12.1 2.4 - 60.8 0.003 0.48 0.76 16.3 2.7 - 98.8 0.002 0.71 0.80 
NCCT ASPECTS > 7 1.2 0.1 - 13.9 0.89 0.77 0.70 1.5 0.12 - 18.0 0.76 0.82 0.72 
Admission NIHSS 0.87 0.79 - 0.96 0.007 0.86 0.79 0.82 0.71 - 0.94 0.004 0.54 0.85 
Onset-to-treatment time 0.99 0.98 - 1.01  0.29 0.06 0.71 1.01 0.99 - 1.03 0.36 0.21 0.71 
Gender 0.98 0.33 - 2.9 0.97 0.89 0.69 0.73 0.36 - 4.3 0.58 0.38 0.72 
Age 0.95 0.90 - 0.99 0.02 0.89 0.69 0.94 0.89 - 0.99 0.03 0.38 0.72 
 
Table 6. Sensitivities and specificities for detecting good clinical outcome (mRS ≤2 at 90 days) for 
the imaging parameters that achieved statistical significance in the regression analysis. When all 
vascular territories were included in the analysis, CBV ASPECTS was the most sensitive predictor of 
good clinical outcome while BASIS had the best specificity. When only the anterior circulation was 
considered, CBV ASPECTS was the most sensitive and CBSV the most specific predictor. In both 
settings BASIS was significantly less sensitive when compared to all the other parameters. CI = 
Confidence Interval, Se = Sensitivity, Sp = Specificity, Acc = Accuracy. 
 All Vascular Territories  Anterior Circulation  
 Se CI 95% Sp CI 95% Acc  Se CI 95% Sp CI 95% Acc 
CBV ASPECTS > 6 0.96 0.86 - 0.99 0.35 0.15 - 0.61 0.82  0.96 0.85 - 0.99 0.40 0.17 - 0.67 0.83 
CBS > 6 0.93 0.83 - 0.98 0.24 0.09 - 0.48 0.77  0.93 0.82 - 0.98 0.35 0.13 - 0.61 0.76 
CBSV > 15 0.93 0.81 - 0.98 0.41 0.19 - 0.67 0.80  0.92 0.80 - 0.97 0.47 0.22 - 0.73 0.82 
M1-BASIS 0.85 0.73 - 0.92 0.52 0.30 - 0.74 0.77  0.88 0.75 - 0.94 0.40 0.17 - 0.67 0.77 
BASIS 0.70 0.57 - 0.81 0.57 0.34 - 0.77 0.67  0.71 0.58 - 0.82 0.41 0.19 - 0.67 0.66 
 
Figure 1. Receiver-operating characteristic curves for CBSV, CBS and CBV ASPECTS with clinical 
outcome as the state variable. Good clinical outcome was defined as mRS ≤2 at 90 days. AUCCBSV = 
0.72, AUCCBV ASPECTS = 0.70 and AUCCBS = 0.69. 
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Background and purpose: We studied the impact of the location of the thrombus
(internal carotid artery, proximal M1 segment, distal M1 segment, M2 segment, and
M3 segment of the middle cerebral artery) in predicting the clinical outcome of pa-
tients treated with intravenous thrombolytic therapy (<3 h) in a retrospective cohort.
Methods: Anterior circulation thrombus was detected with computed tomography
angiography in 105 patients. Baseline clinical and radiological information was col-
lected and entered into logistic regression analysis to predict favorable clinical out-
come (3-month modiﬁed Rankin Scale from 0 to 2 was a primary outcome measure).
Results: Three months after stroke, there was a signiﬁcant increase in mortality (32%
vs. 3%, P < 0.001) and functional dependency (82% vs. 29%, P < 0.001) in patients
with internal carotid artery or proximal M1 segment of the middle cerebral artery
thrombus compared to a more distal occlusion. In the regression analysis, after
adjusting for National Institutes of Health Stroke Scale, age, sex, and onset-to-
treatment time, the clot location was an independent predictor of good clinical out-
come (P = 0.001) and exhibited dose-response type behavior when moving from a
proximal vessel position to a more distal one. When the location was dichotomized, a
cutoﬀ between the proximal and the distal M1 segments best diﬀerentiated between
good and poor clinical outcome (OR = 16.0, 95% CI 3.9–66.2).
Conclusions: The outcome of acute internal carotid artery or proximal M1 segment of
the middle cerebral artery occlusion is generally poor even if treated with intravenous
thrombolysis. Alternative revascularization strategies should be considered. Vascular
imaging at the admission is required to guide this decision.
Introduction
The location and the volume of the thrombus are
independent prognostic factors in acute ischemic stroke
(AIS) with proximal, high-volume clots predicting poor
clinical outcome when compared to distal, low-volume
clots [1–11]. In addition, the location and the volume of
the clot induce limitations to the eﬀectiveness of intra-
venous thrombolysis (IVT) with recombinant tissue
plasminogen activator (rtPA) in dissolving the occlud-
ing thrombus [1–11].
The purpose of our study was to analyze in more
depth the impact of the location of the clot, visualized
in the anterior circulation using computed tomography
angiography (CTA), to the clinical outcome in AIS
patients treated with IVT. We assumed that separating
the M1 segment of the middle cerebral artery (MCA) to
proximal (M1P) and distal (M1D) parts could provide
increased accuracy in predicting the clinical outcome.
We discuss the implications of the anterior clot location
and clinical baseline information in evaluating the
outcomes in an IVT cohort.
Methods
Study population
Our retrospective observational cohort study was ap-
proved by Tampere University Hospital ethics com-
mittee. Altogether, 315 anterior or posterior circulation
AIS patients from January 2004 to December 2007 were
treated with thrombolytic therapy and had a 3-month
follow-up after thrombolysis at the department of
neurology of the Tampere University Hospital. CTA
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had been performed to 285 patients (90%). The
thrombolytic therapy protocol used was similar to the
American Heart Association (AHA) guidelines [12].
Inclusion criteria for the study were acute anterior cir-
culation vessel occlusion conﬁrmed with CTA and
treatment with standard IVT administration scheme.
From 2004 to 2007, intra-arterial interventions were not
performed to anterior circulation occlusions at our
institution.
Participants and variables
Baseline clinical characteristics included age, sex, time
from both symptom onset and imaging to the initiation
of IVT, and stroke clinical risk factors (hypertension,
diabetes, coronary heart disease, atrial ﬁbrillation).
These data were collected from the patient records.
National Institutes of Health Stroke Scale (NIHSS)
score at the time of initiation of the rtPA had been
prospectively stored according to a speciﬁc protocol. A
follow-up non-contrast-enhanced computed tomogra-
phy (NCCT) and NIHSS scoring were performed for all
patients 24 h after the administration of the thrombo-
lytic agent. A hemorrhagic complication was considered
symptomatic if there was no notable (>4 points)
improvement in 24 h NIHSS compared to admission
NIHSS. Causative Classiﬁcation of Stroke (CCS) sys-
tem was used by certiﬁed CCS-rater (J.T.S.) to assess
stroke etiology [13]. Modiﬁed Rankin Scale (mRS),
scored 3 months after the stroke, was the primary
outcome measure. In the years from 2004 to 2005, the
3-month mRS score was prospectively recorded based
on a follow-up visit to neurologist and from 2006 to
2007 on a phone interview by neurologist. One patient
had not been reached with telephone or by other means.
Death during the primary university hospital episode or
discharge from neurology ward to a rehabilitation
facility was considered to signify unfavorable clinical
outcome at discharge. This status was used as the sec-
ondary outcome measure. The seven (7%) patients who
were discharged temporarily to primary health care
centers only because of adjustment of the warfarin dose
were included to the favorable discharge group along
with patients discharged directly to their homes. All the
prospectively stored clinical data were carefully evalu-
ated (J.T.S.) for possible errors.
Imaging parameters
Computed tomography scans were obtained using two
diﬀerent multidetector scanners: General Electrics
LightSpeed 16-slice (GE Healthcare, Milwaukee, WI,
USA) and Philips Brilliance 64-slice (Philips, Cleveland,
OH, USA). The imaging procedures and the parameters
used are described in our previous study available on-
line as an open-access article at the website of the
publisher [14].
Image analysis
Non-contrast-enhanced computed tomography (NCCT)
examinations were reviewed using dedicated medical
imaging workstations. The Alberta Stroke Program
Early CT Score (ASPECTS) was assessed from admis-
sion and follow-up NCCT images as described in our
previous article [14]. CTA images were analyzed with
Advantage Workstation version 3.2 (GE Healthcare).
The examinations were reviewed in the order NCCT
and CTA paralleling that of the clinical work ﬂow. The
reviewers were blinded to the clinical data apart from
the side and nature of the acute symptoms. CTA images
were studied by examining the raw data and maximum
intensity projection images.
The location of the clot was recorded based on the
most proximal position of the occlusion. The M1 seg-
ment of the MCA was divided into two parts of equal
length: the proximal and the distal half.
The principles of the Clot Burden Score (CBS)
scoring system have been described in recent studies
[8,9]. The location of the clot was determined, and CBS
was scored independently by two radiologists (N.S. and
A.L.). In cases where the scoring or the assignment
diﬀered, a consensus opinion was agreed on. Intraclass
correlation coeﬃcient (ICC) between a staﬀ radiologist
(N.S) and an experienced neuroradiologist (J.H.) for a
test sample (n = 20) for CBS was 0.87. Cohens kappa
for the location of the clot was 0.94.
Statistics
A biostatistician was consulted (H.H.). The data were
analyzed with SPSS version 18 (SPSS Inc., Chicago, IL,
USA). Group comparisons were performed using the
Student t-test, the Chi-squared test, the Fisher exact
test, and the Kruskal–Wallis test. The Bonferroni cor-
rection for multiple comparisons was applied where
necessary. Patients who had 3-month mRS £ 2 or who
were discharged to home from neurology ward were
considered to have experienced favorable clinical out-
come. Binary logistic regression modeling using these
outcome measures as the dependent variable was re-
peated for diﬀerent variables of interest. NIHSS, age,
sex, time from onset to treatment, and clinical risk
factors were examined as potential confounders and
were tested both in univariate models and with clot
location. The calibration of the models was evaluated
with the Hosmer–Lemeshow test and the discrimination
with the C statistic. Odds ratio (OR) with 95% CI was
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calculated for each covariate. Sensitivity, speciﬁcity,
and CI calculations were performed using standard
procedures. The normal and extended McNemar tests
were used to compare the overall diagnostic perfor-
mance, the sensitivities, and the speciﬁcities.
Results
Baseline characteristics
Of the 285 patients, 105 (37%) met the inclusion crite-
ria: acute anterior circulation vessel occlusion followed
by IVT. A thrombus was not detected in 142 (50%)
cases, and 38 (13%) patients had a posterior circulation
clot. The ﬁrst data column of Table 1 summarizes the
baseline characteristics of the study cohort, and the
number of patients with diﬀerent clot locations is de-
scribed in Fig. 1. The mean onset-to-treatment time
(OTT) was 132 min (SD = 27). There was one patient
(1%) with OTT > 180 min (217 min). The median
time from imaging to the initiation of IVT was 35 min.
The median preictal mRS was 1, and the median
3-month mRS was 2. There were no patients with pre-
ictal mRS > 2 in the study population. At 24 h, a local
hemorrhagic complication or parenchymal hemorrhage
distant to the site of the infarct was detected in seven
out of 105 cases (7%) in NCCT. The hemorrhage was
symptomatic in 5 (5%) cases. According to the 5-sub-
type CCS, large artery atherosclerosis was the etiology
in 23 (22%), cardiac embolism in 55 (52%), and other
uncommon cause in 6 (6%) patients. Twenty-one (20%)
patients had AIS of undetermined cause.
The location of the clot predicts the clinical outcome at
discharge and at 3 months and exhibits a dose-
response type relationship
Three months after stroke (primary outcome), patients
with more proximal clots had worse functional outcome
Table 1 Demographic and baseline characteristics of all patients and by the locus of the thrombus and outcome (mRS) at 3 months after
intravenous thrombolysis
Characteristic
All patients
(n = 105)
mRS £ 2
at day 90
(n = 54)
mRS 3–6
at day 90
(n = 50) P1
Proximal thrombus
(ICA + M1P,
n = 38)
Distal thrombus
(M1D + M2 + M3,
n = 67) P2
Age (y), mean (SD) 68.8 (13.5) 66.4 (13.1) 71.3 (13.6) 0.06 66.0 (15.1) 70.4 (12.3) 0.11
Male sex (%) 60 (57) 32 (59) 28 (56) 0.74 27 (71) 33 (49) 0.03
National Institutes
of Health Stroke Scale
(NIHSS) before
treatment,
median (IQR)
13 (10) 9 (10) 17 (7) <0.001 18 (7) 11 (10) <0.001
NIHSS 24 h after
thrombolysis,
median (IQR)
6 (14) 2 (4) 16 (11) <0.001 15 (10) 3 (7) <0.001
ASPECTS score
at admission CT,
median (IQR)
10 (2) 10 (1) 9 (2) 0.20 9 (3) 10 (2) 0.07
ASPECTS score
at 24 h CT,
median (IQR)
7 (5) 9 (3) 5 (4) <0.001 4 (5) 8 (4) <0.001
Onset-to-treatment
time (min), mean (SD)
132 (27) 133 (26) 129 (29) 0.46 131 (31) 132 (25) 0.85
Hypertension n (%) 69 (65.7) 36 (66.7) 33 (66.0) 0.94 22 (57.9) 47 (70.1) 0.20
Diabetes n (%) 17 (16.2) 6 (11.1) 11 (22.0) 0.13 8 (21.1) 9 (13.4) 0.31
Atrial ﬁbrillation n (%) 41 (39.0) 23 (42.6) 18 (36.0) 0.49 12 (31.6) 29 (43.3) 0.24
Coronary artery
disease n (%)
35 (33.3) 12 (22.2) 23 (46.0) 0.01 16 (42.1) 19 (28.4) 0.15
P1, P value between mRS £ 2 and mRS 3–6 groups; P2, P-value between proximal and distal thrombus groups.
Figure 1 Clinical outcome (3-month mRS) for different clot
locations. Good clinical outcome was deﬁned as mRS £ 2 at
3 months.
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(Fig. 1). There was a signiﬁcant increase in mortality
(32% vs. 3%, P < 0.001) and functional dependency
(82% vs. 29%, P < 0.001) in patients with an ICA or
M1P occlusion compared to a more distal occlusion.
When adjoining clot locations (ICA-M1P, M1P-M1D,
M1D-M2, M2-M3) were compared in pairs to ﬁnd
diﬀerences in the rate of favorable clinical outcome, the
largest diﬀerence in prognosis (2.5 fold) between
adjoining clot locations was found between M1P and
M1D with 24% and 59% having good clinical outcome,
respectively. This was the only diﬀerence that proved to
be statistically signiﬁcant (P = 0.01).
Evaluated at the time of discharge from the neurol-
ogy ward (secondary outcome), seven (7%) patients,
who all had either ICA or M1P occlusion, had died
during the primary hospitalization. Sixty-three (60%)
patients were discharged to a skilled nursing facility or
to a rehabilitation facility. Thirty-ﬁve (33%) patients
were discharged to their homes.
Only one patient (6%) within an ICA group and one
patient (5%) within a M1P group were discharged to
home. On the other hand, 13 (45%) patients within a
M1D group, 15 (48%) patients within a M2 group, and
5 (71%) patients within a M3 group had favorable
outcome at discharge. The results for pairwise com-
parisons between adjoining clot locations were similar
to the 3-month outcome with the diﬀerence in favorable
outcome between M1P (5%) and M1D (45%) being the
only statistically signiﬁcant one (P = 0.003).
To further assess the prognostic value of the clot
location, we performed binary logistic regression anal-
ysis using 3-month mRS dichotomized with the
threshold £2 and outcome at discharge (dichotomous)
as the dependent variables (Table 2). When the clot
location was included in the model, OTT, sex, diabetes,
hypertension, atrial ﬁbrillation, and coronary heart
disease, tested one at a time, were not statistically sig-
niﬁcant covariates. Age, NIHSS, sex, and OTT were
kept in the ﬁnal multivariate regression model and
treated as potential confounders. The latter two vari-
ables were selected only because of theoretical reasons.
The clot location was a highly signiﬁcant
(P = 0.001) predictor of good clinical outcome even
when the model was adjusted for NIHSS (Table 2).
Interestingly, when tested in the absence of the other,
the clot location resulted in a model ﬁt that was better
than that of NIHSS based on Nagelkerke R2 measure
(0.47 vs. 0.40). Setting ICA as the reference for the clot
location, the odds ratio for good clinical outcome at
3 months exhibited dose-response type behavior when
moving from a proximal vessel position to a more distal
one. The diﬀerence between ICA and M1P was not
statistically signiﬁcant (P = 0.21) whilst the diﬀerences
to more distal locations were highly signiﬁcant
(P = 0.004 for M1D and P = 0.001 for M2 and M3)
implying that the two proximal and the two distal
vessel positions behave diﬀerently. The largest diﬀer-
ence (6.5 fold) in the odds ratios of adjoining vessel
positions was between M1P and M1D. The admission
NIHSS score and age signiﬁcantly predicted the clinical
outcome.
The model was also tested using CBS instead of the
clot location. CBS was an independent predictor
(P < 0.001) having an odds ratio of 1.7 per one point
(95% CI 1.3–2.2). When CBS and the clot location were
added to the model at the same time, both variables
were rendered non-signiﬁcant.
A cut-off between M1P and M1D best differentiates
between good and poor clinical outcome
To study the context of location-based decision making,
the clot location was dichotomized using three cutoﬀs:
ICA-M1P, M1P-M1D, and M1D-M2 and M3 com-
Table 2 Logistic regression analysis for favorable clinical outcome
mRS at 3 months £2 (H–L = 0.57, C = 0.90) Discharge to home (H–L = 0.71, C = 0.86)
Odds ratio CI 95% P value Odds ratio CI 95% P value
Clot location – 0.001 – – 0.007
ICA ref ref – ref ref –
M1 Proximal 4.2 0.45–38.2 0.21 0.8 0.04–18.6 0.89
M1 Distal 27.4 2.9–257.9 0.004 31.1 2.3–417.8 0.009
M2 and M3 57.3 6.0–549.0 0.001 26.2 3.3–340.2 0.01
Onset-to-treatment time 1.0 0.98–1.02 0.81 1.0 0.99–1.03 0.52
Sex 0.49 0.15–1.6 0.23 0.86 0.29–2.5 0.77
Age 0.94 0.90–0.98 0.005 0.93 0.89–0.97 0.002
Admission National Institutes
of Health Stroke Scale (NIHSS)
0.82 0.74–0.92 0.001 0.91 0.82–0.99 0.03
H–L, Hosmer–Lemeshow signiﬁcance; C, C statistic; ref, reference location.
Odds ratios are per minute for onset-to-treatment time, per year for age, and per one point for NIHSS.
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bined. These dichotomized variables were entered into
the regression model one at a time (Table 3). In the case
of the 3-month outcome, ICA-M1P and M1P-M1D
had near equal odds ratios (17.1 vs. 16.0) with the latter
having a narrower 95% CI (2.3–129.5 vs. 3.9–66.2)
whilst the most distal cutoﬀ had a considerably smaller
odds ratio (5.5, 95% CI 1.8–16.8). When the discharge
status was the dependent variable, the cutoﬀM1P-M1D
yielded the largest odds ratio (31.0, 95% CI 4.5–215.3)
whilst again the most distal cutoﬀ had the smallest odds
ratio (2.5, 95% CI 0.98–6.7, P = 0.07).
Next, sensitivities and speciﬁcities for detecting good
clinical outcome were calculated. A clot distal to the
cutoﬀ location constituted a positive test result. The
cutoﬀ M1P-M1D had the highest diagnostic accuracy
(0.75) in predicting good clinical outcome at 3 months
(Table 4). When outcome at the discharge was ana-
lyzed, the cutoﬀ M1D-M2 and M3 combined per-
formed slightly better (0.69 vs. 0.66). This was
attributed to 34 patients (51%) having a M1D or a
more distal thrombus that were discharged into a
rehabilitation facility, whilst 3 months later only 19
(29%) of these patients had mRS £ 2. When the cutoﬀs
were tested in pairs, the overall diagnostic performance
was signiﬁcantly diﬀerent in every pair (P < 0.001 for
each pair). The diﬀerences between the sensitivities and
the speciﬁcities were all statistically signiﬁcant
(P < 0.01 for each pair) for both outcome measures
apart from the diﬀerences in the sensitivities between
the cutoﬀs ICA-M1P and M1P-M1D. The diﬀerences
in baseline characteristics between groups deﬁned by
the cutoﬀ M1P-M1D are depicted in Table 1.
Discussion
We studied the impact of the location of the clot in
predicting the clinical outcome of patients suﬀering
from AIS treated with intravenous thrombolytic
therapy. The results showed that the outcome
improved and the mortality decreased consistently
when moving from a proximal to a more distal vessel
position. The odds ratios for good clinical outcome
(3-month mRS £ 2) exhibited corresponding dose-
response type relationship in the logistic regression
analysis with ICA as the reference for the clot loca-
tion. When individual adjoining vessel locations were
tested in pairs, only the diﬀerence between M1P and
M1D proved to be statistically signiﬁcant. After
dichotomization of the clot location, a cut-point be-
tween M1P and M1D was associated with the largest
increase in the odds of favorable outcome compared
to neighboring cut-points and had the highest diag-
nostic accuracy in predicting favorable outcome.
Certain anatomic and pathophysiological factors
conceivably contribute to the last ﬁnding. First, the
lenticulostriate arteries, which supply blood to the basal
ganglia, mainly originate from the proximal M1 seg-
ment of MCA. An infarction in this region aﬀects gait,
an important component of functional independence.
Secondly, as the diameter of the MCA vessel increases
toward the proximal segment, the volume of the clot
increases substantially decreasing the eﬀectiveness of
IVT. Moreover, a proximal thrombus has the tendency
to propagate distally, which also increases the total
volume of the clot.
Table 3 Logistic regression analysis for favorable clinical outcome for different dichotomization cutoffs of clot location
Cutoff
mRS at 3 months £2 Discharge to home
Odds ratio CI 95 % P value H–L C Odds ratio CI 95 % P value H–L C
ICA/M1 Proximal 17.1 2.3–129.5 0.006 0.59 0.87 11.2 1.1–118.8 0.04 0.84 0.80
M1 Proximal/M1 Distal 16.0 3.9–66.2 <0.001 0.68 0.89 31.0 4.5–215.3 0.001 0.47 0.87
M1 Distal/M2 and M3 5.5 1.8–16.8 0.003 0.87 0.86 2.5 0.93–6.7 0.07 0.82 0.79
H–L, Hosmer–Lemeshow signiﬁcance; C, C statistic.
The model was adjusted for age, onset-to-treatment time, sex, and National Institutes of Health Stroke Scale. The proximal vessel location is the
reference.
Table 4 Diagnostic accuracies of different dichotomization cutoffs for clot location in predicting favorable clinical outcome
Cutoff
mRS at 3 months £2 Discharge to home
Se CI 95% Sp CI 95% Acc Se CI 95% Sp CI 95% Acc
ICA/M1 Proximal 0.96 0.86–0.99 0.30 0.18–0.45 0.64 0.97 0.83–1.00 0.23 0.14–0.35 0.48
M1 Proximal/M1 Distal 0.87 0.74–0.94 0.62 0.47–0.75 0.75 0.94 0.79–0.99 0.51 0.39–0.63 0.66
M1 Distal/M2 and M3 0.56 0.41–0.62 0.86 0.73–0.94 0.70 0.57 0.40–0.73 0.74 0.62–0.84 0.69
Se, sensitivity; Sp, speciﬁcity; Acc, accuracy.
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Two classiﬁcation methods based in part on the
location of the clot have been introduced recently
[7–10]. These scoring schemes are correlated with the
clinical outcome. We found that CBS was an indepen-
dent predictor of good clinical outcome and that per-
formed comparably to the clot location. Some studies
have previously addressed the eﬀect of the clot location
on recanalization and the clinical outcome in the
anterior circulation AIS in the context of IVT. Del
Zoppo et al. [1] used DSA to ﬁnd that the M2 and M3
segments are more likely to undergo recanalization than
the M1 segment and ICA. Saqqur et al. [3] arrived at
similar results in a more recent work utilizing repeated
transcranial Doppler ultrasonography in studying
recanalization and its eﬀect on clinical outcome at
3 months. Diﬀerent parts of the M1 segment were not
addressed. However, the rate of good outcome at M1P
in our study was comparable to that of the proximal
MCA and M1D to that of the distal MCA in these
studies. Still other studies with more heterogeneous
setups have reported that large vessel occlusions are less
likely to recanalize and predict poor clinical outcome
[2, 5, 6].
An observational study by Mattle et al. [15] com-
pared intra-arterial thrombolysis to IVT in patients
with hyperdense middle cerebral artery sign, a sign of
proximal occlusion of the MCA, and found intra-arte-
rial thrombolysis to be more beneﬁcial. In a recent re-
port, multimodal therapy resulted in the highest
recanalization rates of anterior circulation clots [16].
Moreover, according to a scientiﬁc statement from the
American Heart Association, it would be ideal to ob-
tain vascular imaging studies such as CTA to poten-
tially triage patient to primary intra-arterial therapies if
an endovascular team is available and undue delay is
not caused [17]. CTA can also be used to guide bridging
therapy even if immediate IVT is preferred as the
therapy of choice [18]. In our study population,
the rate-limiting step was waiting for the results of the
mandatory laboratory parameters, not the multimodal
CT imaging. Interestingly, the onset-to-treatment time
was not a signiﬁcant determinant of clinical outcome
(Table 2).
Owing to the retrospective study design, selection
bias is a potential limitation of this study, and data on
vessel recanalization were not available. Even so, a low
ASPECTS score at 24 h NCCT and poor clinical out-
comes are intimately related to delayed or failed
recanalization and can be used as a surrogate.
The results of this study show that the outcome of
acute ICA and proximal M1 segment occlusion is
generally poor even if treated with intravenous throm-
bolysis and that a cut-point between proximal and
distal M1 segment best diﬀerentiates between good and
poor clinical outcome and has the highest accuracy in
predicting good clinical outcome. These ﬁndings sup-
port the notion that alternative treatment strategies,
primary intra-arterial, or bridging therapy, should be
taken into consideration if the thrombus is located in
the ICA or in the proximal M1 segment. Vascular
imaging at the admission is required to guide this
decision. Veriﬁcation of these results with prospective
studies is necessary, optimally in a randomized setup.
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Abstract 
Purpose: Perfusion computed tomography (PCT) is increasingly performed in multimodal CT 
evaluation of acute ischemic stroke. We compared the technical quality of perfusion studies 
performed with a 16-row and a 64-row scanner and analyzed the differences between the 
scanners in their ability to detect perfusion defects. 
Methods: We analyzed retrospectively the clinical and imaging data of 140 consecutive acute 
(<3h) stroke patients who underwent multimodal CT evaluation and received intravenous rtPA. 
Alberta Stroke Program Early CT Score (ASPECTS) was assigned to PCT maps. Clinical and imaging 
parameters were compared between the two scanners. 
Results: There were more motion artifacts in the 16-row studies (p=0.04) and the analysis 
software was able to completely correct significantly fewer of these (p<0.001). Both ASPECTS 
levels were optimally covered in only 29% of the 16-row studies whereas in the 64-row studies 
both levels were invariably optimally visualized (p<0.001). This significantly decreased the 
sensitivity of the 16-row scanner to detect perfusion defects in the upper ASPECTS level (p=0.02). 
The 64-row scanner was able to detect more perfusion defects that were located entirely outside 
the ASPECTS regions (p=0.03). There was no significant difference in the 3-month functional 
outcome. 
Conclusions: The 16-row scanner suffered from limited anatomic coverage that decreased the 
sensitivity to detect perfusion defects in the cranial parts of the middle cerebral artery region. The 
16-row studies had poorer technical quality that was in part attributable to higher sampling 
frequency and smaller slice thickness making the imaging more sensitive to small scale movement 
of the patient. 
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Abbreviation key: AIF = arterial input function, ASPECTS = Alberta Stroke Program Early CT Score,  
CBV = cerebral blood volume, MCA = middle cerebral artery, MRI = magnetic resonance imaging, 
MTT = mean transit time, NCCT = non-contrast-enhanced computed tomography, NIHSS = National 
Institutes of Health Stroke Scale, mRS = modified Rankin Scale, PCT = perfusion computed 
tomography, rtPA = recombinant tissue plasminogen activator, VOF = venous output function 
 
Key words: computed tomography perfusion, thrombolytic therapy, stroke 
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Introduction 
Multimodal CT imaging may improve the prognosis of acute stroke patients especially in the 
context of revascularization therapy [1]. The heart of the multimodal approach is the perfusion 
study which allows the detection of the infarct core and the penumbra and the quantification of 
salvageable brain tissue. This can be accomplished with high accuracy and full anatomic coverage 
by using perfusion and diffusion weighted MRI [2-4]. However, the availability of MRI in an acute 
setting is scarce and motion artifacts and length of the study induce limitations. Perfusion CT (PCT) 
has emerged as an alternative to MRI [5-8]. The pathophysiologic information obtained from PCT 
is comparable to that of MRI [9-10]. 
The main disadvantages of PCT are limited craniocaudal (z-axis) anatomic coverage, typically 20 to 
80mm with 16- and 64-row scanners, and insensitivity in detecting lacunar ischemic events [11-
12]. State-of-the-art scanners can achieve whole brain coverage [13], but the bulk of acute stroke 
imaging will be performed with 16- and 64-row scanners for several years to come.  
The impact of using CT scanners of differing detector widths and acquisition protocols in the 
imaging evaluation of stroke has been little studied previously in the context of acute 
revascularization therapy. We reviewed retrospectively the clinical and imaging data of 140 
consecutive acute (<3h) ischemic stroke patients who underwent full multimodal CT assessment 
with either a 64-row or a 16-row scanner and received intravenous thrombolytic therapy. We 
compared the technical quality of the perfusion studies and analyzed the differences in the ability 
to detect perfusion defects between the two scanners. We hypothesized that the 16-row scanner 
might miss information potentially critical to the clinical decision making when compared to the 
64-row scanner. 
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Materials and Methods 
Overview 
We analyzed retrospectively the clinical and imaging data of 140 consecutive patients who were 
admitted to Tampere University Hospital between January 2006 and December 2007 because of 
acute (duration <3h) strokelike symptoms, imaged with non-contrast computed tomography 
(NCCT) and PCT and who subsequently received intravenous recombinant tissue plasminogen 
activator (rtPA) to treat acute ischemic stroke. The patients were scanned with either a 64-row or 
a 16-row scanner located in neighboring rooms. Although the patients were not explicitly 
randomized to be imaged with either scanner, the selection of the scanner was effectively 
random. The decision to administer thrombolytic therapy was based on institutional guidelines 
that did not have PCT derived parameters as exclusion or inclusion criteria at the time. Standard 
intravenous rtPA administration scheme was used: Actilyse (Boehringer-Ingelheim, Ingelheim, 
Germany), total dose 0.9 mg/kg from which 10% given as a bolus and the remaining 90% as a 
continuous infusion for 1h. A follow-up NCCT was performed for all patients 24h after the 
administration of the thrombolytic agent. National Institutes of Health Stroke Scale (NIHSS) was 
assessed at the admission and 24h after the thrombolytic therapy. Modified Rankin Scale (mRS) 
was evaluated preictally and on day 90. The clinical data was stored prospectively to the patient 
records during the hospital stay and on day 90 after the ictus, the latter following a phone 
interview. This data was collected from the patient records and critically reviewed for errors using 
the data available from all medical and related disciplines. The study was approved by (**) 
Hospital ethics committee. 
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Imaging parameters 
CT scans were obtained using two different multidetector scanners:  General Electrics LightSpeed 
16-row (GE Healthcare, Milwaukee, Wis) and Philips Brilliance 64-row (Philips, Cleveland, Oh). 
Brain NCCT was performed using the parameters 120 kV, 430 mAs, collimation 12 x 1.25mm, 
rotation 1.5s (64-row) or 120kV, 320mAs, collimation 16 x 1.25mm, rotation 1s (16-row). 
Contiguous slices were reconstructed to the thickness of 5mm in the whole scanning range (64-
row) or to the thickness of 5mm in the skull base and 7.5mm in the supratentorial region (16-row). 
PCT was performed using the parameters 80kV, 200mAs (effective), collimation 32 x 1.25mm, 
rotation 0.4s (64-row) or 80kV, 200mAs, collimation 8 x 2.5mm, rotation 1s (16-row). 120 slices 
covering a range of 80mm were generated in 55s using a protocol utilizing two alternating table 
positions to increase z-axis coverage, i.e. ‘shuttle mode’ (64-row), or 200 slices covering a range of 
20mm were generated in 50s with a stationary table position (16-row). Contiguous slices were 
reconstructed to the thickness of 10mm (64-row) or to the thickness of 5mm (16-row) at even 
time intervals. The imaging range was positioned so that the Alberta Stroke Program Early CT 
Score (ASPECTS) levels [14] would be covered. The rest of the 80mm range (64-row) was 
positioned both cranial and caudal to the ASPECTS levels with the exact balancing depending on 
the clinical presentation. The contrast agent (Xenetix 350 mgI/ml, Aulnay-sous-Bois, France) was 
administered through an antecubital 18G cannula using a double piston power injector with a flow 
rate of 5ml/s using 60ml of contrast agent followed by a 40ml saline flush. 
 
Image analysis 
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The NCCT examinations were reviewed using dedicated medical imaging workstations. The PCT 
images were analyzed and areas and volumes were measured with Advantage Workstation 
version 3.2 (GE Healthcare). Parametric perfusion maps – mean transit time (MTT) and cerebral 
blood volume (CBV) – were generated with the CT Perfusion 3 software (GE Healthcare) that uses 
a deconvolution based algorithm. The anterior cerebral artery (ACA) was used as a source for the 
arterial input function (AIF) and the region of interest for the venous output function (VOF) was 
positioned in the superior sagittal sinus.  These curves were considered noisy if there was a clear 
dip or spike in the curve potentially affecting the calculations. Minor rippling of the signal, 
although a phenomenon caused by noise sources, was not recorded as noise in this context. 
Persisting poor image quality was corrected when feasible by manually adjusting the parameters 
that control the motion artifact correction algorithm of the software. 
The use of ASPECTS in reporting and quantifying the PCT findings was dictated by the limited 
anatomic coverage of the 16-row scanner and the differing slice thicknesses. ASPECTS offers an 
attracting measure of coverage as it has been designed to reflect most of the volume of the 
middle cerebral artery (MCA) territory. It also has clinical relevance. The principles of ASPECTS 
scoring in NCCT and PCT maps and the evaluation of PCT ASPECTS mismatch (core-penumbra 
mismatch) have been described in previous studies [11, 14-15]. In short, each hemisphere is 
divided to 10 regions in two axial sections at the level of the basal ganglia (the ganglionic level) 
and corona radiata (the supraganglionic level). Each of these regions has a score of one point. This 
point is deducted if the region has ischemic changes. Thus a negative finding yields a score of 10 
and extensive ischemia covering the whole MCA region yields a score of 0. The location of the 
image section closest to a ASPECTS level was considered suboptimal if the location did not exactly 
correspond to the reference level described in the literature [14] but allowed reliable scoring. 
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ASPECTS was considered not interpretable if this section clearly represented a different anatomic 
region, for example the cranial parts of the basal ganglia when evaluating the upper level. 
MTT maps were used to detect tissue at risk and CBV maps were used to approximate the infarct 
core. We adopted a semiquantitative approach where the presence of a perfusion defect was 
determined from color coded maps visually by comparing the appearance of the affected location 
to that of the healthy tissue on the contralateral side. In order to increase the accuracy of the 
measurements and based on theoretical considerations we required that the area measured in the 
visually identified location was larger than 25mm2 with mean MTT>7s (or mean CBV<2.5 mL/100g, 
correspondingly). The technical quality of the study was assessed, the NCCT and PCT ASPECTS 
scores were assigned and the other imaging parameters were evaluated by two radiologists. In 
cases where the findings differed, a consensus was agreed on. These findings were correlated with 
the original report issued by an experienced neuroradiologist and if significant discrepancies were 
present that neuroradiologist was further consulted. The examinations were reviewed in the order 
NCCT first and then PCT paralleling that of the clinical work flow. The reviewers were blinded to 
the clinical data apart from the side and nature of the acute symptoms. Perfusion defect areas and 
final infarct volumes were measured by one radiologist. The boundaries of the affected areas were 
determined visually and absolute value thresholds described above were applied. Volume was 
calculated by multiplying the measured area with the slice thickness. Intraclass correlation 
coefficients (ICC) between a staff radiologist and an experienced neuroradiologist were calculated 
for ASPECTS assignments in a test sample (n=20): ICCNCCT=0.86, ICCMTT=0.79, ICCCBV=0.73 and 
ICCNCCT24h=0.93.  Median interobserver agreement indices for areas and volumes were AREAMTT: 
68%, AREACBV: 90% and VOLUMEINFARCT: 80%. 
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Statistics 
The data was analyzed with SPSS version 18 (SPSS Inc., Chicago, Ill). Patients with mRS≤2 at 90 
days were considered to have experienced good clinical outcome. Group comparisons were 
performed by using the Student t-test, the Mann-Whitney U test, the Chi-squared test and the 
Fisher exact test depending on the variable analyzed. The Bonferroni correction was applied to 
adjust for multiple comparisons. 
 
Results 
Baseline characteristics 
The median age of the patients was 71 years (interquartile range 58-80 years, 45% female). The 
64-row scanner was used to perform the perfusion study with 67 patients (48%). A perfusion 
defect could be detected in the ASPECTS levels in 70 cases (50%). An additional 9 perfusion defects 
were found outside the ASPECTS levels. In total, a perfusion defect could be demonstrated in 56% 
of the PCT studies.  Based on the clinical features and the imaging studies, in 16 of the 140 
patients evaluated (11%) the ischemic episode involved the posterior circulation.  
The median NIHSS score at the admission was 7 (interquartile range 4-12, 54% had NIHSS<8, 13% 
had NIHSS>15) and 24h later the median score was 2. The median mRS was 1 preictally and 2 
three months later. Seventy-seven percent of the patients experienced favorable clinical outcome 
at 90 days (mRS≤2). At 24h a local hemorrhagic complication (HI1, HI2, PH1 or PH2) was detected 
in 5 cases (3.6%) and 4 patients (2.9%) had parenchymal hemorrhage distant to the site of the 
infarct (PHr1 or PHr2).  
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The differences in age, admission NIHSS, prestroke mRS, total infarct volume at 24h, number of 
hemorrhagic complications or onset-to-treatment times were not statistically significant between 
the patients imaged with the 64-row and the ones examined with the 16-row scanner (Table 1). 
Further, the clinical outcome (mRS at 90 days) was not significantly different in these groups. 
There were significantly fewer females in the 16-row group (p=0.02). 
 
Comparison of the technical quality of the perfusion studies 
The 16-row studies suffered in quality because of limited anatomic coverage (20mm vs. 80mm) 
and higher sampling frequency (1/s vs. 0.27/s) that combined with smaller slice thickness (5mm vs. 
10mm) rendered the image acquisition more susceptible to motion artifacts. Six studies out of 140 
(4%) were deemed not reliably interpretable because of severe motion artifacts and/or because 
AIF and/or VOF did not peak during the scan due to hemodynamic or technical reasons (Table 2). 
While all of these studies were performed with the 16-row scanner (p=0.03), there were no 
statistically significant differences between the scanners in AIF or VOF not peaking. However, the 
AIF and the VOF curves were significantly noisier in the 16-row studies (p<0.001). This is in part 
related to the larger number of motion artifacts in the 16-row group (p=0.04). The analysis 
software was able to completely correct significantly fewer of these artifacts in the 16-row group 
(p=0.001). A typical artifact resulting from minute movement (eg. tremor) that was incompletely 
corrected by the software but that did not render the study uninterpretable is demonstrated in 
Figure 1. Both ASPECTS levels were optimally covered in only 29% of the 16-row studies whereas 
in the 64-row studies both levels were optimally included in the imaging volume in every case 
(p<0.001). In 46 of the 16-row studies (63%) only the lower level was optimally covered. ASPECTS 
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could not be reliably assigned for the upper level because of this in 26 cases (34%). There were 2 
cases (3%) where the lower level could not be scored. Suboptimal slice orientation due to 
anteroposterior or lateral tilt was found in 9 studies (6%) with no significant differences between 
the scanners. The 64-row scanner was able to fully or partially visualize also the subtentorial 
compartment significantly more often because of the larger craniocaudal coverage (p<0.001). 
 
Comparison of the perfusion defect detection properties 
There were no statistically significant differences between the scanners in the ASPECTS scores for 
MTT and CBV maps or the ASPECTS mismatch scores (Table 3). Nor were there significant 
differences when the upper and the lower ASPECTS levels were analyzed individually. When the 
ASPECTS regions that were missed by the 16-row scanner because of limited anatomic coverage 
were scored normal and included in the analysis, the average number of regions affected in the 
upper level diminished reflecting decreased sensitivity in the detection. In the case of MTT the 
difference became statistically significant when compared to the 64-row scanner (p=0.02). 
However, there were no significant differences between the scanners in the total MTT and CBV 
scores or the mean and number of ASPECTS mismatches in this setting either.  
There were in total 9 patients (6%) who had perfusion defects that were located entirely outside 
the regions covered by the ASPECTS levels and the volume between the levels (Table 3). Eight of 
them were detected by the 64-row scanner (p=0.03). 
 
Discussion 
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We compared the technical quality of perfusion studies performed with a 16-row and a 64-row 
scanner and analyzed the differences between the scanners in their ability to detect perfusion 
defects in a clinically managed intravenous thrombolytic therapy cohort.  
The 64-row scanner covered 80mm of the z-axis while the 16-row scanner covered 20mm. The 
coverage of the 64-row scanner was increased by alternating the table between two positions. 
This procedure can be utilized also with 16-row scanners resulting in 40-mm-coverage. Another 
method to double the imaging volume is to use two contrast injections and image adjoining 20mm 
ranges separately. While these techniques improve the detection rate of perfusion defects, the 
results are still inferior compared to z-axis ranges larger than 40mm [16, 17].   
The selection of the scanner the patient was imaged with was based on availability or the 
preferences of the imaging nurses performing the scanning procedure when both scanners were 
available. Although the patients were not explicitly randomized to be imaged with either scanner, 
effectively randomization took place as the presence of a selection bias is very unlikely. This is 
reflected by close to equal number of PCT studies performed with the scanners during the 2 years 
and the similarity of other baseline characteristics between the study groups (Table 1). 
The 16-row studies suffered in quality because of limited anatomic coverage that often resulted in 
inadequate visualization of the cranial MCA region evident in the finding that ASPECTS could not 
be assigned to the upper level in one-third (34%) of the studies (Table 2). This led to significantly 
decreased sensitivity in the detection of perfusion defects in the upper level (Table 3). However, 
this has only a mild impact in the overall ASPECTS score as the lower level is weighted considerably 
heavier (7 vs. 3 regions). Further, there were no significant differences in the number and extent 
of perfusion mismatches found (Table 3). The 64-row scanner was able to discover a significantly 
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larger number of perfusion defects entirely outside the volume limited by the ASPECTS levels 
(Table 3). 
Some studies have previously addressed the impact of different z-axis ranges in the detection of 
perfusion defects. Using a 320-row scanner Page et al. found that 160-mm-coverage better 
defined the extent of the infarct core and the penumbra compared to 40-mm-coverage [17]. 
Morhard et al. observed that 20-mm-coverage missed 24.1% of pathological findings when 
compared to 96-mm-coverage [18]. Furtado et al. found that z-axis coverage of 75mm is required 
to reliably detect a perfusion mismatch ratio of 0.5 while 50mm was sufficient when a ratio of 0.2 
is used [16]. Fifty-five mm need to be covered to estimate if more than one-third of the MCA 
region is involved. However, if this coverage is not achieved, rules based on ASPECTS provide 
potential alternatives for excluding patients from thrombolytic therapy [11, 14-15]. Youn et al. 
reported that 80-mm-coverage had significantly higher lesion detection rate compared to 20-mm-
coverage [19]. Our results are in congruence with these previous findings. While all these studies 
had somewhat heterogeneous populations and simulated narrower coverage by selecting ranges 
of larger volumes imaged with one scanner, we studied patients that all received intravenous 
revascularization therapy and compared two scanners with different detection widths. 
The limited coverage of a 16-row device makes the positioning of the perfusion imaging volume a 
crucial factor as small offsets from the optimal placement, minor patient movement after the 
acquisition of the scout image and disadvantageous slice orientation can mean that either of the 
ASPECTS levels escapes visualization. Our institution had 18 months experience in routinely 
performing multimodal stroke evaluations before the study population was imaged so operator 
inexperience probably plays only a minor role. 
14 
 
Another quality issue was the movement artifacts that were significantly more abundant and 
severe in the 16-row group (Table 2). This can be mainly attributed to higher sampling frequency 
(1/s vs. 0.27/s) and smaller slice thickness (5mm vs. 10mm) which seems to make the capture of 
small scale periodic patient movements like tremor, swallowing, nodding and minor swinging of 
the head more frequent. This type of movement was poorly corrected by the analysis software. 
While this does not render the study uninterpretable, it introduces inaccuracies to the 
measurement of absolute values of the perfusion parameters. On the other hand, lower sampling 
frequency potentially has this same effect and larger slice thickness may decrease the sensitivity of 
the detection of small perfusion defects because of averaging. Interestingly, the motion artifacts 
often coincided with the arrival of the contrast bolus to the central nervous system emphasizing 
the importance of instructing the patient. 
There was no significant difference in the clinical outcome between the study groups (Table 1). 
This is to be expected as our institutional guidelines on management of stroke did not define any 
role for PCT findings at the time and so the treatment was essentially the same in both groups.   
Our study is limited by retrospective design. There was minor heterogeneity in the details of 
conventional stroke treatment which is to be expected in a clinically managed population. There 
were significantly fewer females in the 16-row group. This can be attributed to chance as no 
selection process that would potentially produce this result could be identified. 
In conclusion, PCT studies performed with the 16-row scanner suffered from limited anatomic 
coverage that decreased the sensitivity to detect perfusion defects in the cranial parts of the MCA 
region when compared to the 64-row scanner. The 16-row studies also had more motion artifacts 
resulting from small scale periodic patient movements possibly due to higher sampling frequency. 
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However, the potential impact of these findings seems to be limited as there were no statistically 
significant differences in the total ASPECTS scores or the number of perfusion mismatches found. 
On the other hand, extensive z-axis coverage allows near comprehensive evaluation of both the 
anterior and the posterior circulation. The possible benefits of the larger z-axis coverage have to 
be balanced with the radiation exposure. 
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Figure 1: A typical artifact in a 16-row study resulting from minute movement that was 
incompletely corrected by the software. The serrated appearance of the contour of the time-
density curve is a result of small scale movement of the head (Panel a). Especially the segments 
where the rate of change of the density is slow are affected. Panel b demonstrates this movement 
between consecutive acquisitions of the same 5mm slice 1s apart in the surroundings of the 
region-of-interest of the AIF positioned in the left anterior cerebral artery. There is minor rotation 
of the head in the axial plane. A typical smooth time-density curve obtained with the 64-row 
scanner is shown in Panel c. 
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Table 1. Baseline characteristics in the 64-row and the 16-row groups. All values mean ± SD or 
number of patients (percentage). 
 64-row (n = 67) 16-row (n = 73) p 
Age 67.1 ± 14.4 70.0 ± 13.7 0.22 
Female gender 37 (55%) 26 (36%) 0.02 
Admission NIHSS  8.4 ± 6.1 8.5 ± 6.0 0.92 
mRS, prestroke  0.6 ± 0.8 0.9 ± 0.8 0.10 
mRS ≤2 at 90 days 51 (76%) 57 (78%) 0.78 
Total infarct volume at 24h (ccm) 23.0 ± 54.2 20.7 ± 42.4 0.77 
Hemorrhagic complication 4 (6%) 4 (5%) 0.90 
Onset-to-treatment time (min) 133 ± 27 131 ± 28 0.74 
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Table 2. Comparison of the technical quality of the perfusion studies. AIF = Arterial Input 
Function, ASPECTS = Alberta Stroke Program Early CT Score, VOF = Venous Output Function. 
 64-row (n = 67) 16-row (n = 73) p 
Both ASPECTS levels optimally covered 67 (100%) 21 (29%) < 0.001 
Motion artifacts 36 (54%) 52 (71%) 0.04 
Incompletely corrected motion artifacts 8 (12%) 33 (42%) 0.001 
Noisy AIF and/or VOF 1 (1%) 28 (38%) < 0.001 
Arterial phase not finished 2 (3%) 4 (5%) 0.68 
Venous phase not finished 5 (7%) 7 (10%) 0.77 
Multiple boluses 0 (0%) 1 (1%) 1.00 
Suboptimal slice orientation 2 (3%) 7 (10%) 0.17 
Subtentorial parenchyma not visualized 1 (1%) 31 (42%) < 0.001 
ASPECTS score not interpretable 0 (0%) 31 (42%) < 0.001 
Study not reliably interpretable 0 (0%) 6 (8%) 0.03 
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Table 3. Comparison of the perfusion defect detection properties. The ‘16-row (n=67)’ column 
heading refers to the inclusion of patients with ASPECTS regions that were missed by the 16-row 
scanner because of limited anatomic coverage. These regions were scored normal. In the n = 42 
population these patients were excluded. p1: 64-row (n=67) vs. 16-row (n=42), p2: 64-row (n=67) vs. 
16-row (n=67). ASPECTS = Alberta Stroke Program Early CT Score, CBV = Cerebral Blood Volume, 
MTT = Mean Transit Time, NCCT = Non-contrast Computed Tomography.  
 64-row (n = 67) 16-row (n = 42) p1 16-row (n = 67) p2 
ASPECTS regions affected    
    MTT lower ASPECTS level (mean ± SD)  1.4 ± 2.0 1.1 ± 1.6 0.74 1.5 ± 2.0 0.74 
    MTT upper ASPECTS level (mean ± SD) 0.9 ± 1.1 0.7 ± 1.1 0.54 0.5 ± 1.0 0.02 
    CBV lower ASPECTS level (mean ± SD) 0.7 ± 1.4 0.5 ± 1.2 0.35 0.6 ± 1.2 0.77 
    CBV upper ASPECTS level (mean ± SD) 0.3 ± 0.7 0.3 ± 0.7 0.87 0.2 ± 0.6 0.25 
ASPECTS score       
    MTT (mean ± SD) 7.8 ± 3.0 8.2 ± 2.6 0.70 7.9 ± 2.8 0.97 
    CBV (mean ± SD) 9.0 ± 1.9 9.2 ± 1.7 0.50 9.0 ± 2.0 0.85 
    NCCT 24h (mean ± SD) 8.3 ± 2.6 8.7 ± 1.9 1.00 8.6 ± 2.1 0.99 
    ASPECTS mismatch (mean ± SD) 1.2 ± 2.0 1.0 ± 1.3 0.98 1.2 ± 2.0 0.92 
Number of patients        
    ASPECTS mismatch present (%) 28 (42%) 19 (45%) 0.72 30 (45%) 0.73 
    Perfusion defect not in ASPECTS regions (%) 8 (12%) 1 (2%) 0.15 1 (1%) 0.03 
    Perfusion mismatches in total (%) 36 (54%) 20 (48%) 0.53 31 (46%) 0.39 
 
 
